09/12/2025 | Press release | Distributed by Public on 09/12/2025 14:07
Table of Contents
Table of Contents
|
(1)
|
elect the eleven nominees named in the attached proxy statement as directors to serve until the next annual meeting of stockholders, and until their respective successors are elected and qualified;
|
(2)
|
cast an advisory vote to approve our named executive officer compensation ("Say on Pay");
|
(3)
|
approve the adoption of the Lam 2025 Stock Incentive Plan;
|
(4)
|
ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026;
|
(5)
|
approve an amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law; and
|
(6)
|
vote on the stockholder proposal described in this proxy statement, if properly presented at the annual meeting.
|
Table of Contents
|
|
|
|
|
|
Notice of 2025 Annual Meeting of Stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
Category
|
|
|
Details
|
|
|
Date and Time
|
|
|
Tuesday, November 4, 2025
9:30 a.m. Pacific Time
|
|
|
Place
|
|
|
Via the Internet at virtualshareholdermeeting.com/
LRCX2025
|
|
|
Record Date
|
|
|
Only stockholders of record at the close of business on September 5, 2025, the "Record Date," are entitled to notice of, and to vote at, the annual meeting.
|
|
|
|
|
|
|
|
|
|
|
|
Elect Electronic Delivery
|
|
|
Save Time, Money, & Trees
|
|
|
As part of our efforts to be an environmentally responsible corporate citizen, we encourage Lam stockholders to voluntarily elect to receive future proxy and annual report materials electronically.
|
|
|
• If you are a registered stockholder, please visit enroll.icsdelivery.com/lrcxfor simple instructions.
|
|
|
• If you are a stockholder who owns stock through a broker or brokerage account, please opt for e-delivery at enroll.icsdelivery.com/lrcxor by contacting your nominee.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
#
|
|
|
Proposal
|
|
|
Our Board's
Recommendation
|
|
|||
|
1.
|
|
|
Election of 11 directors to serve until the next annual meeting of stockholders, and until their respective successors are elected and qualified
|
|
|
|
|
|
FOReach Director Nominee
|
|
|
2.
|
|
|
Advisory vote to approve our named executive officer compensation
|
|
|
|
|
|
FOR
|
|
|
3.
|
|
|
Approval of the adoption of the Lam 2025 Stock Incentive Plan
|
|
|
|
|
|
FOR
|
|
|
4.
|
|
|
Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026
|
|
|
|
|
|
FOR
|
|
|
5.
|
|
|
Approval of an amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law
|
|
|
|
|
|
FOR
|
|
|
6.
|
|
|
Stockholder proposal, if properly presented at the meeting
|
|
|
|
|
|
AGAINST
|
|
|
Transaction of such other business as may properly come before the annual meeting (including any adjournment or postponement thereof)
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By internet
|
|
|
By phone
|
|
|
By mail
|
|
|
|
|
|
|
|
Table of Contents
|
|
|
|
|
|
|
Proxy Statement Summary
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
About Lam Research Corporation
|
|
|
1
|
|
|
Fiscal Year 2025 Financial Highlights
|
|
|
2
|
|
|
Proposals and Voting Recommendations
|
|
|
2
|
|
|
Summary Information Regarding Director Nominees
|
|
|
3
|
|
|
Director Nominee Composition Highlights
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director Nominee Key Qualifications, Skills, and Experiences
|
|
|
4
|
|
|
Corporate Governance Highlights
|
|
|
6
|
|
|
Executive Compensation Highlights
|
|
|
7
|
|
|
Environmental, Social and Governance Highlights
|
|
|
8
|
|
|
2025 Stock Incentive Plan Highlights
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Ownership
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Security Ownership of Certain Beneficial Owners and Management
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Governance Matters
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Governance
|
|
|
13
|
|
|
Corporate Governance Policies
|
|
|
13
|
|
|
Our Approach to Ensuring Board Effectiveness
|
|
|
13
|
|
|
Board Nomination Policies and Procedures
|
|
|
15
|
|
|
Director Independence Policies
|
|
|
16
|
|
|
Leadership Structure of the Board
|
|
|
16
|
|
|
Other Governance Practices
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Meeting Attendance
|
|
|
17
|
|
|
Board Committees
|
|
|
18
|
|
|
Board's Role and Engagement
|
|
|
19
|
|
|
Stockholder Engagement
|
|
|
22
|
|
|
Culture and Human Capital Management
|
|
|
23
|
|
|
Environmental, Social, and Governance
|
|
|
24
|
|
|
Director Compensation
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation Matters
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Compensation and Other Information
|
|
|
29
|
|
|
Compensation Discussion and Analysis (see Table of Contents on page 29 )
|
|
|
29
|
|
|
Compensation Committee Report
|
|
|
54
|
|
|
Compensation Committee Interlocks and Insider Participation
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Compensation Tables
|
|
|
55
|
|
|
CEO Pay Ratio
|
|
|
64
|
|
|
Pay Versus Performance
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit Matters
|
|
|
70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit Committee Report
|
|
|
70
|
|
|
Relationship with Independent Registered Public Accounting Firm
|
|
|
71
|
|
|
Annual Evaluation and Selection of Independent Registered Public Accounting Firm
|
|
|
71
|
|
|
Change in Independent Registered
Accounting Firm
|
|
|
71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Billed by Ernst & Young LLP
|
|
|
72
|
|
|
Policy on Audit Committee Pre-Approval of Audit and Non-Audit Services
|
|
|
72
|
|
|
Certain Relationships and Related Party Transactions
|
|
|
72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Voting Proposals
|
|
|
73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal No. 1: Election of Directors
|
|
|
73
|
|
|
2025 Nominees for Director
|
|
|
74
|
|
|
Proposal No. 2: Advisory Vote to Approve Our Named Executive Officer Compensation
|
|
|
85
|
|
|
Proposal No. 3: Approval of the Adoption of the Lam 2025 Stock Incentive Plan
|
|
|
86
|
|
|
Securities Authorized for Issuance under Equity Compensation Plans
|
|
|
93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal No. 4: Ratification of the Appointment of our Independent Registered Public Accounting Firm for Fiscal Year 2026
|
|
|
94
|
|
|
Proposal No. 5: Approval of an Amendment to the Company's Restated Certificate of Incorporation to Limit the Liability of Certain Officers as Permitted by Delaware Law
|
|
|
95
|
|
|
Proposal No. 6: Stockholder Proposal
|
|
|
97
|
|
|
Other Voting Matters
|
|
|
100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Voting and Meeting Information
|
|
|
101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Information Concerning Solicitation and Voting
|
|
|
101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Meeting Information
|
|
|
103
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendices
|
|
|
A-1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendix A - Lam 2025 Stock Incentive Plan
|
|
|
A-1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendix B - Information Regarding Non-GAAP Financial Measures
|
|
|
B-1
|
|
|
|
|
|
|
|
Table of Contents
|
|
Proxy Statement Summary
|
Lam Research Corporation 2025 Proxy Statement 1
|
Table of Contents
•
|
our focus on research and development, with several ongoing programs relating to sustaining engineering, product and process development, and concept and feasibility;
|
•
|
our ability to effectively leverage cycles of learning from our broad installed base;
|
•
|
our collaborative focus with semi-ecosystem partners, including our close-to-customer focus;
|
•
|
our ability to identify and invest in the breadth of our product portfolio to meet technology inflections; and
|
•
|
our focus on delivering our multi-product solutions with a goal to enhance the value of Lam's solutions to our customers.
|
(1)
|
Figures for capital returned to stockholders and amounts repurchased include brokerage fees and commissions and excise taxes.
|
|
|
|
|
|
|
|
Voting Matters
|
|
|
Board Vote
Recommendation
|
|
|
Proposal No. 1: Election of Directors
|
|
|
FOReach nominee
|
|
|
Proposal No. 2: Advisory Vote to Approve Our Named Executive Officer Compensation
|
|
|
FOR
|
|
|
Proposal No. 3: Approval of the Adoption of the Lam 2025 Stock Incentive Plan
|
|
|
FOR
|
|
|
Proposal No. 4: Ratification of the Appointment of KPMG LLP as our Independent Registered Public Accounting Firm for Fiscal Year 2026
|
|
|
FOR
|
|
|
Proposal No. 5: Approval of an Amendment to the Company's Restated Certificate of Incorporation to Limit the Liability of Certain Officers as Permitted by Delaware Law
|
|
|
FOR
|
|
|
Proposal No. 6: Stockholder proposal, if properly presented at the annual meeting
|
|
|
AGAINST
|
|
|
Transaction of such other business as may properly come before the annual meeting (including any adjournment or postponement thereof)
|
|
|
|
|
|
|
|
|
|
|
2
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
Director
|
|
|
Committee
Membership
|
|
|
|
|||||||||||||||||
|
Name
|
|
|
Age
|
|
|
Since
|
|
|
Independent(1)
|
|
|
AC
|
|
|
CHC
|
|
|
NGC
|
|
|
ITC
|
|
|
Other Current Public Boards
|
|
|
Sohail U. Ahmed
|
|
|
67
|
|
|
2019
|
|
|
Yes
|
|
|
|
|
|
|
|
|
M
|
|
|
|
||||
|
Timothy M. Archer
|
|
|
58
|
|
|
2018
|
|
|
No
|
|
|
|
|
|
|
|
|
|
|
Johnson Controls
|
|
||||
|
Eric K. Brandt
|
|
|
63
|
|
|
2010
|
|
|
Yes
|
|
|
C/FE
|
|
|
|
|
M
|
|
|
|
|
Gen Digital,
Nutanix,
Option Care Health
|
|
||
|
Ita M. Brennan
|
|
|
58
|
|
|
2024
|
|
|
Yes
|
|
|
M/FE
|
|
|
|
|
|
|
|
|
Cadence Design Systems,
Planet Labs
|
|
|||
|
Michael R. Cannon
|
|
|
72
|
|
|
2011
|
|
|
Yes
|
|
|
*
|
|
|
M
|
|
|
C
|
|
|
|
|
Seagate Technology
|
|
|
|
John M. Dineen
|
|
|
62
|
|
|
2023
|
|
|
Yes
|
|
|
M
|
|
|
|
|
|
|
|
|
Cognizant Technology Solutions
|
|
|||
|
Mark Fields
|
|
|
64
|
|
|
2024
|
|
|
Yes
|
|
|
*
|
|
|
M
|
|
|
|
|
|
|
Hertz Global,
QUALCOMM
|
|
||
|
Ho Kyu Kang
|
|
|
63
|
|
|
2023
|
|
|
Yes
|
|
|
|
|
|
|
|
|
C
|
|
|
|
||||
|
Bethany J. Mayer
|
|
|
63
|
|
|
2019
|
|
|
Yes
|
|
|
M/FE
|
|
|
|
|
M
|
|
|
M
|
|
|
Astera Labs,
Box,
Hewlett Packard Enterprise
|
|
|
|
Jyoti K. Mehra
|
|
|
49
|
|
|
2021
|
|
|
Yes
|
|
|
|
|
C
|
|
|
|
|
|
|
|
||||
|
Abhijit Y. Talwalkar
|
|
|
61
|
|
|
2011
|
|
|
Yes
(Chair)
|
|
|
|
|
M
|
|
|
M
|
|
|
M
|
|
|
Advanced Micro Devices,
iRhythm Technologies,
TE Connectivity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Independence determined in accordance with Nasdaq rules.
|
|
|
|
|
|
AC -Audit committee
CHC -Compensation and human resources committee
NGC -Nominating and governance committee
ITC - Innovation and technology committee
|
|
|
C -Chair
M -Member
FE -Audit committee financial expert (as determined based on SEC rules)
* - Qualifies as an audit committee financial expert (as determined by SEC rules)
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 3
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Key Qualifications, Skills, & Experiences of Director Nominees
|
|
|
Sohail U. Ahmed
|
|
|
Timothy M. Archer
|
|
|
Eric K. Brandt
|
|
|
Ita M. Brennan
|
|
|
Michael R. Cannon
|
|
|
John M. Dineen
|
|
|
Mark Fields
|
|
|
Ho Kyu Kang
|
|
|
Bethany J. Mayer
|
|
|
Jyoti K. Mehra
|
|
|
Abhijit Y. Talwalkar
|
|
|
Industry Knowledge- Knowledge of and experience with semiconductor and broader technology industries and markets provides our Board members with a deeper understanding of our products and services, the market sectors in which we and our customers compete, and the broader technology end markets that drive demand in our industry.
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
||
|
Customer/Deep Technology Knowledge- Directors who possess deep knowledge and understanding of semiconductor processing equipment technologies assist our Board in overseeing our business and strategies and enhance the Board's understanding of our customers' markets and needs.
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
✔
|
|
|
|
|
|
|
✔
|
|
||||||
|
Marketing, Disruptive Technology, and Strategy Experience- Directors with extensive knowledge and experience in business-to-business marketing and sales, and services and/or business development, or experience identifying and developing disruptive technologies and leading corporate strategy, provide value to the Board by offering critical insights and expertise on identifying and understanding new markets, expanding market share, and communicating with customers, particularly where such experience is in a capital equipment industry, and also provide the Board with critical guidance needed to progress in our innovation goals and drive semiconductor breakthroughs.
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
|
|
✔
|
|
|||
|
Leadership Experience - Current or former experience in an executive-level leadership position at a significant business allows our directors to provide the Board with important perspectives and knowledge regarding business strategy, operations, corporate culture, succession planning, and management and leadership best practices.
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Key Qualifications, Skills, & Experiences of Director Nominees
|
|
|
Sohail U. Ahmed
|
|
|
Timothy M. Archer
|
|
|
Eric K. Brandt
|
|
|
Ita M. Brennan
|
|
|
Michael R. Cannon
|
|
|
John M. Dineen
|
|
|
Mark Fields
|
|
|
Ho Kyu Kang
|
|
|
Bethany J. Mayer
|
|
|
Jyoti K. Mehra
|
|
|
Abhijit Y. Talwalkar
|
|
|
Finance Experience - Directors with profit and loss ("P&L") and financing experience as an executive responsible for financial results of a breadth and level of complexity comparable to the Company help our Board oversee the Company's financial planning, operations, investment strategies, capital allocation, and financial reporting.
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
|
|
✔
|
|
|||
|
Global Business Experience - Experience as a current or former business executive of a business with substantial global operations provides our Board with unique insights on managing an international business, global scale expansion, and understanding cultural norms.
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
Mergers and Acquisitions ("M&A") Experience - Directors with M&A and integration experience (including buy- and sell-side and hostile M&A experience) as a public company director or officer provide our Board with key background and insights in assisting management with reviewing strategic alternatives, analyzing potential targets, post-deal integration, and oversight of transactions.
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
||
|
Comparative Board/Governance Experience - Recent or current experience as a director of another public company or significant involvement with the corporate governance requirements and practices of a public company board while serving in a senior leadership position at another public company, provides our Board with an understanding of the board's role in essential matters, including oversight of strategy, operations, risk, compliance and succession planning, effective interactions with significant stockholders, and the proper dynamics between the board and senior management.
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
||
|
Cybersecurity Experience - An understanding of and/or experience overseeing corporate cybersecurity or information security programs and a history of participation in relevant cyber education, is an increasingly important background for our directors to possess and provides our Board with valuable knowledge in overseeing and navigating cybersecurity threats.
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
|
|
✔
|
|
|
✔
|
|
|
|
||||
|
Human Capital Management Experience - Experience serving as a member of the compensation committee of a public company, head of human resources, or as direct manager of the head of human resources, or other experience in setting talent management policies in large organizations, aids our Board in overseeing the management of human capital, including culture, engagement, recruiting, retention, compensation, and succession planning.
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
||
|
Risk Management Experience - Directors with experience serving as a member of the audit committee of a public company, or directly overseeing enterprise risk management or business continuity planning in a large organization, or other experience in managing risk at the enterprise level or in a senior compliance or regulatory role assist our Board in understanding how to effectively evaluate and oversee the management and reporting of enterprise risks.
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
|
|
✔
|
|
|||
|
Manufacturing/Operations Experience - Directors with relevant experience in manufacturing and operations processes or management experience in operations at a company comparable to Lam serve as a valuable asset to our Board and have deeper knowledge of our business, products, services, and customers.
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
✔
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 5
|
Table of Contents
|
|
|
|
|
|
|
Board and Other Governance Information
|
|
|
As of September 2025
|
|
|
Size of Board as Nominated
|
|
|
11
|
|
|
Number of Independent Nominated Directors
|
|
|
10
|
|
|
Number of Nominated Directors Who Attended ≥75% of Meetings
|
|
|
11
|
|
|
Number of Nominated Directors on More Than Four Public Company Boards
|
|
|
0
|
|
|
Number of Nominated Non-Employee Executive Officer Directors Who Are on More Than Two Public Company Boards
|
|
|
0
|
|
|
Limitations on Director Commitments, Including Other Board and Committee Memberships and Leadership, With Commitments Evaluated Annually (Page 17)
|
|
|
Yes
|
|
|
Directors Subject to Stock Ownership Guidelines (Page 17)
|
|
|
Yes
|
|
|
Hedging and Pledging Prohibited (Page 13)
|
|
|
Yes
|
|
|
Annual Election of Directors (Page 73)
|
|
|
Yes
|
|
|
Voting Standard (Page 102)
|
|
|
Majority
|
|
|
Plurality Voting Carveout for Contested Elections
|
|
|
Yes
|
|
|
Separate Chair and CEO
|
|
|
Yes
|
|
|
Independent Board Chair (Page 16)
|
|
|
Yes
|
|
|
Independent Directors Meet Without Management Present (Page 16)
|
|
|
Yes
|
|
|
Annual Board (Including Individual Director) and Committee Self-Evaluations (Page 14)
|
|
|
Yes
|
|
|
Annual Independent Director Evaluation of CEO (Page 19)
|
|
|
Yes
|
|
|
Risk Oversight by Full Board and Committees (Page 20)
|
|
|
Yes
|
|
|
Board Refreshment (Page 14)
|
|
|
Yes
|
|
|
Robust Director Nomination Process (Page 15)
|
|
|
Yes
|
|
|
Significant Board Engagement (Page 19)
|
|
|
Yes
|
|
|
Board Orientation/Education Program (Page 15)
|
|
|
Yes
|
|
|
Code of Ethics Applicable to Directors (Page 13)
|
|
|
Yes
|
|
|
Stockholder Proxy Access (Pages 15, 103)
|
|
|
Yes
|
|
|
Stockholder Ability to Act by Written Consent
|
|
|
Yes
|
|
|
Stockholder Right to Call a Special Meeting
|
|
|
Yes
|
|
|
Stockholder Engagement Program (Page 22)
|
|
|
Yes
|
|
|
Poison Pill
|
|
|
No
|
|
|
Board Oversight of Environmental, Social and Governance (Including Climate), Human Capital, Information Security & Political Activities (Page 19)
|
|
|
Yes
|
|
|
Publication of Annual Global Impact Report aligned with GRI, SASB, and TCFD(1) standards (Pages 8, 24)
|
|
|
Yes
|
|
|
|
|
|
|
|
(1)
|
GRI refers to the Global Reporting Initiative, SASB refers to the Sustainability Accounting Standards Board, and TCFD refers to the Task Force on Climate-Related Financial Disclosures.
|
6
|
Table of Contents
|
|
|
|
What We Do
|
|
|
Pay for Performance (Pages 30-32, 65) - Our executive compensation program is designed to pay for performance; over 90% of the annual incentive program is tied to company financial, strategic, and operational performance metrics; the long-term incentive program uses a combination of market-based performance restricted stock units ("Market-based PRSUs") with performance based on relative total shareholder return ("TSR"), and service-based restricted stock units ("RSUs").
|
|
|
Three-Year Performance Period for Our Long-Term Incentive Program (Pages 35, 48) - Our current long-term incentive program is designed to pay for performance over a period of three years.
|
|
|
Absolute and Relative Performance Metrics(Pages 33, 36, 42, 46) - Our annual and long-term incentive programs for executive officers include the use of absolute and relative performance factors.
|
|
|
Balance of Annual and Long-Term Incentives- Our incentive programs provide a balance of annual and long-term incentives.
|
|
|
Different Performance Metrics for Annual and Long-Term Incentive Programs(Pages 33, 35, 42, 46) - Our annual and long-term incentive programs use different performance metrics.
|
|
|
Capped Amounts(Pages 33, 34) - Amounts that can be earned under the annual and long-term incentive programs are capped. Beginning with our 2025/2027 long-term incentive program, the maximum payout is capped at 100% of target if our absolute TSR is negative.
|
|
|
Compensation Recovery/Clawback Policy(Page 52) - We have a clawback policy, approved in 2023, which applies to the Company's current and former executive officers covered by Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to which we must recoup, on a pre-tax basis, the excess amount of incentive-based compensation granted, earned, or vested wholly or in part on the attainment of any financial reporting measure during the three completed fiscal years immediately preceding the date on which the Company is required to prepare a restatement. The policy applies regardless of fault, fraud, or misconduct and supersedes our prior clawback policy, with respect to any and all incentive-based compensation that was received on or after October 2, 2023.
|
|
|
Prohibit Option Repricing- Our stock incentive plans prohibit option repricing without stockholder approval.
|
|
|
Stock Ownership Guidelines(Page 52) - We have stock ownership guidelines for each of our executive officers and certain other senior executives; each of our named executive officers as set forth in Figure 19 has met their individual ownership level under the current program or has a period of time remaining under the guidelines to do so.
|
|
|
Independent Compensation Advisor(Page 38) - The compensation and human resources committee benefits from its utilization of an independent compensation advisor retained directly by the committee that provides no other services to the Company.
|
|
|
Stockholder Engagement(Page 37) - We engage with stockholders on an annual basis and stockholder advisory firms on an as needed basis to obtain feedback concerning our executive compensation program.
|
|
|
|
|
|
|
|
|
What We Don't Do
|
|
|
Tax "Gross-Ups" for Perquisites, for Other Benefits or upon a Change in Control (Pages 53, 56, 60) - Our executive officers do not receive tax "gross-ups" for perquisites, for other benefits, or upon a change in control.(1)
|
|
|
Single-Trigger Change in Control Provisions (Pages 53, 60) - Our executive change in control policy does not have single-trigger provisions.
|
|
|
|
|
(1)
|
Our executive officers may receive tax gross-ups in connection with relocation benefits and anniversary milestone awards, which are widely available to all of our employees.
|
Lam Research Corporation 2025 Proxy Statement 7
|
Table of Contents
|
|
|
|
|
|
|
Goals
|
|
|
2024 Progress
|
|
|
Governance
|
|
|
|
|
|
•
Continue to expand our disclosure and alignment with industry-recognized frameworks and standards
|
|
|
•
Our efforts to increase disclosure maintained or improved our ratings and rankings with third parties, and joined RE100, a global corporate renewable energy initiative led by the Climate Group
|
|
|
Product Innovation
|
|
|
|
|
|
•
83% of customers measured by emissions have science-based targets ("SBTs")(1)
|
|
|
•
9% of customers measured by emissions have SBTs
|
|
|
•
Reduce Scope 3 emissions from use of sold products 63.8% per USD value added by 2034 from a 2022 base year
|
|
|
•
New goal(2)
|
|
|
Sustainable Operations(3)
|
|
|
|
|
|
•
Achieve net zero greenhouse gas ("GHG") emissions by 2050, including by meeting the following targets:
|
|
|
|
|
|
-
Achieve 100% renewable electricity by 2030
|
|
|
•
Sourced 55% renewable electricity globally in 2024
|
|
|
-
Reduce absolute Scope 1 and 2 (market-based) GHG emissions 25% by 2025 and 46.2% by 2030 from a 2019 baseline; by the end of 2040, achieve net zero operations(4)
|
|
|
•
42% decrease year-over-year and 18.6% decrease from a 2019 baseline for Scope 1 and 2 (market-based) GHG emissions
|
|
|
-
Achieve 12 million kilowatt-hours ("kWh") in total energy savings from a 2019 baseline
|
|
|
•
Achieved 1.96 million kWh in in 2024, for a cumulative 11.7 million kWh in savings toward our 2025 goal
|
|
|
•
Achieve zero waste to landfill for hazardous waste
|
|
|
•
Diverted 99.95% of hazardous waste to landfill in 2024
|
|
|
•
Achieve 80 million gallons of water savings in water-stressed regions from a 2019 baseline
|
|
|
•
Achieved 80.6 million gallons of water savings from a 2019 baseline, one year ahead of schedule, including 14.7 million gallons in 2024
|
|
|
Our Workplace(5)
|
|
|
|
|
|
•
Build on our high-performance culture with best-in-class employee engagement at the global benchmark as measured by our annual employee survey
|
|
|
•
90% participation in our annual employee survey, with an engagement score up two points from 2023 and exceeding benchmarks
|
|
|
•
Maintain an Occupational Safety and Health Administration recordable injury rate at or below 0.4 annually
|
|
|
•
Realized a recordable injury rate of 0.28
|
|
|
|
|
|
|
|
(1)
|
The percentage of customers measured by emissions who have set SBTs is calculated by summing the emissions associated with category 11 use of sold products for each customer with a Science-Based Targets initiative ("SBTi") or SBTi aligned methodology and then dividing by the total emissions for category 11 use of sold products to get a proportion of emissions represented by customers with SBTi or SBTi aligned methodology. Estimated annual emissions are determined using a GHG Protocol spend-based methodology and emissions factors derived from the environmentally-extended input-output ("EEIO") database.
|
(2)
|
This goal was added to our net zero roadmap at the end of 2024 and thus progress to that goal was not started within the 2024 calendar year.
|
(3)
|
Energy and water savings data exclude Lam's subsidiaries Avonisys, Coventor, and Metryx.
|
(4)
|
We have revised our 2030 Scope 1 and 2 emissions reduction target due to ongoing due diligence revealing a need to adjust our baseline. The revised goal remains in line with SBTi expectations.
|
(5)
|
A previously stated Workplace goal has been removed for 2024.
|
8
|
Table of Contents
|
|
|
|
|
|
|
Goals
|
|
|
2024 Progress
|
|
|
Responsible Supply Chain
|
|
|
|
|
|
•
Achieve more than 90% compliance with our social and environmental expectations across our top suppliers(6)
|
|
|
•
Exceeded our goal with 99% of top suppliers responding to our conflict minerals survey
|
|
|
•
Engage with at least 50% of our top suppliers on environmental sustainability opportunities
|
|
|
•
Engaged with 100% of top suppliers through surveys, energy assessments, and education programs
|
|
|
•
Increase engagement with suppliers on social and environmental topics through assessment, training, and capacity building
|
|
|
•
Continued to deepen supplier engagement with top suppliers through 19 webinars, as well as training tailored to our growth regions
|
|
|
•
46.5% of suppliers measured by emissions have SBTs(7)
|
|
|
•
32.7% of suppliers as measured by emissions have SBTs
|
|
|
Our Communities
|
|
|
|
|
|
•
Determine key targets for larger-scale impact aligned to a new strategic focus
|
|
|
•
Having achieved this goal in 2023, Lam's Powering Breakthroughs Together community impact framework continues to guide our giving and signature program initiatives
|
|
|
•
Implement measurement of outcomes for key program and large-scale grants
|
|
|
•
Identified gaps in measurement and reporting processes and assessing alternative approach for large-scale grants
|
|
|
•
Increase annual unique participation rate in all employee giving programs from 10% to 30%
|
|
|
•
Increased annual unique employee participation rate from 20% in 2023 to 22% in 2024
|
|
|
•
Contribute 40,000 employee volunteer hours annually
|
|
|
•
Contributed 31,956 employee volunteer hours in 2024
|
|
|
|
|
|
|
|
(6)
|
Top suppliers are defined as the top 100 direct suppliers, who account for approximately 91% of spend and 90% of direct supplier emissions, with some variability year over year. Direct suppliers are defined as those who provide parts, assemblies, and services to produce parts used to manufacture and support Lam's products. Indirect suppliers are all other goods and services used by Lam's daily operations that are not parts, assemblies, or services directly tied to producing parts used to manufacture or support Lam's products.
|
(7)
|
The percentage of suppliers measured by emissions who have set SBTs is calculated by dividing the estimated annual emissions associated with our suppliers (direct and indirect) who have set SBTs by the estimated annual emissions of our suppliers (direct and indirect); estimated annual emissions are determined using a GHG Protocol spend-based methodology and emissions factors derived from the EEIO.
|
Lam Research Corporation 2025 Proxy Statement 9
|
Table of Contents
|
|
|
|
What The Plan Includes
|
|
|
Share Reserve(Page 87) - 96.8 million new shares will be available for issuance under the 2025 Stock Incentive Plan (the "2025 Plan"). In addition, the shares that remain available for grants under the 2015 Stock Incentive Plan (the "2015 Plan") immediately prior to the expiration of the 2015 Plan, and any shares that would otherwise return to the 2015 Plan as a result of the forfeiture, termination, expiration, or cash settlement of awards previously granted under the 2015 Plan, will also be available for issuance under the 2025 Plan, in addition to the 96.8 million shares.
|
|
|
Award Types (Page 88) - The 2025 Plan provides for options, restricted stock, restricted stock units, stock appreciation rights ("SARs") and other awards (including, but not limited to, purchase rights for shares, the grant of shares as a bonus, deferred shares, performance shares, phantom shares, and other similar types of awards).
|
|
|
Fungible Share Ratio(Page 89) - Consistent with the 2015 Plan, awards under the 2025 Plan, other than stock options and SARs, count against the share reserve at a 2:1 ratio (i.e., will count as two shares against the share reserve for every one share subject to such award).
|
|
|
Limits on Outside Director Compensation (Page 89) - The aggregate annual dollar limit (including total cash and equity compensation) is $1,000,000 for each non-employee director and $1,500,000 for a non-executive Board chair.
|
|
|
Minimum Vesting Periods(Page 90) - Awards may not vest sooner than the one year anniversary of the date of grant (except with respect to awards to non-employee directors vesting on or about the one year anniversary of the applicable date of grant and the next annual stockholder meeting, shares delivered in lieu of currently payable cash obligations, or additional awards up to 5% of the maximum number of shares that may be issued under the 2025 Plan). Awards may provide for earlier vesting in certain circumstances (e.g., death, disability, termination, and in certain corporate transactions).
|
|
|
Recoupment/Clawback (Page 91) - Awards under the 2025 Plan are subject to Lam's clawback policy and any other applicable clawback provisions, applicable sections of any Award Agreement or any related documents, or requirements of applicable law or regulations.
|
|
|
Plan Term (Page 91) - The 2025 Plan shall continue in effect until the tenth (10th) anniversary of its effective date unless earlier terminated or suspended by the Board. No Incentive Stock Options may be granted after August 26, 2035.
|
|
|
Shares Available for Awards Provisions (Page 90) - Shares covered by an award that is forfeited, canceled or expires, or is settled in cash, before the shares are issued will be available for future issuance under the 2025 Plan. Shares tendered or withheld in payment of any tax withholding obligation for an award other than an option or SAR will also be returned to the 2025 Plan and available for future issuance.
The following types of shares will notbe returned to the 2025 Plan and will notbecome available for future issuances:
|
|
|
•
Shares that have been issued (e.g., restricted stock), except in the case of unvested shares that are forfeited or repurchased by the Company at the lower of their original purchase price or their fair market value.
•
Shares tendered or withheld in payment of an option or SAR exercise price, or withheld to pay any option or SAR tax withholding obligation.
•
Shares subject to share-settled SARs that are not actually issued in connection with the settlement of such SARs upon exercise.
•
Shares reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of options.
|
|
|
|
|
|
|
|
|
What The Plan Does Not Include
|
|
|
Repricing Without Stockholder Approval(Page 90) - Stockholder approval must be obtained prior to the reduction of the exercise price of any option or SAR or the cancellation of an option or SAR when its exercise price exceeds the fair market value of the shares in exchange for cash, another award, or an option or SAR with a lower exercise price (excluding adjustments due to specified corporate transactions and changes in capitalization).
|
|
|
Dividend Payment on Unvested Awards (Page 90) - If awards provide for the payment of dividends or dividend equivalent rights, such amounts will be subject to the same vesting restrictions as the underlying award and will be deferred until, and paid contingent upon, the vesting of the underlying award.
|
|
|
|
|
10
|
Table of Contents
|
|
Stock Ownership
|
|
|
|
|
|
|
|
|
|
|
Name of Person or Identity of Group
|
|
|
Shares
Beneficially
Owned (#)(1)
|
|
|
Percentage
of Class
|
|
|
5% Stockholders
|
|
|
|
|
|
||
|
BlackRock, Inc.
50 Hudson Yards New York, NY 10001 |
|
|
117,779,780(2)
|
|
|
9.34%
|
|
|
The Vanguard Group
100 Vanguard Boulevard Malvern, PA 19355 |
|
|
129,149,892(3)
|
|
|
10.24%
|
|
|
Directors
|
|
|
|
|
|
||
|
Sohail U. Ahmed
|
|
|
33,580
|
|
|
*
|
|
|
Timothy M. Archer (also a Named Executive Officer)
|
|
|
1,481,175
|
|
|
*
|
|
|
Eric K. Brandt
|
|
|
287,070
|
|
|
*
|
|
|
Ita M. Brennan
|
|
|
3,707
|
|
|
*
|
|
|
Michael R. Cannon
|
|
|
189,740
|
|
|
*
|
|
|
John M. Dineen
|
|
|
7,500
|
|
|
*
|
|
|
Mark Fields
|
|
|
4,247
|
|
|
*
|
|
|
Ho Kyu Kang
|
|
|
8,693
|
|
|
*
|
|
|
Bethany J. Mayer
|
|
|
31,880
|
|
|
*
|
|
|
Jyoti K. Mehra
|
|
|
16,840
|
|
|
*
|
|
|
Abhijit Y. Talwalkar
|
|
|
108,360
|
|
|
*
|
|
|
Named Executive Officers ("NEOs")
|
|
|
|
|
|
||
|
Douglas R. Bettinger
|
|
|
1,093,082
|
|
|
*
|
|
|
Patrick J. Lord
|
|
|
71,455
|
|
|
*
|
|
|
Ava A. Harter
|
|
|
15,046
|
|
|
*
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
237,783
|
|
|
*
|
|
|
All current directors and executive officers as a group (17 people)
|
|
|
3,971,889
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
*
|
Less than 1%
|
Lam Research Corporation 2025 Proxy Statement 11
|
Table of Contents
(1)
|
Includes shares subject to outstanding stock options that are now exercisable or will become exercisable within 60 days after September 5, 2025, as well as RSUs, that will vest within that time period, as follows:
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
|
Sohail U. Ahmed
|
|
|
2,950
|
|
|
Timothy M. Archer
|
|
|
616,410
|
|
|
Eric K. Brandt
|
|
|
2,950
|
|
|
Michael R. Cannon
|
|
|
2,950
|
|
|
Ita M. Brennan
|
|
|
2,950
|
|
|
John M. Dineen
|
|
|
2,950
|
|
|
Mark Fields
|
|
|
2,950
|
|
|
Ho Kyu Kang
|
|
|
2,950
|
|
|
Bethany J. Mayer
|
|
|
2,950
|
|
|
Jyoti K. Mehra
|
|
|
2,950
|
|
|
Abhijit Y. Talwalkar
|
|
|
2,950
|
|
|
Douglas R. Bettinger
|
|
|
113,730
|
|
|
Ava A. Harter
|
|
|
6,010
|
|
|
Patrick J. Lord
|
|
|
34,810
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
88,190
|
|
|
All current directors and executive officers as a group (17 people)
|
|
|
959,030
|
|
|
|
|
|
|
|
(2)
|
All information regarding BlackRock Inc. ("BlackRock") is based solely on information disclosed in amendment number 16 to Schedule 13G filed by BlackRock with the SEC on January 25, 2024 on behalf of BlackRock and certain subsidiaries. According to the Schedule 13G filing, of 117,779,780 shares of Lam common stock reported as beneficially owned by BlackRock as of December 31, 2023, BlackRock had sole voting power with respect to 106,801,210 shares, did not have shared voting power with respect to any shares, had sole dispositive power with respect to 117,779,780 shares, and did not have shared dispositive power with respect to any shares of Lam common stock.
|
(3)
|
All information regarding The Vanguard Group ("Vanguard") is based solely on information disclosed in amendment number 13 to Schedule 13G filed by Vanguard with the SEC on April 8, 2025. According to the Schedule 13G filing, of the 129,149,892 shares of Lam common stock reported as beneficially owned by Vanguard as of March 31, 2025, Vanguard did not have sole voting power with respect to any shares, had shared voting power with respect to 1,685,647 shares, had sole dispositive power with respect to 123,061,464 shares, and had shared dispositive power with respect to 6,088,428 shares of Lam common stock.
|
12
|
Table of Contents
|
|
Governance Matters
|
|
|
|
|
|
|
|
Policy or
Procedure
|
|
|
Summary
|
|
|
Board committee charters*
|
|
|
Each of the Board's audit, compensation and human resources, nominating and governance, and innovation and technology committees has a written charter adopted by the Board that delegates authority and responsibilities to the committee.
Each committee reviews its charter, and the nominating and governance committee reviews the charters of all of the committees annually and recommends changes to the Board, as appropriate. See "Board Committees" below for additional information regarding these committees.
|
|
|
Corporate governance guidelines*
|
|
|
We adhere to written corporate governance guidelines, adopted by the Board and reviewed annually by the nominating and governance committee and the Board.
Selected provisions of the guidelines are discussed below, including in the "Board Nomination Policies and Procedures," "Director Independence Policies," and "Other Governance Practices" sections below.
|
|
|
Corporate Code of Ethics*
|
|
|
We maintain a code of ethics that applies to all employees, officers, and members of the Board.
The code of ethics establishes standards reasonably necessary to promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships, and full, fair, accurate, timely, and understandable disclosure in the periodic reports we file with the SEC and in other public communications. We will promptly disclose to the public any amendments to, or waivers from, any provision of the code of ethics to the extent required by applicable laws. We intend to make this public disclosure by posting the relevant material on our website, to the extent permitted by applicable laws.
|
|
|
Code of Conduct*
|
|
|
We maintain a written code of conduct to address a variety of situations that apply to our worldwide workforce. Among other items, the code of conduct addresses relationships and/or conduct with one another, with Lam (including conflicts of interest, safeguarding of Company assets, and protection of confidential information), and with other companies and stakeholders (including anti-corruption).
|
|
|
Insider Trading Policy**
|
|
|
Our insider trading policy restricts the trading of Company stock by our directors, officers, and employees, and includes provisions addressing insider blackout periods and prohibiting pledges of Company stock, and prohibiting such persons from engaging in hedging transactions, such as "cashless" collars, forward sales, equity swaps, and other similar arrangements. Investments in exchange funds are permitted if the fund is broadly diversified and comprises less than 2% of Company stock; exceptions to the 2% threshold may be permitted on a case-by-case basis.
|
|
|
|
|
|
|
|
*
|
A copy is available on the Investors section of our website at investor.lamresearch.com/corporate-governance.
|
**
|
A copy is available as Exhibit 19.1 to our 2025 Annual Report on Form 10-K.
|
Lam Research Corporation 2025 Proxy Statement 13
|
Table of Contents
14
|
Table of Contents
•
|
experience;
|
•
|
business acumen;
|
•
|
wisdom;
|
•
|
integrity;
|
•
|
judgment;
|
•
|
the ability to make independent analytical inquiries;
|
•
|
the ability to understand the Company's business environment;
|
•
|
the candidate's willingness and ability to devote adequate time to board duties;
|
•
|
specific skills, background, or experience considered necessary or desirable for board or committee service;
|
•
|
specific experiences with other businesses or organizations that may be relevant to the Company or its industry;
|
•
|
the interplay of a candidate's experiences and skills with those of other Board members; and
|
•
|
any other attribute(s) the Board considers appropriate.
|
Lam Research Corporation 2025 Proxy Statement 15
|
Table of Contents
16
|
Table of Contents
Lam Research Corporation 2025 Proxy Statement 17
|
Table of Contents
•
|
oversee the Company's accounting and financial reporting processes, independent auditors (including by carrying out an assessment of their qualifications and independence), internal audit program, and the audits of its financial statements;
|
•
|
oversee the Company's investment policies and performance,
|
•
|
review the Company's hedging strategy and tax strategies;
|
•
|
oversee the Company's ethics and compliance program;
|
•
|
oversee the Company's cybersecurity and information security policies and internal controls;
|
•
|
oversee management's implementation and maintenance of internal control over accounting and financial reporting and of reporting systems and procedures designed to identify material misstatements in financial reporting, whether due to error or fraud, including the review of any material changes to the system of internal control over financial reporting;
|
•
|
review and monitor risk associated with the Company's (i) investment policy and its investment portfolio performance, (ii) counterparty risk, including the financial position of key counterparties, including key customers, and (iii) debt and banking covenants, liquidity, available credit under revolving or other lines of credit, and access to financing;
|
•
|
review and approve the Company's Insider Trading Policy, including amendments and changes thereto;
|
•
|
review the Company's earnings press releases, as well as financial information and earnings guidance provided therein;
|
•
|
review and oversee potential related party and conflict of interest situations, transactions required to be disclosed pursuant to Item 404 of Regulation S-K of the SEC, and any other transaction involving an executive or Board member, and
|
•
|
oversee (i) the determination of whether an accounting restatement is required due to the material noncompliance of the Company with any financial reporting requirement under the securities laws and (ii) the preparation of the Company's accounting restatements to correct such noncompliance.
|
•
|
review and approve the Company's executive officer compensation philosophy, objectives, and strategies;
|
•
|
recommend to the independent members of the Board corporate goals and objectives under our compensation plans;
|
•
|
recommend to the independent members of the Board compensation packages and compensation payouts for the CEO, and approve the compensation packages and compensation payouts for our other executive officers;
|
•
|
oversee incentive, equity-based plans, and other compensatory plans in which our executive officers and/or directors participate;
|
•
|
produce an annual report on executive compensation for inclusion, as required, in our annual proxy statement;
|
•
|
oversee management's determination as to whether our compensation policies and practices, including those related to pay equity laws, create risks that are reasonably likely to have a material adverse effect on the Company; and
|
•
|
discharge certain responsibilities of the Board with respect to organization and people matters, including executive succession planning, employee engagement programs, and assisting the Board in overseeing environmental, social and governance matters relating to our workforce.
|
18
|
Table of Contents
•
|
identify individuals qualified to serve as members of the Board and recommend nominees for election as directors;
|
•
|
recommend committee membership and leadership assignments;
|
•
|
review our corporate governance guidelines and other governing documents and recommend amendments to the Board;
|
•
|
oversee self-evaluations of the Board, committees, and individual directors;
|
•
|
assist the Board in overseeing environmental, social and governance matters not assigned to other committees, including our overall strategy and goals with respect to such matters, sustainability initiatives, climate-related goals, and, in each instance, our progress toward achieving those goals, as well as its related reporting;
|
•
|
oversee the Company's political activities and review our policy regarding political contributions and spending;
|
•
|
develop, assess, and make recommendations to the Board concerning corporate governance matters;
|
•
|
review the independence of the Board and its committees and recommend director independence determinations to the Board;
|
•
|
monitor and evaluate the educational needs of directors and make recommendations to the Board where appropriate; and
|
•
|
administer the process for director candidates nominated by stockholders.
|
•
|
assist the Board in overseeing the Company's management of risks associated with the scope, direction, and quality of the Company's major technology plans and strategies, including its research and development ("R&D") programs, capabilities, and activities, levels of investment, competitive positioning and intellectual property protection, and the technical, market, and business risks associated with product development and investment;
|
•
|
review and assess the performance, progress, and effectiveness of the Company's execution of its technology strategies; and
|
•
|
assist the Board in overseeing the Company's management of risks associated with existing and future trends in technology and relevant markets that may affect the Company's plans and strategies.
|
•
|
overseeing the Company's business strategies, and approving the Company's capital allocation plans and priorities, annual operating plan, and major corporate actions as set forth in the below sub-bullets;
|
°
|
a strategic plan is presented to the Board for discussion on an annual basis;
|
°
|
an operating plan is presented to the Board for discussion on an annual basis, and updates are presented at each quarterly Board meeting; and
|
°
|
capital allocation plans and priorities and other major corporate actions are presented and discussed as part of regular management updates and as special agenda topics, as appropriate.
|
•
|
appointing, annually evaluating the performance of, and approving the compensation of, our CEO;
|
Lam Research Corporation 2025 Proxy Statement 19
|
Table of Contents
•
|
reviewing with our CEO the performance of the Company's other executive officers and approving their compensation;
|
•
|
reviewing and approving CEO and top leadership succession planning;
|
•
|
advising and mentoring the Company's senior management;
|
•
|
overseeing the Company's internal control over financial reporting and disclosure controls and procedures;
|
•
|
overseeing the Company's material risks and enterprise risk management processes and programs, with critical enterprise risks presented to the full Board at least annually;
|
•
|
overseeing the Company's ethics and compliance programs, including the Company's code of ethics, with updates presented to Board annually and to the audit committee or Board quarterly;
|
•
|
overseeing the Company's information security programs (including cybersecurity), with updates presented to the Board annually and to the audit committee or Board quarterly;
|
•
|
overseeing the Company's human capital management, with updates presented to the compensation and human resources committee quarterly and to the full Board annually;
|
•
|
overseeing environmental, social and governance matters, with quarterly updates on our program and performance provided to the nominating and governance committee, and the Company's strategy, goals and performance presented to, and its related reporting reviewed by, the full Board annually; and
|
•
|
overseeing the Company's political activities, with updates presented quarterly to the nominating and governance committee.
|
20
|
Table of Contents
•
|
risk assessments designed to help identify risks to our critical systems, information, services, and our broader global information systems environment;
|
•
|
a security team principally responsible for managing (i) our cybersecurity risk assessment processes, (ii) our security controls, and (iii) our response to cybersecurity incidents;
|
•
|
the use of external service providers, where appropriate, to aid in assessing specific risks, providing benchmarking data, providing information regarding trends or recent regulatory changes applicable to our risk profile, or to test or otherwise assist with aspects of our security processes;
|
•
|
the periodic engagement of an independent third-party expert to evaluate our security capabilities;
|
•
|
mandatory annual cybersecurity awareness training of our employees, including incident response personnel and senior management, as well as conducting periodic tests with our user population to reinforce good information security practices;
|
•
|
a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents, including those impacting the Company's manufacturing sites;
|
•
|
processes to identify vulnerabilities, breach attempts, and possible criminal activity by external parties; and
|
•
|
processes to assess the practices of our suppliers and third-party service providers relative to protecting the security of our information.
|
Lam Research Corporation 2025 Proxy Statement 21
|
Table of Contents
22
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
Topics
|
|
|
What we heard from our stockholders in 2024
|
|
|
Our Perspective/How we responded
|
|
|
Board Composition, and Governance
|
|
|
We continued to receive positive feedback from stockholders on our board composition, structure, governance practices, refreshment, and the Board's approach to considering director skills and experiences. A small number of stockholders equate long board tenure with a lack of independence, or have more stringent policies on overboarding, especially for board chairs. Some stockholders noted expectations for higher levels of female representation on boards.
|
|
|
We continue to refresh our Board composition while balancing the benefits that longer-tenured directors provide in the form of strong institutional knowledge of the Company and its industry. We also continue to monitor regulations, stockholder guidelines and peer practices for consideration of whether our current composition and service limitations are appropriate.
|
|
|
Environmental, Social and Human Capital Oversight
|
|
|
Stockholders provided favorable feedback on our comprehensive disclosures, and well-disclosed progress on our goals. Many stockholders were pleased with our customer- and supplier-focused goals and engagement, our employee engagement, development and retention practices, and the progress we made with water management, product sustainability, and Scope 1 and 2 emissions. Some stockholders expressed a desire for additional disclosures on Scope 3 goals and objectives, our supplier due diligence process, the environmental impacts of our products, and our approach to Per- and polyfluoroalkyl substances ("PFAS").
|
|
|
In our Global Impact report for calendar year 2024 (available on our website at lamresearch.com/company/environmental-social-and-governance/), we have provided further disclosures regarding our Scope 3 goals and initiatives, supplier due diligence process, our efforts to reduce our product emissions, and our approach to PFAS.
|
|
|
AI Governance and Oversight
|
|
|
Some stockholders asked questions regarding AI risks and opportunities, particularly related to product innovation, Board oversight of AI, and internal applications of AI tools.
|
|
|
We have clarified in our disclosures that emerging and evolving areas of risk, such as AI, are included in our enterprise risk management system. Further, we engaged with our Board on our AI risk governance approach and updated our Board on our AI business technology framework. In addition, we continue to monitor the regulatory landscape, technological developments, and peer practices to evolve our governance framework.
|
|
|
Executive Compensation
|
|
|
See "Compensation Discussion and Analysis - Overview of Executive Compensation - 2024 Say on Pay Voting Results and Stockholder Outreach" beginning on page 37.
|
|
|||
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 23
|
Table of Contents
24
|
Table of Contents
Lam Research Corporation 2025 Proxy Statement 25
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual Retainers(1)
|
|
|
Calendar Year 2025
($)
|
|
|
Calendar Year 2024
($)
|
|
|
Fiscal Year 2025
($)
|
|
|
Non-employee Director
|
|
|
100,000
|
|
|
100,000
|
|
|
100,000
|
|
|
Chair
|
|
|
152,500
|
|
|
152,500
|
|
|
152,500
|
|
|
Audit Committee - Chair
|
|
|
35,000
|
|
|
35,000
|
|
|
35,000
|
|
|
Audit Committee - Member
|
|
|
15,000
|
|
|
15,000
|
|
|
15,000
|
|
|
Compensation and Human Resources Committee - Chair
|
|
|
30,000
|
|
|
30,000
|
|
|
30,000
|
|
|
Compensation and Human Resources Committee - Member
|
|
|
10,000
|
|
|
10,000
|
|
|
10,000
|
|
|
Innovation and Technology Committee - Chair
|
|
|
20,000
|
|
|
20,000
|
|
|
20,000
|
|
|
Innovation and Technology Committee - Member
|
|
|
10,000
|
|
|
10,000
|
|
|
10,000
|
|
|
Nominating and Governance Committee - Chair
|
|
|
20,000
|
|
|
20,000
|
|
|
20,000
|
|
|
Nominating and Governance Committee - Member
|
|
|
10,000
|
|
|
10,000
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Each Director is entitled to an annual non-employee director cash retainer. Directors are also entitled to supplemental retainer fees if they have board leadership positions (e.g., chair) and/or are either committee chairs or members.
|
26
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned
or Paid in Cash
($)
|
|
|
Stock
Awards
($)(1)
|
|
|
Total
($)
|
|
|
|
Sohail U. Ahmed
|
|
|
110,000(2)
|
|
|
228,094(3)
|
|
|
338,094
|
|
|
Eric K. Brandt
|
|
|
145,000(4)
|
|
|
228,094(3)
|
|
|
373,094
|
|
|
Ita M. Brennan
|
|
|
143,750(5)
|
|
|
285,727(3)(6)
|
|
|
429,477
|
|
|
Michael R. Cannon
|
|
|
130,000(7)
|
|
|
228,094(3)
|
|
|
358,094
|
|
|
John M. Dineen
|
|
|
115,000(8)
|
|
|
228,094(3)
|
|
|
343,094
|
|
|
Mark Fields
|
|
|
137,500(9)
|
|
|
285,727(3)(6)
|
|
|
423,227
|
|
|
Ho Kyu Kang
|
|
|
120,000(10)
|
|
|
228,094(3)
|
|
|
348,094
|
|
|
Bethany J. Mayer
|
|
|
135,000(11)
|
|
|
228,094(3)
|
|
|
363,094
|
|
|
Jyoti K. Mehra
|
|
|
130,000(12)
|
|
|
228,094(3)
|
|
|
358,094
|
|
|
Abhijit Y. Talwalkar
|
|
|
282,500(13)
|
|
|
228,094(3)
|
|
|
510,594
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amounts shown in this column represent the grant date fair value of unvested RSU awards granted during fiscal year 2025 in accordance with Financial Accounting Standards Board Accounting Standards Codification ("ASC") 718, Compensation - Stock Compensation ("ASC 718"). However, pursuant to SEC rules, these values are not reduced by an estimate for the probability of forfeiture. The fair value of RSUs was calculated based on the fair market value of the Company's common stock at the date of grant, discounted for dividends since the RSUs do not have dividend equivalent rights.
|
(2)
|
Mr. Ahmed received $110,000, representing his annual retainers for calendar year 2025 of $100,000 for service as a director and $10,000 for service as a member of the innovation and technology committee.
|
(3)
|
On November 8, 2024, each non-employee director who was on the Board at such time received an annual grant for calendar year 2025 of 2,950 RSUs, based on the 30 trading day average of the closing price per share of Lam's common stock prior to the grant date, $77.95, and the target value of $230,000, rounded down to the nearest share. All of these RSUs were outstanding and unvested as of June 29, 2025.
|
(4)
|
Mr. Brandt received $145,000, representing his annual retainers for calendar year 2025 of $100,000 for service as a director, $35,000 for service as the chair of the audit committee, and $10,000 for service as a member of the nominating and governance committee.
|
(5)
|
Ms. Brennan received $143,750, representing her annual retainers for calendar year 2025 of $100,000 for service as a director and $15,000 for service as a member of the audit committee, and prorated annual retainers for calendar year 2024 of $25,000 for service as a director and $3,750 for service as a member of the audit committee.
|
(6)
|
On November 8, 2024, Ms. Brennan and Mr. Fields each received a prorated annual grant for calendar year 2024 of 737 RSUs, based on the $77.95 per share closing price of Lam's common stock and the target value of $57,500, rounded down to the nearest share.
|
(7)
|
Mr. Cannon received $130,000, representing his annual retainers for calendar year 2025 of $100,000 for service as a director, $20,000 for service as the chair of the nominating and governance committee, and $10,000 for service as a member of the compensation and human resources committee.
|
(8)
|
Mr. Dineen received $115,000, representing his annual retainers for calendar year 2025 of $100,000 for service as a director and $15,000 for service as a member of the audit committee.
|
(9)
|
Mr. Fields received $137,500, representing his annual retainers for calendar year 2025 of $100,000 for service as a director and $10,000 for service as a member of the compensation and human resources committee, and prorated annual retainers for calendar year 2024 of $25,000 for service as a director and $2,500 for service as a member of the compensation and human resources committee.
|
(10)
|
Dr. Kang received $120,000, representing his annual retainers for calendar year 2025 of $100,000 service as a director and $20,000 for service as chair of the innovation and technology committee.
|
(11)
|
Ms. Mayer received $135,000, representing her annual retainers for calendar year 2025 of $100,000 for service as a director, $15,000 for service as a member of the audit committee, and $10,000 for service as a member of the innovation and technology committee, and $10,000 for service as a member of the nominating and governance committee.
|
Lam Research Corporation 2025 Proxy Statement 27
|
Table of Contents
(12)
|
Ms. Mehra received $130,000, representing her annual retainer for calendar year 2025 of $100,000 for service as a director and $30,000 for service as chair of the compensation and human resources committee.
|
(13)
|
Mr. Talwalkar received $282,500, representing his annual retainers for calendar year 2025 of $100,000 for service as a director, $152,500 for service as chair of the Board, $10,000 for service as a member of the compensation and human resources committee, $10,000 for service as a member of the innovation and technology committee, and $10,000 for service as a member of the nominating and governance committee.
|
28
|
Table of Contents
|
|
Compensation Matters
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Position(s)
|
|
|
Timothy M. Archer
|
|
|
President, Chief Executive Officer
|
|
|
Douglas R. Bettinger
|
|
|
Executive Vice President, Chief Financial Officer
|
|
|
Patrick J. Lord
|
|
|
Executive Vice President, Chief Operating Officer
|
|
|
Ava A. Harter(1)
|
|
|
Senior Vice President, Chief Legal Officer and Secretary
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
Senior Vice President, Global Products Group
|
|
|
|
|
|
|
|
(1)
|
Ms. Harter's employment with the Company began on July 8, 2024.
|
|
|
|
|
|
|
|
|
|
|
|
|
Table of Contents
|
|
|
Page
|
|
|
|
I.
|
|
|
Overview of Executive Compensation
|
|
|
30
|
|
|
|
|
Our Compensation Cycle
|
|
|
30
|
|
|
|
|
|
Our Business, Our Industry Environment, and Our Financial Performance
|
|
|
30
|
|
|
|
|
|
Our Pay-for-Performance Orientation
|
|
|
30
|
|
|
|
|
|
Executive Compensation Snapshot: Programs and Recent Outcomes
|
|
|
33
|
|
|
|
|
|
Executive Compensation Philosophy and Program Design
|
|
|
35
|
|
|
|
|
|
2024 Say on Pay Voting Results and Stockholder Outreach
|
|
|
37
|
|
|
|
II.
|
|
|
Executive Compensation Governance and Procedures
|
|
|
38
|
|
|
|
|
Role of the Compensation and Human Resources Committee
|
|
|
38
|
|
|
|
|
|
Role of Committee Advisors
|
|
|
38
|
|
|
|
|
|
Role of Management
|
|
|
39
|
|
|
|
|
|
Peer Group Practices and Survey Data
|
|
|
39
|
|
|
|
|
|
Assessment of Compensation Risk
|
|
|
40
|
|
|
|
|
|
Policies and Practices Related to the Timing of Option Awards
|
|
|
40
|
|
|
|
|
|
Tax and Accounting Considerations
|
|
|
40
|
|
|
|
III.
|
|
|
Primary Components of NEO Compensation; CY2024 Compensation Payouts; CY2025 Compensation Targets and Metrics
|
|
|
41
|
|
|
|
|
Base Salary
|
|
|
41
|
|
|
|
|
|
Annual Incentive Program
|
|
|
42
|
|
|
|
|
|
Long-Term Incentive Program
|
|
|
48
|
|
|
|
|
|
New Hire Compensation
|
|
|
51
|
|
|
|
|
|
Compensation Recovery Policy, or "Clawback" Policy
|
|
|
52
|
|
|
|
|
|
Insider Trading Policy
|
|
|
52
|
|
|
|
|
|
Stock Ownership Guidelines
|
|
|
52
|
|
|
|
|
|
Severance/Change in Control Arrangements
|
|
|
53
|
|
|
|
|
|
Other Benefits Not Available to All Employees
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 29
|
Table of Contents
•
|
achieved revenue of approximately $16.2 billion for the calendar year, representing an approximately 13% increase over calendar year 2023;
|
•
|
generated operating cash flow of approximately $4.6 billion, which represents approximately 28% of revenues; and
|
•
|
generated sufficient cash flow to support payment of approximately $1.1 billion in dividends to stockholders.
|
30
|
Table of Contents
(1)
|
"CEO Total Compensation" consists of base salary, annual incentive payments, and "All Other Compensation" as reported in the "Summary Compensation Table" below, and the target award opportunities for equity-based awards both under the long-term incentive program or otherwise, . Target award opportunities for equity-based awards under the long-term incentive program (expressed as a U.S. dollar value) are approved by the committee and converted to equity awards on the grant date using the 30 trading day average of the closing price of our common stock prior to the grant date. Target award opportunities differ from the values of equity awards shown in "Summary Compensation Table" below, which represent the grant date value of the awards determined in accordance with ASC 718.
|
Lam Research Corporation 2025 Proxy Statement 31
|
Table of Contents
*
|
$100 invested on June 28, 2020 in stock or index, including reinvestment of dividends.
|
**
|
Copyright © 2025 Standard & Poor's, a division of S&P Global. All rights reserved.
|
32
|
Table of Contents
(1)
|
Determined based on the final result for the Company's non-GAAP operating income as a percentage of revenue ("non-GAAP operating margin") for CY 2024. Non-GAAP operating margin is derived from results determined in accordance with generally accepted accounting principles ("GAAP"), with charges and credits in the following line items excluded from GAAP results for applicable quarters during calendar year 2024: amortization related to intangible assets acquired through certain business combinations; elective deferred compensation-related liability increase; restructuring charges, net; transformational costs; and impairment of long-lived assets. For additional information, see section below titled,"Appendix B - Information Regarding Non-GAAP Financial Measures."
|
Lam Research Corporation 2025 Proxy Statement 33
|
Table of Contents
(2)
|
Determined based on the final result for the Company's non-GAAP gross margin as a percentage of revenue ("non-GAAP gross margin") for CY 2024. Non-GAAP gross margin is derived from results determined in accordance with GAAP, with charges and credits in the following line items excluded from GAAP results for applicable quarters during calendar year 2024: amortization related to intangible assets acquired through certain business combinations; elective deferred compensation-related liability increase; restructuring charges, net; transformational costs; and impairment of long-lived assets. For additional information, see section below titled, "Appendix B - Information Regarding Non-GAAP Financial Measures."
|
(3)
|
Individual performance factor was consistent at 1.05 across all NEOs.
|
•
|
The committee adjusted the equity award mixfor the 2025/2027 LTIP design to eliminate stock options, resulting in a new mix consisting of Market-based PRSUs and service-based RSUs. The committee resolved to take this approach to improve the resilience of our executive compensation design given significant stock price volatility in both the semiconductor equipment industry and broader market, and to generally align our equity award mix with our Peer Group practices.
|
•
|
The committeeadjusted the relative total shareholder return ("TSR")1 performance criteria for the Market-based PRSUsawarded under the 2025/2027 LTIP, to measure performance by the percentile ranking of the Company's TSR relative to the TSRs for the companies making up the performance index, rather than being measured by comparison to the performance of the overall index as in prior years, to avoid unintended outsized impacts from outlier index constituents.
|
•
|
The committee adopted a cap on Market-based PRSU payoutsunder the 2025/2027 LTIP at 100% of target in the event the Company's absolute TSR is negative over the performance period, to ensure above target payouts only occur in the event of absolute return to shareholders.
|
1
|
TSR is determined using "total return" stock price performance, assuming dividends are reinvested on the ex-dividend date.
|
34
|
Table of Contents
•
|
provide competitive compensation to attract and retain top talent;
|
•
|
provide total compensation packages that are fair to employees and reward corporate, organizational, and individual performance;
|
•
|
align pay with business objectives while driving exceptional performance;
|
•
|
optimize value to employees while maintaining cost-effectiveness to the Company;
|
•
|
create stockholder value over the long-term;
|
•
|
align our annual program to annual performance and our long-term program to longer-term performance;
|
•
|
recognize that a long-term, high-quality management team is a competitive differentiator for Lam, enhancing customer trust/market share and, therefore, stockholder value; and
|
•
|
provide rewards when results have been demonstrated.
|
•
|
performance that creates long-term stockholder value;
|
•
|
outstanding performance at the corporate, organization, and individual levels; and
|
•
|
retention of a long-term, high-quality management team.
|
Lam Research Corporation 2025 Proxy Statement 35
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
Element
|
|
|
How it is Paid
|
|
|
Purpose/Design
|
|
|
Base Salary
|
|
|
Cash
|
|
|
We believe the purpose of base salary is to provide competitive compensation to attract and retain top talent and to provide employees, including our NEOs, with a fixed and fair amount of compensation for the jobs they perform. Accordingly, we seek to ensure that our base salary levels are competitive in reference to peer group practice and market survey data.
|
|
|
Annual Incentive Program (AIP)
|
|
|
Cash
|
|
|
Our annual incentive program is designed to provide annual, performance-based compensation that is based on the achievement of pre-set annual financial, strategic, and operational objectives aligned with outstanding performance, and will allow us to attract and retain top talent, while maintaining cost-effectiveness to the Company.
For more details regarding the design of the annual incentive program, see "III. Primary Components of NEO Compensation; CY2024 Compensation Payouts; CY2025 Compensation Targets and Metrics - Annual Incentive Program" below.
|
|
|
Long-Term Incentive Program (LTIP)(1)
|
|
|
A combination of:
•
Market-based PRSUs;
and
•
service-based RSUs
|
|
|
Our long-term incentive program is designed to attract and retain top talent, provide competitive levels of compensation, align pay with stock performance over a multi-year period, reward our NEOs for outstanding Company performance, and create stockholder value over the long-term.
To accomplish these objectives, the program design provides that the target award opportunity is awarded in a combination of Market-based PRSUs and service-based RSUs.
For more details regarding the design of the LTIP, see "III. Primary Components of NEO Compensation; CY 2024 Compensation Payouts; CY 2025 Compensation Targets and Metrics - Long-Term Incentive Program - Design" below.
|
|
|
|
|
|
|
|
|
|
|
(1)
|
As is initially noted above, the Company's LTIP previously included stock options prior to an update made by the committee for the 2025/2027 LTIP.
|
(1)
|
The calendar year 2024 average NEO target pay mix is based on the Company's NEOs for fiscal year 2024, and the calendar year 2025 average NEO target pay mix is based on the NEOs for fiscal year 2025. As such, the calendar year 2024 average pay mix includes compensation paid to Dr. Vahid Vahedi who was classified as an NEO for fiscal year 2024, and does not include Ms. Harter who commenced her employment with the Company in July 2024 after the end of the Company's fiscal year 2024. For additional detail regarding Ms. Harter's calendar 2024 LTIP award which was made during fiscal year 2025, see "III. Primary Components of NEO Compensation; CY 2024 Compensation Payouts; CY 2025 Compensation Targets and Metrics - Long-Term Incentive Program - Calendar Year 2024 LTIP Decisions" and for additional detail regarding Ms. Harter's new hire compensation, see "III. Primary Components of NEO Compensation; CY 2024 Compensation Payouts; CY 2025 Compensation Targets and Metrics - New Hire Compensation" for further information.
|
(2)
|
The term "At-risk pay", as used in Figure 27, above, refers to all compensation other than base salary.
|
36
|
Table of Contents
(3)
|
The Company's LTIP design provides that the target award opportunity is awarded in a combination of Market-based PRSUs, service-based RSUs and, in prior years, stock options. We consider Market-based PRSUs and stock options to be performance-based, but do not classify service-based RSUs as performance-based notwithstanding the variable pay outcome they provide.
|
|
|
|
|
|
|
|
|
|
|
Topics
|
|
|
What we heard from our stockholders
|
|
|
Our perspective/How we responded
|
|
|
Our Annual Incentive Program
|
|
|
We continued to receive favorable feedback from stockholders on our addition of the Profitability Performance Factor as the third component of the AIP, and, more specifically, the selection of non-GAAP gross margin as the Profitability Performance Metric.
|
|
|
We maintained the structure of our AIP, including the Profitability Performance Factor with non-GAAP gross margin as the relevant metric, in light of both the overall positive feedback we received from stockholders regarding that change, as well as the continuing importance of this metric to our business and financial results.
|
|
|
Our Long-Term Incentive Program
|
|
|
Overall, stockholders continued to be satisfied with the design and pay-for-performance alignment of our LTIP, and also expressed positive remarks regarding the alignment of our vesting periods and performance structure. A number of stockholders noted interest in the addition of a payout cap on negative absolute TSR performance.
|
|
|
The committee regularly evaluates the structure of our compensation programs, with the assistance of its compensation consultant, to ensure that our programs continue to serve their intended purposes. In light of feedback we received from stockholders, we structured our 2025 LTIP to cap payouts at 100% of target in the event of negative absolute TSR. For additional details, please see the section titled, "III. Primary Components of NEO Compensation; CY2024 Compensation Payouts; CY2025 Compensation Targets and Metrics" below
|
|
|
|
|
|
|
|
|
|
|
2
|
For purposes of this CD&A, a reference to a compensation action or decision by the committee with respect to our CEO means an action or decision by the independent members of our Board after considering the recommendation of the committee and, in the case of all other NEOs, an action or decision by the committee.
|
Lam Research Corporation 2025 Proxy Statement 37
|
Table of Contents
•
|
reviewing and approving the Company's executive compensation philosophy, objectives, and strategies;
|
•
|
reviewing and approving the appropriate peer group companies for purposes of evaluating the Company's compensation competitiveness;
|
•
|
reviewing, and approving where appropriate, equity-based compensation plans;
|
•
|
causing the Board to perform a periodic performance evaluation of our CEO;
|
•
|
recommending to the independent members of the Board corporate goals and objectives under the Company's compensation plans, compensation packages (e.g., annual base salary level, annual cash incentive award, long-term incentive award and any employment agreement, severance arrangement, change-in-control arrangement, equity grant, or special or supplemental benefits, and any material amendment to any of the foregoing) applicable to our CEO, and compensation payouts for our CEO;
|
•
|
annually reviewing with our CEO the performance of the Company's other executive officers in light of the Company's executive compensation goals and objectives and approving the compensation packages and compensation payouts for such individuals;
|
•
|
reviewing and recommending for appropriate Board action all cash, equity-based, and other compensation packages, and compensation payouts applicable to the chair and other non-employee members of the Board;
|
•
|
overseeing management's determination as to whether the compensation policies and practices, including those related to pay equity laws, create risks that are reasonably likely to have a material adverse effect on the Company;
|
•
|
reviewing the results of "Say on Pay" votes and considering whether any adjustments to the Company's executive compensation program are appropriate; and
|
•
|
establishing stock ownership guidelines applicable to the Company's executive officers and recommending to the Board stock ownership guidelines applicable to the chair and other members of the Board.
|
38
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
Metric
|
|
|
Lam Research
($M)
|
|
|
Target for Peer Group
|
|
|
Peer Group
Median
($M)
|
|
|
Revenue (last completed reported four quarters as of July 2, 2024)
|
|
|
14,241
|
|
|
Approximately 0.33 to 3 times Lam
|
|
|
16,801
|
|
|
Market Capitalization (30-day average as of July 2, 2024)
|
|
|
131,343
|
|
|
Approximately 0.33 to 3 times Lam
|
|
|
130,926
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advanced Micro Devices, Inc.
|
|
|
Cisco Systems, Inc.
|
|
|
Microchip Technology Incorporated
|
|
|
Qualcomm Incorporated
|
|
|
Agilent Technologies, Inc.
|
|
|
Corning Incorporated
|
|
|
Micron Technology, Inc.
|
|
|
Texas Instruments Inc.
|
|
|
Analog Devices, Inc.
|
|
|
Intel Corporation
|
|
|
NVIDIA Corporation
|
|
|
|
|
|
Applied Materials, Inc.
|
|
|
KLA Corporation
|
|
|
NXP Semiconductors N.V.
|
|
|
|
|
|
Broadcom Inc.
|
|
|
Marvell Technology, Inc.
|
|
|
ON Semiconductor Corporation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 39
|
Table of Contents
40
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Annual Base Salary
2025(1)
($)
|
|
|
Annual Base Salary
2024(2)
($)
|
|
|
Timothy M. Archer
|
|
|
1,300,000
|
|
|
1,200,000
|
|
|
Douglas R. Bettinger
|
|
|
775,000
|
|
|
726,150
|
|
|
Patrick J. Lord
|
|
|
725,000
|
|
|
685,000
|
|
|
Ava A. Harter
|
|
|
693,450
|
|
|
670,000(3)
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
766,000
|
|
|
685,000
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Effective February 17, 2025
|
(2)
|
Effective May 27, 2024
|
(3)
|
Ms. Harter's base salary took effect upon commencement of employment on July 8, 2024.
|
Lam Research Corporation 2025 Proxy Statement 41
|
Table of Contents
(1)
|
By excluding certain costs and expenses that are not indicative of core results, non-GAAP results are more useful for analyzing business trends over multiple periods.
|
(2)
|
For an illustration of the Individual Performance Factor components, see "Figure 37. Individual Performance Factor Components for Calendar Year 2024" below.
|
42
|
Table of Contents
•
|
Over the three years through calendar year 2022, the committee raised the Corporate Performance Factor goal year-over-year each year as our outlook and the industry outlook improved (there was no Profitability Performance Factor in these years).
|
•
|
For calendar year 2023, the weakened industry outlook for wafer fabrication equipment spending prompted the committee to establish a Corporate Performance Factor goal that was below that of the prior year, reflecting the increased difficulty of achieving similar profitability on a significantly smaller revenue base. The committee also for the first time established a Profitability Performance Factor goal, with the metric of non-GAAP gross margin, in light of the focus by the Board, committee, and management team on the profitability of the Company, setting a stretch goal relative to our Annual Operating Plan.
|
•
|
In calendar year 2024, the committee established a slightly increased Corporate Performance Factor goal to incentivize improved performance relative to calendar year 2023, despite continued industry uncertainty. The committee also continued to include a Profitability Performance Factor, and established a significantly increased goal, reflecting the continued focus on profitability.
|
Lam Research Corporation 2025 Proxy Statement 43
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Target Award
Opportunity
(% of Base Salary)
|
|
|
Target Award
Opportunity
($)(1)
|
|
|
Timothy M. Archer
|
|
|
200
|
|
|
2,400,000
|
|
|
Douglas R. Bettinger
|
|
|
115
|
|
|
835,073
|
|
|
Patrick J. Lord
|
|
|
110
|
|
|
753,500
|
|
|
Ava A. Harter(2)
|
|
|
90
|
|
|
291,852
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
100
|
|
|
685,000
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Calculated by multiplying each NEO's annual base salary as of October 1, 2024 by their respective target award opportunity percentage.
|
(2)
|
Ms. Harter's calendar year 2024 target award opportunity reflects a pro-rated amount calculated to account for her commencement with the Company starting in July 2024.
|
44
|
Table of Contents
(1)
|
Minimum is set by the Funding Factor.
|
(2)
|
Appendix B contains a reconciliation of non-GAAP operating margin and non-GAAP gross margin to the results reported in our financial statements.
|
Lam Research Corporation 2025 Proxy Statement 45
|
Table of Contents
(1)
|
Market Performance and Execution relate to: growth in our served addressable market; success of new product launches; penetration of new market opportunities and defense of established positions; and achievement of market share targets, among other factors.
|
(2)
|
Safety, Quality and Customer Satisfaction relate to: safety; quality; growth of Customer Support Business Group revenue; on-time and complete delivery of products; and customer satisfaction, among other factors.
|
(3)
|
Human Capital and Sustainability relate to: employee engagement, as measured by employee survey; talent retention; and recognition of sustainability progress through continued inclusion in the Dow Jones Best-in-Class North America Index, among other factors.
|
(4)
|
Financial Performance relates to: operating income; earnings per share; and improvement of gross margin, among other factors.
|
(5)
|
Mr. Archer's Individual Performance Factor was determined as the average of the Individual Performance Factors of the other NEOs.
|
(6)
|
Individual Performance Factors were rounded up to the nearest two decimal places.
|
46
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Target Award
Opportunity
($)(1)
|
|
|
Maximum Award Opportunity
Funding Factor (250.0% of
Target Award Opportunity)
($)(2)
|
|
|
Individual
Performance
Factor
|
|
|
Corporate
Performance
Factor
|
|
|
Profitability
Performance
Factor
|
|
|
Actual
Payouts
($)(3)
|
|
|
Timothy M. Archer
|
|
|
2,400,000
|
|
|
6,000,000
|
|
|
1.05
|
|
|
1.06
|
|
|
1.10
|
|
|
2,938,320
|
|
|
Douglas R. Bettinger
|
|
|
835,073
|
|
|
2,087,683
|
|
|
1.05
|
|
|
1.06
|
|
|
1.10
|
|
|
1,022,379
|
|
|
Patrick J. Lord
|
|
|
753,500
|
|
|
1,883,750
|
|
|
1.05
|
|
|
1.06
|
|
|
1.10
|
|
|
922,510
|
|
|
Ava A. Harter(4)
|
|
|
291,852
|
|
|
729,630
|
|
|
1.05
|
|
|
1.06
|
|
|
1.10
|
|
|
357,314
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
685,000
|
|
|
1,712,500
|
|
|
1.05
|
|
|
1.06
|
|
|
1.10
|
|
|
838,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Calculated by multiplying each NEO's annual base salary as of October 1, 2024 by their respective target award opportunity percentage.
|
(2)
|
The Funding Factor resulted in annual incentive program funding at 250.0% of target award opportunity for the calendar year (based on the actual non-GAAP operating margin results and the specific goal detailed under "2024 Annual Incentive Program Funding Factor, Corporate Performance Factor, and Profitability Performance Factor" above).
|
(3)
|
Calculated by multiplying each NEO's target award opportunity, in dollars, by each of (i) the Corporate Performance Factor of 1.06, (ii) the Profitability Performance Factor of 1.10, and (iii) that NEO's individual Performance Factor.
|
(4)
|
Ms. Harter's calendar year 2024 target award opportunity reflects a pro-rated amount calculated to account for her commencement with the Company starting in July 2024.
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Target Award Opportunity
(% of Base Salary)
|
|
|
Timothy M. Archer
|
|
|
200
|
|
|
Douglas R. Bettinger
|
|
|
115
|
|
|
Patrick J. Lord
|
|
|
110
|
|
|
Ava A. Harter
|
|
|
90
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
100
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 47
|
Table of Contents
48
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
Equity Vehicles
|
|
|
Vesting
|
|
|
Terms
|
|
|
Market-based PRSUs
•
CEO/EVPs: 60% of Target Award Opportunity
•
SVPs: 55% of Target Award Opportunity
|
|
|
•
Awards cliff vest three years from the February 28, 2025 grant date (the "Grant Date") subject to satisfaction of a minimum performance requirement and continued employment.
•
Awards that vest at the end of the performance period are distributed in shares of our common stock.
|
|
|
•
The target number of Market-based PRSUs granted is determined by dividing the applicable percentage of the target opportunity by the 30 trading day average of the closing price of our common stock prior to the Grant Date, $81.35, rounded down to the nearest share.
•
The number of shares represented by the Market-based PRSUs that can be earned over the performance period is determined according to the performance parameters described in Figure 41 below.
|
|
|
Service-based RSUs
•
CEO/EVPs: 40% of Target Award Opportunity
•
SVPs: 45% of Target Award Opportunity
|
|
|
•
Awards vest one-third on the first, second, and third anniversaries of the Grant Date, subject to continued employment.
•
Awards are distributed in shares of our common stock upon vesting.
|
|
|
•
The number of RSUs granted is determined by dividing the applicable percentage of the target opportunity by the 30 trading day average of the closing price of our common stock prior to the Grant Date, $81.35, rounded down to the nearest share.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parameter
|
|
|
Terms
|
|
|
Performance Period
|
|
|
Three years from the first business day in February (February 3, 2025 through February 2, 2028).
|
|
|
Performance Index
|
|
|
PHLX Semiconductor Sector Total Return Index, or "XSOX index"
|
|
|
Number of Shares
|
|
|
•
Based on our TSR performance compared to the TSR performance of the components of the XSOX index, on a percentile rank basis. The TSR performance is measured using the average closing price for the 50 trading days prior to the dates the performance period begins and ends, assuming that any dividends paid are reinvested on the ex-dividend date. Percentile rank is rounded down to the nearest one tenth of a percentile using conventional rounding.
•
A table reflecting the potential payouts is shown below in Figure 42
•
The final shares awarded cannot exceed 100% of the target if our TSR is negative over the performance period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lam's TSR Percentile Rank
Compared to XSOX Index
|
|
|
Market-based PRSUs That Can Be Earned
(% of Target)(1)
|
|
|
75th percentile or more
|
|
|
150
|
|
|
50th percentile
|
|
|
100
|
|
|
25th percentile
|
|
|
50
|
|
|
Less than 25th percentile
|
|
|
0
|
|
|
|
|
|
|
|
(1)
|
The results of the vesting criteria (reflecting the number of Market-Based PRSUs that can be earned) are linearly interpolated between the stated percentiles and percentages. The result of the vesting criteria is rounded down to the nearest whole number.
|
Lam Research Corporation 2025 Proxy Statement 49
|
Table of Contents
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Target Award Opportunity(1)(2)
|
|
|
Timothy M. Archer
|
|
|
24,100,000
|
|
|
Douglas R. Bettinger
|
|
|
6,800,000
|
|
|
Patrick J. Lord
|
|
|
5,500,000
|
|
|
Ava A. Harter
|
|
|
3,500,000
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
5,650,000
|
|
|
|
|
|
|
|
(1)
|
Target award opportunities (expressed as a U.S. dollar value) are approved by the committee and converted to awards on the grant date as described in Figure 40 using the 30 trading day average of the closing price of our common stock prior to the Grant Date. Target award opportunities differ from the amounts shown in "Executive Compensation Tables" following this CD&A, which represent the grant date fair value of the awards determined in accordance with ASC 718.
|
(2)
|
The three-year performance period for the 2025/2027 LTIP began on February 3, 2025 and ends on February 2, 2028.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Target Award
Opportunity
($)
|
|
|
Market-based PRSUs
Award
(#)(1)
|
|
|
Service-based
RSUs Award
(#)
|
|
|
Timothy M. Archer
|
|
|
24,100,000
|
|
|
177,750
|
|
|
118,500
|
|
|
Douglas R. Bettinger
|
|
|
6,800,000
|
|
|
50,153
|
|
|
33,435
|
|
|
Patrick J. Lord
|
|
|
5,500,000
|
|
|
40,565
|
|
|
27,043
|
|
|
Ava A. Harter
|
|
|
3,500,000
|
|
|
23,663
|
|
|
19,360
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
5,650,000
|
|
|
38,199
|
|
|
31,253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The number of Market-based PRSUs awarded is reflected at target. The final number of shares that may be earned will be 0% to 150% of target.
|
|
|
|
|
|
|
|
Parameter
|
|
|
Terms
|
|
|
Performance Period
|
|
|
Three years from the first business day in February (February 1, 2022 through January 31, 2025).
|
|
|
Performance Index
|
|
|
PHLX Semiconductor Sector Total Return Index, or "XSOX index"
|
|
|
Number of Shares
|
|
|
•
Based on our TSR performance compared to the market price performance of the Performance Index, subject to a ceiling as shown in Figure 46 below. The TSR performance or market price performance is measured using the closing price for the 50 trading days prior to the dates the performance period begins and ends, assuming that any dividends paid on our common stock are reinvested on the ex-dividend date (consistent with the treatment of dividends in the Performance Index).
•
Potential payouts are as shown in Figure 46 below. The result of the vesting formula is rounded down to the nearest whole number.
|
|
|
|
|
|
|
|
50
|
Table of Contents
|
|
|
|
|
|
|
Lam's TSR % Change Performance
Compared to XSOX Index % Change Performance
|
|
|
Market-based PRSUs That Can Be Earned
(% of Target)(1)
|
|
|
+ 25% or more
|
|
|
150
|
|
|
10%
|
|
|
120
|
|
|
0% (equal to index)
|
|
|
100
|
|
|
- 10%
|
|
|
80
|
|
|
- 25%
|
|
|
50
|
|
|
- 50% or less
|
|
|
0
|
|
|
|
|
|
|
|
(1)
|
The results of the vesting formula (reflecting the number of Market-based PRSUs that can be earned) are linearly interpolated between the stated percentages.
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
Target Market-based
PRSUs
(#)
|
|
|
Actual Payout of Market-based PRSUs
(56.94% of Target Award Opportunity)
(#)
|
|
|
Timothy M. Archer
|
|
|
152,000
|
|
|
86,548
|
|
|
Douglas R. Bettinger
|
|
|
38,000
|
|
|
21,637
|
|
|
Patrick J. Lord
|
|
|
30,400
|
|
|
17,309
|
|
|
Ava A. Harter
|
|
|
-
|
|
|
-
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
25,540
|
|
|
14,542
|
|
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 51
|
Table of Contents
52
|
Table of Contents
|
|
|
|
|
|
|
Position
|
|
|
Guidelines
|
|
|
President and Chief Executive Officer
|
|
|
6x base salary
|
|
|
Executive Vice Presidents
|
|
|
2x base salary
|
|
|
Senior Vice Presidents
|
|
|
1x base salary
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 53
|
Table of Contents
|
|
|
|
|
|
|
Named Executive Officer
|
|
|
As of June 29, 2025
($)
|
|
|
Timothy M. Archer
|
|
|
810,000
|
|
|
Douglas R. Bettinger(1)
|
|
|
-
|
|
|
Patrick J. Lord(1)
|
|
|
-
|
|
|
Ava A. Harter(1)
|
|
|
-
|
|
|
Seshasayee (Sesha) Varadarajan(1)
|
|
|
-
|
|
|
|
|
|
|
|
(1)
|
Mr. Bettinger, Dr. Lord, Ms. Harter and Mr. Varadarajan are not eligible to participate under the terms of the program.
|
54
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Principal
Position
|
|
|
Fiscal Year
|
|
|
Salary
($)
|
|
|
Bonus
($)
|
|
|
Stock
Awards
($)(1)
|
|
|
Option
Awards
($)(2)
|
|
|
Non-Equity
Incentive Plan
Compensation
($)
|
|
|
All Other
Compensation
($)(3)
|
|
|
Total
($)
|
|
|
Timothy M. Archer
President, Chief
Executive Officer
|
|
|
2025
|
|
|
1,236,539
|
|
|
-
|
|
|
24,101,123
|
|
|
-
|
|
|
2,938,320(4)
|
|
|
22,179
|
|
|
28,298,161
|
|
|
2024
|
|
|
1,176,923
|
|
|
-
|
|
|
19,847,946
|
|
|
6,261,433
|
|
|
2,831,300(5)
|
|
|
17,439
|
|
|
30,135,041
|
|
|||
|
2023
|
|
|
1,150,000
|
|
|
-
|
|
|
11,291,907
|
|
|
3,643,192
|
|
|
2,212,600(6)
|
|
|
12,400
|
|
|
18,310,099
|
|
|||
|
Douglas R. Bettinger
Executive Vice President,
Chief Financial Officer
|
|
|
2025
|
|
|
743,999
|
|
|
-
|
|
|
6,800,221
|
|
|
-
|
|
|
1,022,379(4)
|
|
|
27,136
|
|
|
8,593,735
|
|
|
2024
|
|
|
720,591
|
|
|
-
|
|
|
5,353,700
|
|
|
1,689,107
|
|
|
1,001,195(5)
|
|
|
17,239
|
|
|
8,781,832
|
|
|||
|
2023
|
|
|
705,000
|
|
|
-
|
|
|
3,198,654
|
|
|
1,031,855
|
|
|
778,320(6)
|
|
|
12,183
|
|
|
5,726,012
|
|
|||
|
Patrick J. Lord
Executive Vice President,
Chief Operating Officer
|
|
|
2025
|
|
|
699,615
|
|
|
-
|
|
|
5,500,184
|
|
|
-
|
|
|
922,510(4)
|
|
|
19,805
|
|
|
7,142,114
|
|
|
2024
|
|
|
599,091
|
|
|
-
|
|
|
4,292,294
|
|
|
1,353,582
|
|
|
806,579(5)
|
|
|
15,736
|
|
|
7,067,282
|
|
|||
|
2023
|
|
|
577,661
|
|
|
-
|
|
|
2,633,964
|
|
|
849,515
|
|
|
610,010(6)
|
|
|
11,392
|
|
|
4,682,542
|
|
|||
|
Ava A. Harter
Senior Vice President,
Chief Legal Officer and
Secretary
|
|
|
2025
|
|
|
665,684
|
|
|
500,000(7)
|
|
|
8,388,408
|
|
|
517,991
|
|
|
357,314(4)
|
|
|
162,285
|
|
|
10,591,682
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Seshasayee (Sesha) Varadarajan
Senior Vice President,
Global Products Group
|
|
|
2025
|
|
|
714,596
|
|
|
2,560(8)
|
|
|
5,609,261
|
|
|
-
|
|
|
838,646(4)
|
|
|
15,789
|
|
|
7,180,852
|
|
|
2024
|
|
|
561,697
|
|
|
2,800(8)
|
|
|
4,528,866
|
|
|
857,469
|
|
|
649,805(5)
|
|
|
12,684
|
|
|
6,613,321
|
|
|||
|
2023
|
|
|
537,151
|
|
|
6,400(8)
|
|
|
2,603,133
|
|
|
520,842
|
|
|
516,739(6)
|
|
|
9,312
|
|
|
4,193,577
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amounts shown in this column represent the value of service-based RSU and Market-based PRSU awards granted, under the LTIP and, in the case of Ms. Harter, as a new hire award, in accordance with ASC 718. However, pursuant to SEC rules, these values are not reduced by an estimate for the probability of forfeiture. For fiscal year 2025, the aggregate grant date fair value of the RSU and Market-based PRSU awards that may be earned by each NEO assuming the highest level of performance conditions for the Market-based PRSU awards will be achieved is as follows: Mr. Archer: $31,750,594; Mr. Bettinger: $8,958,512; Dr. Lord: $7,245,855; Ms. Harter: $10,099,414; and Mr. Varadarajan: $7,253,112. The fair value of service-based RSUs was calculated based on the fair market value of the Company's common stock at the date of grant, discounted for dividends because the RSUs do not have dividend equivalent rights. The fair value of Market-based PRSUs granted in fiscal year 2025 under the 2025/2027 LTIP on February 28, 2025 was calculated using a Monte Carlo simulation model using the assumptions shown below.
|
|
|
|
|||||||||
|
Market-based PRSU Award Valuation Assumptions
|
|
|||||||||
|
Expected Volatility
|
|
|
Risk-free Interest Rate
|
|
|
Expected Term (Years)
|
|
|
Dividend Yield
|
|
|
44.06%
|
|
|
3.95%
|
|
|
2.92
|
|
|
1.20%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Market-based PRSU Award Valuation Assumptions
|
|
|||||||||
|
Expected Volatility
|
|
|
Risk-free Interest Rate
|
|
|
Expected Term (Years)
|
|
|
Dividend Yield
|
|
|
43.96%
|
|
|
3.77%
|
|
|
2.49
|
|
|
1.04%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2)
|
The amounts shown in this column represent the value of the stock option awards granted, under the LTIP, in accordance with ASC 718. However, pursuant to SEC rules, these values are not reduced by an estimate for the probability of forfeiture. The fair value of stock options granted in fiscal year 2025 was calculated using a Black-Scholes option valuation model using the assumptions shown below. For additional details regarding the grants see "Grants of Plan-Based Awards for Fiscal Year 2025" below.
|
|
|
|
|||||||||
|
Stock Option Award Valuation Assumptions
|
|
|||||||||
|
Expected Volatility
|
|
|
Risk-free Interest Rate
|
|
|
Expected Term (Years)
|
|
|
Dividend Yield
|
|
|
43.62%
|
|
|
3.61%
|
|
|
4.40
|
|
|
1.04%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 55
|
Table of Contents
(3)
|
Please refer to "All Other Compensation Table for Fiscal Year 2025," which immediately follows this table, for additional information.
|
(4)
|
Represents the amount earned and subsequently paid under the calendar year 2025 AIP.
|
(5)
|
Represents the amount earned and subsequently paid under the calendar year 2024 AIP.
|
(6)
|
Represents the amount earned and subsequently paid under the calendar year 2023 AIP.
|
(7)
|
Represents a new hire bonus.
|
(8)
|
Represents patent awards.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company Matching
Contribution to
the Company's
Section 401(k) Plan
($)
|
|
|
Company-Paid
Long-Term
Disability Insurance
Premiums
($)
|
|
|
Company
Contribution to the
Elective Deferred
Compensation Plan
($)
|
|
|
Other
($)
|
|
|
Total
($)
|
|
|
|
Timothy M. Archer
|
|
|
10,500
|
|
|
9,179
|
|
|
2,500
|
|
|
-
|
|
|
22,179
|
|
|
Douglas R. Bettinger
|
|
|
10,532
|
|
|
9,179
|
|
|
2,500
|
|
|
4,925(1)
|
|
|
27,136
|
|
|
Patrick J. Lord
|
|
|
11,937
|
|
|
5,843
|
|
|
-
|
|
|
2,025(2)
|
|
|
19,805
|
|
|
Ava A. Harter
|
|
|
14,166
|
|
|
8,105
|
|
|
-
|
|
|
140,014(3)
|
|
|
162,285
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
12,143
|
|
|
3,646
|
|
|
-
|
|
|
-
|
|
|
15,789
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents (1) the $4,900 cost of an executive medical examination benefit, and (2) a matching or employee-designated charitable contribution of $25 made by the Company pursuant to its employee gift match and volunteerism program, which is available to all Company employees.
|
(2)
|
Represents a matching or employee-designated charitable contribution made by the Company pursuant to its employee gift match and volunteerism program, which is available to all Company employees.
|
(3)
|
Represents (1) relocation expenses of $95,646 in connection with Ms. Harter's hiring, (2) a tax gross-up of $42,333 associated with Ms. Harter's relocation expenses, which is a benefit widely available to all of our employees, and (3) a matching or employee-designated charitable contribution of $2,035 made by the Company pursuant to its employee gift match and volunteerism program, which is available to all Company employees.
|
56
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
Estimated Future
Payouts Under
Non-Equity Incentive
Plan Awards
|
|
|
Estimated Future
Payouts Under
Equity Incentive
Plan Awards
|
|
|
All Other
Stock
Awards:
Number of
Shares of
Stock or
Units
(#)
|
|
|
All Other
Option
Awards:
Number of
Securities
Underlying
Options
(#)
|
|
|
Exercise
or Base
Price of
Option
Awards
($/Sh)
|
|
|
Grant Date
Fair Value
of Stock
and Option
Awards
($)(3)
|
||||||||||
|
Name
|
|
|
Award Type
|
|
|
Grant
Date
|
|
|
Approved Date
|
|
|
Target
($)(1)
|
|
|
Maximum
($)(1)
|
|
|
Target
(#)(2)
|
|
|
Maximum
(#)(2)
|
|
|||||||||||
|
Timothy M. Archer
|
|
|
Annual Incentive Program
|
|
|
N/A
|
|
|
2/5/25
|
|
|
2,600,000
|
|
|
6,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
LTIP-Equity
|
|||||||||||||||||||||||||||||||||
|
Market-based PRSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
177,750(4)
|
|
|
266,625(4)
|
|
|
|
|
|
|
|
|
15,298,943
|
||||||||
|
Service-based RSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
|
|
|
|
118,500(5)
|
|
|
|
|
|
|
8,802,180
|
|||||||||
|
Douglas R. Bettinger
|
|
|
Annual Incentive Program
|
|
|
N/A
|
|
|
2/5/25
|
|
|
891,250
|
|
|
2,228,125
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
LTIP-Equity
|
|||||||||||||||||||||||||||||||||
|
Market-based PRSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
50,153(4)
|
|
|
75,229(4)
|
|
|
|
|
|
|
|
|
4,316,669
|
||||||||
|
Service-based RSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
|
|
|
|
33,435(5)
|
|
|
|
|
|
|
2,483,552
|
|||||||||
|
Patrick J. Lord
|
|
|
Annual Incentive Program
|
|
|
N/A
|
|
|
2/5/25
|
|
|
797,500
|
|
|
1,993,750
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
LTIP-Equity
|
|||||||||||||||||||||||||||||||||
|
Market-based PRSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
40,565(4)
|
|
|
60,847(4)
|
|
|
|
|
|
|
|
|
3,491,430
|
||||||||
|
Service-based RSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
|
|
|
|
27,043(5)
|
|
|
|
|
|
|
2,008,754
|
|||||||||
|
Ava A. Harter
|
|
|
Annual Incentive Program
|
|
|
N/A
|
|
|
2/5/25
|
|
|
624,105
|
|
|
1,560,263
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Equity - 2024/2026 LTIP
|
|||||||||||||||||||||||||||||||||
|
Market-based PRSUs
|
|
|
8/5/24
|
|
|
8/4/24
|
|
|
|
|
|
|
22,030(6)
|
|
|
33,045(6)
|
|
|
|
|
|
|
|
|
1,385,423
|
||||||||
|
Service-based RSUs
|
|
|
8/5/24
|
|
|
8/4/24
|
|
|
|
|
|
|
|
|
|
|
12,020(7)
|
|
|
|
|
|
|
903,531
|
|||||||||
|
Stock Options
|
|
|
8/5/24
|
|
|
8/4/24
|
|
|
|
|
|
|
|
|
|
|
|
|
18,030(8)
|
|
|
77.04
|
|
|
517,991
|
||||||||
|
Equity - 2025/2027 LTIP
|
|||||||||||||||||||||||||||||||||
|
Market-based PRSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
23,663(4)
|
|
|
35,494(4)
|
|
|
|
|
|
|
|
|
2,036,674
|
||||||||
|
Service-based RSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
|
|
|
|
19,360(5)
|
|
|
|
|
|
|
1,438,061
|
|||||||||
|
New Hire RSU Award
|
|
|
8/5/24
|
|
|
8/4/24
|
|
|
|
|
|
|
|
|
|
|
35,050(5)
|
|
|
|
|
|
|
2,624,719
|
|||||||||
|
Seshasayee (Sesha) Varadarajan
|
|
|
Annual Incentive Program
|
|
|
N/A
|
|
|
2/5/25
|
|
|
766,000
|
|
|
1,915,000
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
LTIP-Equity
|
|||||||||||||||||||||||||||||||||
|
Market-based PRSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
38,199(4)
|
|
|
57,298(4)
|
|
|
|
|
|
|
|
|
3,287,788
|
||||||||
|
Service-based RSUs
|
|
|
2/28/25
|
|
|
2/5/25
|
|
|
|
|
|
|
|
|
|
|
31,253(5)
|
|
|
|
|
|
|
2,321,473
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The calendar year 2025 AIP target and maximum estimated future payouts reflected in this table were calculated using the base salary for calendar year 2025. Awards payouts range from 0% to 250% of target.
|
(2)
|
The amounts reported represent the target and maximum number of Market-based PRSUs that may vest on the terms described in "Executive Compensation and Other Information - Compensation Discussion and Analysis" above. The number of shares that may be earned is equal to from 0% to 150% of target.
|
(3)
|
The amounts reported represent the fair value of Market-based PRSU, service-based RSU, and stock option awards granted during fiscal year 2025 in accordance with ASC 718. However, pursuant to SEC rules, these values are not reduced by an estimate for the probability of forfeiture. For details regarding the assumptions used to calculate the fair value of awards granted during fiscal year 2025, see notes 1 and 2 to the "Summary Compensation Table" above.
|
(4)
|
The Market-based PRSUs will vest on the third anniversary of the grant date, subject to continued employment. The actual conversion of Market-based PRSUs into shares of Lam common stock following the conclusion of the three-year performance period will range from 0% to 150% of the target amount, depending upon the percentile ranking of Lam's TSR relative to the TSR of the companies in the XSOX index over the applicable three-year performance period.
|
(5)
|
The RSUs will vest in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued employment.
|
(6)
|
The Market-based PRSUs will vest on March 1, 2027, subject to continued employment. The actual conversion of Market-based PRSUs into shares of Lam common stock following the conclusion of the three-year performance period will range from 0% to 150% of the target amount, depending upon Lam's TSR performance compared to the market price performance of the XSOX index over the applicable three-year performance period.
|
(7)
|
The RSUs will vest in three equal installments on March 1 of 2025, 2026 and 2027, subject to continued employment.
|
(8)
|
The stock options will become exercisable in three equal installments on March 1 of 2025, 2026 and 2027, subject to continued employment.
|
Lam Research Corporation 2025 Proxy Statement 57
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
||||||||||||||||||||
|
Name
|
Grant Date
|
|
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
|
|
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
|
|
|
Option
Exercise
Price
($)
|
|
|
Option
Expiration
Date
|
|
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)
|
|
|
Market Value
of Shares or
Units of
Stock That
Have Not
Vested
($)(1)
|
|
|
Equity Incentive
Plan Awards:
Number of
Unearned
Shares, Units or
Other Rights
That Have
Not Vested
(#)
|
|
|
Equity Incentive
Plan Awards:
Market or Payout
Value of Unearned
Shares, Units or
Other Rights
That Have
Not Vested
($)(1)
|
|
|
Timothy M. Archer
|
2/28/2025(2)
|
|
|
|
|
|
|
|
|
|
|
118,500
|
|
|
11,518,200
|
|
|
-
|
|
|
-
|
|
||||
2/28/2025(3)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
177,750
|
|
|
17,277,300
|
|
||||||
3/1/2024(4)
|
|
|
49,080
|
|
|
98,160
|
|
|
98.15
|
|
|
3/1/31
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2024(2)
|
|
|
|
|
|
|
|
|
|
|
32,720
|
|
|
3,180,384
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2024(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
147,260
|
|
|
14,313,672
|
|
||||||
3/1/2023(4)
|
|
|
120,680
|
|
|
60,340
|
|
|
49.09
|
|
|
3/1/30
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2023(2)
|
|
|
|
|
|
|
|
|
|
|
20,120
|
|
|
1,955,664
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2023(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
181,020
|
|
|
17,595,144
|
|
||||||
3/1/2022(4)
|
|
|
151,980
|
|
|
-
|
|
|
54.06
|
|
|
3/1/29
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2021(4)
|
|
|
59,970
|
|
|
-
|
|
|
59.88
|
|
|
3/1/28
|
|
|
|
|
|
|
|
|
|
||||||
3/2/2020(4)
|
|
|
121,400
|
|
|
-
|
|
|
30.03
|
|
|
3/2/27
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2019(4)
|
|
|
113,300
|
|
|
-
|
|
|
17.68
|
|
|
3/1/26
|
|
|
|
|
|
|
|
|
|
||||||
|
Douglas R. Bettinger
|
2/28/2025(2)
|
|
|
|
|
|
|
|
|
|
|
33,435
|
|
|
3,249,882
|
|
|
-
|
|
|
-
|
|
||||
2/28/2025(3)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
50,153
|
|
|
4,874,872
|
|
||||||
3/1/2024(4)
|
|
|
13,240
|
|
|
26,480
|
|
|
98.15
|
|
|
3/1/31
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2024(2)
|
|
|
|
|
|
|
|
|
|
|
8,830
|
|
|
858,276
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2024(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
39,720
|
|
|
3,860,784
|
|
||||||
3/1/2023(4)
|
|
|
34,180
|
|
|
17,090
|
|
|
49.09
|
|
|
3/1/30
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2023(2)
|
|
|
|
|
|
|
|
|
|
|
5,700
|
|
|
554,040
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2023(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
51,280
|
|
|
4,984,416
|
|
||||||
3/1/2022(4)
|
|
|
37,980
|
|
|
-
|
|
|
54.06
|
|
|
3/1/29
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2021(4)
|
|
|
16,620
|
|
|
-
|
|
|
59.88
|
|
|
3/1/28
|
|
|
|
|
|
|
|
|
|
||||||
3/2/2020(4)
|
|
|
11,710
|
|
|
-
|
|
|
30.03
|
|
|
3/2/27
|
|
|
|
|
|
|
|
|
|
||||||
|
Patrick J. Lord
|
2/28/2025(2)
|
|
|
|
|
|
|
|
|
|
|
27,043
|
|
|
2,628,580
|
|
|
-
|
|
|
-
|
|
||||
2/28/2025(3)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
40,565
|
|
|
3,942,918
|
|
||||||
3/1/2024(4)
|
|
|
10,610
|
|
|
21,220
|
|
|
98.15
|
|
|
3/1/31
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2024(2)
|
|
|
|
|
|
|
|
|
|
|
7,080
|
|
|
688,176
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2024(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
31,850
|
|
|
3,095,820
|
|
||||||
3/1/2023(4)
|
|
|
14,070
|
|
|
14,070
|
|
|
49.09
|
|
|
3/1/30
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2023(2)
|
|
|
|
|
|
|
|
|
|
|
4,690
|
|
|
455,868
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2023(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
42,230
|
|
|
4,104,756
|
|
||||||
3/1/2022(4)
|
|
|
10,130
|
|
|
-
|
|
|
54.06
|
|
|
3/1/29
|
|
|
|
|
|
|
|
|
|
||||||
|
Ava A. Harter
|
2/28/2025(2)
|
|
|
|
|
|
|
|
|
|
|
19,360
|
|
|
1,881,792
|
|
|
-
|
|
|
-
|
|
||||
2/28/2025(3)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
23,663
|
|
|
2,300,044
|
|
||||||
8/5/2024(6)
|
|
|
6,010
|
|
|
12,020
|
|
|
77.04
|
|
|
8/5/31
|
|
|
|
|
|
|
|
|
|
||||||
8/5/2024(7)
|
|
|
|
|
|
|
|
|
|
|
8,020
|
|
|
779,544
|
|
|
-
|
|
|
-
|
|
||||||
8/5/2024(2)
|
|
|
|
|
|
|
|
|
|
|
35,050
|
|
|
3,406,860
|
|
|
-
|
|
|
-
|
|
||||||
8/5/2024(8)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
22,030
|
|
|
2,141,316
|
|
||||||
|
Seshasayee (Sesha) Varadarajan
|
2/28/2025(2)
|
|
|
|
|
|
|
|
|
|
|
31,253
|
|
|
3,037,792
|
|
|
-
|
|
|
-
|
|
||||
2/28/2025(3)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
38,199
|
|
|
3,712,943
|
|
||||||
3/1/2024(4)
|
|
|
7,960
|
|
|
15,920
|
|
|
98.15
|
|
|
3/1/31
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2024(2)
|
|
|
|
|
|
|
|
|
|
|
10,620
|
|
|
1,032,264
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2024(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
29,190
|
|
|
2,837,268
|
|
||||||
3/1/2023(4)
|
|
|
19,600
|
|
|
9,800
|
|
|
49.09
|
|
|
3/1/30
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2023(2)
|
|
|
|
|
|
|
|
|
|
|
6,540
|
|
|
635,688
|
|
|
-
|
|
|
-
|
|
||||||
3/1/2023(5)
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
35,950
|
|
|
3,494,340
|
|
||||||
3/1/2022(4)
|
|
|
20,880
|
|
|
-
|
|
|
54.06
|
|
|
3/1/29
|
|
|
|
|
|
|
|
|
|
||||||
3/1/2021(4)
|
|
|
12,270
|
|
|
-
|
|
|
59.88
|
|
|
3/1/28
|
|
|
|
|
|
|
|
|
|
||||||
3/2/2020(4)
|
|
|
27,480
|
|
|
-
|
|
|
30.03
|
|
|
3/2/27
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Calculated by multiplying the number of unvested units by $97.20, the closing price of our common stock on June 29, 2025.
|
58
|
Table of Contents
(2)
|
The RSUs will vest in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued employment.
|
(3)
|
The Market-based PRSUs will vest on the third anniversary of the grant date, subject to continued employment. The Market-based PRSUs are shown at their target amount. The actual conversion of the Market-based PRSUs into shares of Lam common stock following the conclusion of the three-year performance period will range from 0% to 150% of that target amount, depending upon the percentile ranking of Lam's TSR relative to the TSR of the companies in the XSOX index over the applicable three-year performance period.
|
(4)
|
The stock options become exercisable in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued employment.
|
(5)
|
The Market-based PRSUs will vest on the third anniversary of the grant date, subject to continued employment. The Market-based PRSUs are shown at their target amount. The actual conversion of the Market-based PRSUs into shares of Lam common stock following the conclusion of the three-year performance period will range from 0% to 150% of that target amount, depending upon Lam's TSR performance compared to the market price performance of the XSOX index over the applicable three-year performance period.
|
(6)
|
The stock options become exercisable in three equal installments on March 1 of 2025, 2026 and 2027, subject to continued employment.
|
(7)
|
The RSUs vest on March 1 of 2025, 2026 and 2027, subject to continued employment.
|
(8)
|
The Market-based PRSUs will vest on March 1, 2027, subject to continued employment. The Market-based PRSUs are shown at their target amount. The actual conversion of the Market-based PRSUs into shares of Lam common stock following the conclusion of the three-year performance period will range from 0% to 150% of that target amount, depending upon Lam's TSR performance compared to the market price performance of the XSOX index over the applicable three-year performance period.
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|||||||
|
Name
|
|
|
Number of
Shares Acquired
on Exercise
(#)
|
|
|
Value Realized
on Exercise
($)
|
|
|
Number of
Shares Acquired
on Vesting
(#)
|
|
|
Value Realized
on Vesting
($)
|
|
|
Timothy M. Archer
|
|
|
-
|
|
|
-
|
|
|
139,908
|
|
|
10,736,540
|
|
|
Douglas R. Bettinger
|
|
|
-
|
|
|
-
|
|
|
35,967
|
|
|
2,760,108
|
|
|
Patrick J. Lord
|
|
|
-
|
|
|
-
|
|
|
28,909
|
|
|
2,218,477
|
|
|
Ava A. Harter
|
|
|
-
|
|
|
-
|
|
|
4,000
|
|
|
306,960
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
110,080
|
|
|
7,913,904
|
|
|
31,032
|
|
|
2,381,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The table shows all stock options exercised and the value realized upon exercise, and all RSUs and Market-based PRSUs vested and the value realized upon vesting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Executive
Contributions
in FY 2025
($)(1)
|
|
|
Registrant
Contributions
in FY 2025
($)(2)
|
|
|
Aggregate
Earnings in
FY 2025
($)(3)
|
|
|
Aggregate
Balance at
2025 Fiscal
Year-End
($)(4)
|
|
|
Timothy M. Archer
|
|
|
866,318
|
|
|
2,500
|
|
|
1,490,811
|
|
|
15,036,657
|
|
|
Douglas R. Bettinger
|
|
|
952,549
|
|
|
2,500
|
|
|
733,159
|
|
|
9,497,149
|
|
|
Patrick J. Lord
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Ava A. Harter
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Seshasayee (Sesha) Varadarajan
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The entire amount of each executive's contributions in fiscal year 2025 is reported in each respective NEO's compensation in our fiscal year 2025 "Summary Compensation Table" above.
|
(2)
|
Represents the amount that Lam credited to the Elective Deferred Compensation Plan (the "EDCP"), which is 3% of the executive's salary contribution during calendar years 2024 and 2025, to a maximum annual benefit of $2,500. These amounts are included in the "Summary Compensation Table" and "All Other Compensation Table for Fiscal Year 2025"above.
|
(3)
|
The NEOs did not receive above-market or preferential earnings in fiscal year 2025.
|
(4)
|
The fiscal year-end balance includes $8,644,511 for Mr. Archer and $4,744,873 for Mr. Bettinger that were previously reported in our Summary Compensation Tables in previous years. The fiscal year-end balance includes $13,826,786 for Mr. Archer and $9,497,149 for Mr. Bettinger that was contributed after December 31, 2004, or constitutes earnings on such contributions, and which is subject to distribution in the event of a Change in Control (as defined in the EDCP) as described in "Potential Payments upon Termination or Change in Control - Elective Deferred Compensation Plan"below.
|
Lam Research Corporation 2025 Proxy Statement 59
|
Table of Contents
60
|
Table of Contents
Lam Research Corporation 2025 Proxy Statement 61
|
Table of Contents
|
|
|
|||||||||||||||
|
Potential Payments to Mr. Archer Upon Termination or Change in Control as of June 29, 2025
|
|
|||||||||||||||
|
|
|
|
|
Involuntary Termination
|
|
|||||||||||
|
|
|
Voluntary
Termination
($)
|
|
|
Disability
or Death
($)
|
|
|
For
Cause
($)
|
|
|
Not for
Cause
($)
|
|
|
Change in Control or
Acquisition by Lam
($)
|
|
|
|
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Severance
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1,950,000
|
|
|
2,600,000
|
|
|
Short-term Incentive (5-year average)
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
2,649,758
|
|
|
5,299,516
|
|
|
Short-term Incentive (pro rata)
|
|
|
-
|
|
|
1,083,333
|
|
|
-
|
|
|
1,083,333
|
|
|
1,104,066
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Stock Options (Unvested and Accelerated)
|
|
|
-
|
|
|
2,902,837
|
|
|
-
|
|
|
725,709
|
|
|
2,902,837
|
|
|
Service-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
16,654,248
|
|
|
-
|
|
|
886,464
|
|
|
16,654,248
|
|
|
Performance-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
56,619,194
|
|
|
-
|
|
|
24,391,757
|
|
|
50,404,906
|
|
|
Benefits and Perquisites
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Health Benefit Continuation/Retiree Health Plans
|
|
|
810,000
|
|
|
810,000
|
|
|
810,000
|
|
|
810,000
|
|
|
810,000
|
|
|
Total
|
|
|
810,000
|
|
|
78,069,612
|
|
|
810,000
|
|
|
32,497,021
|
|
|
79,775,573
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62
|
Table of Contents
|
|
|
|||||||||||||||
|
Potential Payments to Mr. Bettinger Upon Termination or Change in Control as of June 29, 2025
|
|
|||||||||||||||
|
|
|
|
|
Involuntary Termination
|
|
|||||||||||
|
|
|
Voluntary
Termination
($)
|
|
|
Disability
or Death
($)
|
|
|
For
Cause
($)
|
|
|
Not for
Cause
($)
|
|
|
Change in Control or
Acquisition by Lam
($)
|
|
|
|
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Severance
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
775,000
|
|
|
1,162,500
|
|
|
Short-term Incentive (5-year average)
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
500,444
|
|
|
1,501,331
|
|
|
Short-term Incentive (pro rata)
|
|
|
-
|
|
|
371,354
|
|
|
-
|
|
|
371,354
|
|
|
417,036
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Stock Options (Unvested and Accelerated)
|
|
|
-
|
|
|
822,166
|
|
|
-
|
|
|
205,517
|
|
|
822,166
|
|
|
Service-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
4,662,198
|
|
|
-
|
|
|
245,722
|
|
|
4,662,198
|
|
|
Performance-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
15,857,694
|
|
|
-
|
|
|
6,834,229
|
|
|
14,083,502
|
|
|
Benefits and Perquisites
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Health Benefit Continuation/COBRA Benefit
|
|
|
-
|
|
|
35,022
|
|
|
-
|
|
|
35,022
|
|
|
35,022
|
|
|
Total
|
|
|
-
|
|
|
21,748,434
|
|
|
-
|
|
|
8,967,288
|
|
|
22,683,755
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Potential Payments to Dr. Lord Upon Termination or Change in Control as of June 29, 2025
|
|
|||||||||||||||
|
|
|
|
|
Involuntary Termination
|
|
|||||||||||
|
|
|
Voluntary
Termination
($)
|
|
|
Disability
or Death
($)
|
|
|
For
Cause
($)
|
|
|
Not for
Cause
($)
|
|
|
Change in Control or
Acquisition by Lam
($)
|
|
|
|
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Severance
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
725,000
|
|
|
1,087,500
|
|
|
Short-term Incentive (5-year average)
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
397,357
|
|
|
1,192,070
|
|
|
Short-term Incentive (pro rata)
|
|
|
-
|
|
|
332,292
|
|
|
-
|
|
|
332,292
|
|
|
331,131
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Stock Options (Unvested and Accelerated)
|
|
|
-
|
|
|
676,880
|
|
|
-
|
|
|
169,196
|
|
|
676,880
|
|
|
Service-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
3,772,624
|
|
|
-
|
|
|
199,940
|
|
|
3,772,624
|
|
|
Performance-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
12,886,095
|
|
|
-
|
|
|
5,582,780
|
|
|
11,446,272
|
|
|
Benefits and Perquisites
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Health Benefit Continuation/COBRA Benefit
|
|
|
-
|
|
|
52,534
|
|
|
-
|
|
|
52,534
|
|
|
52,534
|
|
|
Total
|
|
|
-
|
|
|
17,720,425
|
|
|
-
|
|
|
7,459,099
|
|
|
18,559,011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Potential Payments to Ms. Harter Upon Termination or Change in Control as of June 29, 2025
|
|
|||||||||||||||
|
|
|
|
|
Involuntary Termination
|
|
|||||||||||
|
|
|
Voluntary
Termination
($)
|
|
|
Disability
or Death
($)
|
|
|
For
Cause
($)
|
|
|
Not for
Cause
($)
|
|
|
Change in Control or
Acquisition by Lam
($)
|
|
|
|
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Severance
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1,040,175
|
|
|
Short-term Incentive (5-year average)
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1,107,378
|
|
|
Short-term Incentive (pro rata)
|
|
|
-
|
|
|
260,044
|
|
|
-
|
|
|
-
|
|
|
307,605
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Stock Options (Unvested and Accelerated)
|
|
|
-
|
|
|
242,335
|
|
|
-
|
|
|
-
|
|
|
242,335
|
|
|
Service-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
6,068,196
|
|
|
-
|
|
|
-
|
|
|
6,068,196
|
|
|
Performance-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
5,129,827
|
|
|
-
|
|
|
-
|
|
|
4,378,763
|
|
|
Benefits and Perquisites
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Health Benefit Continuation/COBRA Benefit
|
|
|
-
|
|
|
10,915
|
|
|
-
|
|
|
10,915
|
|
|
10,915
|
|
|
Total
|
|
|
-
|
|
|
11,711,317
|
|
|
-
|
|
|
10,915
|
|
|
13,155,367
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 63
|
Table of Contents
|
|
|
|||||||||||||||
|
Potential Payments to Mr. Varadarajan Upon Termination or Change in Control as of June 29, 2025
|
|
|||||||||||||||
|
|
|
|
|
Involuntary Termination
|
|
|||||||||||
|
|
|
Voluntary
Termination
($)
|
|
|
Disability
or Death
($)
|
|
|
For
Cause
($)
|
|
|
Not for
Cause
($)
|
|
|
Change in Control or
Acquisition by Lam
($)
|
|
|
|
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Severance
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1,149,000
|
|
|
Short-term Incentive (5-year average)
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1,006,173
|
|
|
Short-term Incentive (pro rata)
|
|
|
-
|
|
|
319,167
|
|
|
-
|
|
|
-
|
|
|
279,493
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Stock Options (Unvested and Accelerated)
|
|
|
-
|
|
|
471,458
|
|
|
-
|
|
|
-
|
|
|
471,458
|
|
|
Service-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
4,705,744
|
|
|
-
|
|
|
-
|
|
|
4,705,744
|
|
|
Performance-based Restricted Stock Units (Unvested and Accelerated)
|
|
|
-
|
|
|
11,662,640
|
|
|
-
|
|
|
-
|
|
|
10,305,824
|
|
|
Benefits and Perquisites
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Health Benefit Continuation/COBRA Benefit
|
|
|
-
|
|
|
49,845
|
|
|
-
|
|
|
49,845
|
|
|
49,845
|
|
|
Total
|
|
|
-
|
|
|
17,208,854
|
|
|
-
|
|
|
49,845
|
|
|
17,967,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Average Summary
Compensation
Table Total for
Non-PEO Named
Executive
Officers
($)(1)
|
|
|
Average
Compensation
Actually Paid to
Non-PEO Named
Executive
Officers
($)(1)(2)
|
|
|
Value of Initial Fixed $100
Investment Based On:(3)
|
|
|
|
|
|
||||||||
|
Fiscal
Year
|
|
|
Summary
Compensation
Table Total for
PEO
($)(1)
|
|
|
Compensation
Actually Paid to
PEO
($)(1)(2)
|
|
|
Total
Shareholder
Return
($)
|
|
|
Peer Group
Total
Shareholder
Return
($)(4)
|
|
|
Net Income
($ in
thousands)
|
|
|
Non-GAAP
Operating
Income as a
Percentage of
Revenue
(%)(5)
|
|
||||||
|
2025
|
|
|
28,298,161
|
|
|
14,697,241
|
|
|
8,377,096
|
|
|
7,038,953
|
|
|
340
|
|
|
307
|
|
|
5,358,217
|
|
|
32.3
|
|
|
2024
|
|
|
30,135,041
|
|
|
71,745,236
|
|
|
6,933,795
|
|
|
15,027,121
|
|
|
368
|
|
|
300
|
|
|
3,827,772
|
|
|
30.3
|
|
|
2023
|
|
|
18,310,099
|
|
|
35,457,770
|
|
|
4,654,089
|
|
|
8,924,931
|
|
|
209
|
|
|
190
|
|
|
4,510,931
|
|
|
30.7
|
|
|
2022
|
|
|
16,941,156
|
|
|
10,266,747
|
|
|
4,179,804
|
|
|
3,029,959
|
|
|
152
|
|
|
145
|
|
|
4,605,286
|
|
|
31.3
|
|
|
2021
|
|
|
15,495,736
|
|
|
56,855,461
|
|
|
4,171,767
|
|
|
17,871,377
|
|
|
211
|
|
|
171
|
|
|
3,908,458
|
|
|
31.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Timothy M. Archer was our CEO for each of the years presented. Our other NEOs, other than the CEO, during the years presented were as follows:
|
•
|
FY 2025: Douglas R. Bettinger, Patrick J. Lord, Ava A. Harter, and Seshasayee (Sesha) Varadarajan
|
•
|
FY 2024: Douglas R. Bettinger, Patrick J. Lord, Seshasayee (Sesha) Varadarajan, and Vahid Vahedi
|
•
|
FY 2023: Douglas R. Bettinger, Patrick J. Lord, Vahid Vahedi, and Seshasayee (Sesha) Varadarajan
|
•
|
FY 2022: Douglas R. Bettinger, Patrick J. Lord, Vahid Vahedi, and Seshasayee (Sesha) Varadarajan
|
•
|
FY 2021: Douglas R. Bettinger, Richard A. Gottscho, Patrick J. Lord, and Vahid Vahedi
|
(2)
|
The following table presents the amounts deducted from and added to our CEO's total compensation for each year, as well as the average amounts deducted from and added to the average of the total compensation for the other NEOs, other than the CEO, for each year, as reported in the Summary Compensation Table, in order to determine the "compensation actually paid" to our CEO and the average "compensation actually paid" to the other NEOs, in accordance with SEC rules. Neither our CEO nor the other NEOs participated in any defined benefit or actuarial pension plans (including supplemental plans) during the years presented, and no such plans are reported in the Summary Compensation Table. As a result, no information regarding deductions or additions related to pension plans is presented.
|
Lam Research Corporation 2025 Proxy Statement 65
|
Table of Contents
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
CEO
|
|
|
Other NEOs (Average)
|
|
|||||||||||||||||||||||||
|
Adjustments
|
|
|
FY 2025
|
|
|
FY 2024
|
|
|
FY 2023
|
|
|
FY 2022
|
|
|
FY 2021
|
|
|
FY 2025
|
|
|
FY 2024
|
|
|
FY 2023
|
|
|
FY 2022
|
|
|
FY 2021
|
|
|
Summary Compensation Table (SCT) Total
|
|
|
28,298,161
|
|
|
30,135,041
|
|
|
18,310,099
|
|
|
16,941,156
|
|
|
15,495,736
|
|
|
8,377,096
|
|
|
6,933,795
|
|
|
4,654,089
|
|
|
4,179,804
|
|
|
4,171,767
|
|
|
(Deduct): SCT "Stock Awards" column value
|
|
|
(24,101,123)
|
|
|
(19,847,946)
|
|
|
(11,291,907)
|
|
|
(10,079,176)
|
|
|
(11,071,172)
|
|
|
(6,574,519)
|
|
|
(4,371,479)
|
|
|
(2,709,589)
|
|
|
(2,122,367)
|
|
|
(2,591,242)
|
|
|
(Deduct): SCT "Option Awards" column value
|
|
|
-
|
|
|
(6,261,433)
|
|
|
(3,643,192)
|
|
|
(2,669,527)
|
|
|
(1,195,482)
|
|
|
(129,498)
|
|
|
(1,160,663)
|
|
|
(737,158)
|
|
|
(510,227)
|
|
|
(295,211)
|
|
|
Add: year-end fair value of equity awards granted in the applicable fiscal year that are outstanding and unvested as of the applicable fiscal year-end
|
|
|
33,443,663
|
|
|
26,917,750
|
|
|
18,979,835
|
|
|
11,041,230
|
|
|
13,042,142
|
|
|
9,026,385
|
|
|
4,637,696
|
|
|
4,391,629
|
|
|
2,280,231
|
|
|
3,081,156
|
|
|
Add (Deduct): year-over-year change in fair value of equity awards granted in prior years that are outstanding and unvested as of the applicable fiscal year-end
|
|
|
(7,464,817)
|
|
|
30,177,855
|
|
|
7,625,472
|
|
|
(7,109,304)
|
|
|
27,474,359
|
|
|
(1,313,954)
|
|
|
6,531,859
|
|
|
1,681,231
|
|
|
(1,644,600)
|
|
|
8,431,240
|
|
|
Add: vesting date fair value of equity awards granted and vested in the applicable fiscal year
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
117,447
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Add (Deduct): year-over-year change in fair value of equity awards granted in prior years that vested in the applicable fiscal year
|
|
|
(15,478,643)
|
|
|
10,623,969
|
|
|
5,477,463
|
|
|
2,142,368
|
|
|
13,109,878
|
|
|
(2,464,004)
|
|
|
2,455,913
|
|
|
1,644,729
|
|
|
847,118
|
|
|
5,073,667
|
|
|
(Deduct): fair value as of prior year-end of equity awards granted in prior years that failed to vest in the applicable fiscal year
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Add: dollar value of dividends/earnings paid on equity awards in the applicable fiscal year
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Compensation Actually Paid
|
|
|
14,697,241
|
|
|
71,745,236
|
|
|
35,457,770
|
|
|
10,266,747
|
|
|
56,855,461
|
|
|
7,038,953
|
|
|
15,027,121
|
|
|
8,924,931
|
|
|
3,029,959
|
|
|
17,871,377
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
Total shareholder return is calculated based on the value of an initial fixed investment of $100 on June 26, 2020 through the end of the listed fiscal year, and assuming dividends are reinvested.
|
(4)
|
The peer group used is the PHLX Semiconductor Sector Total Return Index, which is the same peer group used in Part II, Item 5 of our Form 10-K.
|
(5)
|
Appendix B contains a reconciliation of non-GAAP operating income as a percentage of revenue to the results reported in our financial statements.
|
66
|
Table of Contents
3
|
Appendix B contains a reconciliation of non-GAAP operating income as a percentage of revenue to the results reported in our financial statements.
|
Lam Research Corporation 2025 Proxy Statement 67
|
Table of Contents
(1)
|
Total shareholder return is calculated based on the value of an initial fixed investment of $100 on June 26, 2020 through the end of the listed fiscal year, and assuming dividends are reinvested.
|
(2)
|
Appendix B contains a reconciliation of non-GAAP operating income as a percentage of revenue to the results reported in our financial statements.
|
68
|
Table of Contents
|
|
|
|
Non-GAAP operating income as a percentage of revenue (Company-Selected Measure)
|
|
|
Relative TSR (defined as the Company's TSR relative to the TSR of the PHLX Semiconductor Sector Total Return Index)
|
|
|
Non-GAAP gross margin as a percentage of revenue
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 69
|
Table of Contents
|
|
Audit Matters
|
•
|
Received and discussed the audited financial statements with Company management;
|
•
|
Discussed with EY the matters required to be discussed by applicable requirements of the PCAOB and the SEC;
|
•
|
Received and discussed the written disclosures and the letter from EY as per applicable requirements of the PCAOB regarding the independent registered public accounting firm's communications with the audit committee concerning independence, and discussed with EY its independence; and
|
•
|
Based on the foregoing reviews and discussions, recommended to the Board that the audited financial statements be included in the Company's 2025 Annual Report on Form 10-K for the fiscal year ended June 29, 2025 for filing with the SEC.
|
70
|
Table of Contents
|
|
|
|
Independence Controls
|
|
|
Audit Committee Oversight - Oversight includes regular private sessions with the firm, discussions with the firm about the scope of its audit and business imperatives, a comprehensive annual evaluation when determining whether to engage the firm, and direct involvement by the audit committee and its chair in the selection of a new global coordinating partner in connection with the mandated rotation of this position.
|
|
|
Limits on Non-Audit Services - The audit committee preapproves all professional services (including audit services and permissible non-audit services) provided by the firm in accordance with its pre-approval policy.
|
|
|
Firm's Internal Independence Process - The independent registered public accounting firm conducts periodic internal reviews of its audit and other work, assesses the adequacy of partners and other personnel working on the Company's account, and rotates the lead assurance engagement partner, the global coordinating partner, and other partners on the engagement consistent with independence and rotation requirements established by the PCAOB and SEC.
|
|
|
Strong Regulatory Framework - Independent registered public accounting firms are subject to PCAOB inspections, peer reviews, and PCAOB and SEC oversight.
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 71
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year 2025
($)
|
|
|
Fiscal Year 2024
($)
|
|
|
|
Audit Fees(1)
|
|
|
7,953,223
|
|
|
7,666,615
|
|
|
Audit-Related Fees
|
|
|
-
|
|
|
-
|
|
|
Tax Fees(2)
|
|
|
236,158
|
|
|
308,247
|
|
|
All Other Fees(3)
|
|
|
-
|
|
|
41,270
|
|
|
TOTAL
|
|
|
8,189,382
|
|
|
8,016,132
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Audit Fees represent fees for professional services provided in connection with the audits of annual financial statements. Audit Fees also include reviews of quarterly financial statements, audit services related to other statutory or regulatory filings or engagements, and fees related to EY's audit of the effectiveness of the Company's internal control over financial reporting pursuant to section 404 of the Sarbanes-Oxley Act.
|
(2)
|
Tax Fees represent fees for professional services for tax planning, tax compliance, and review services related to foreign tax compliance and assistance with tax audits and appeals.
|
(3)
|
All Other Fees represent fees for permitted services other than the services reported in audit fees, audit-related fees, and tax fees.
|
72
|
Table of Contents
|
|
Voting Proposals
|
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" EACH OF THE ELEVEN DIRECTOR NOMINEES SET FORTH BELOW.
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 73
|
Table of Contents
|
|
|
|
|
|
||
Sohail U. Ahmed Director since 2019 Age 67 Board Committees:
•
Audit
° Member: 2022-2024
•
Compensation and
Human Resources ° Member: 2020-2022
•
Innovation and Technology
° Member since 2024 |
|
|
Experience
Sohail U. Ahmed is the former Senior Vice President and General Manager of the Technology and Manufacturing Group at Intel Corporation, a leading producer of microchips, computing and communications products, where he was responsible for overseeing the research and development and deployment of next-generation silicon logic technologies for production of future Intel microprocessors. He held that position from January 2015 to October 2018. Immediately prior to that, he was Corporate Vice President and General Manager, Logic Technology Department at Intel from 2004 to January 2015. Mr. Ahmed joined Intel in 1984, working as a process engineer, and held progressive technical and management positions in logic process development. Mr. Ahmed earned an M.S. degree in chemical engineering from the University of California, Davis, and a B.S. degree in chemical engineering from the University of Southern California. Qualifications The Board has concluded that Mr. Ahmed should serve as a director of the Company because of his extensive knowledge and experience acquired as an executive of a major semiconductor manufacturer focused on next-generation silicon logic technologies, his deep knowledge and understanding of semiconductor processing equipment technologies, and his experience as a senior executive of a major Company customer. Key Skills and Experiences
•
Industry Knowledge
•
Customer/Deep Technology Knowledge
•
Leadership Experience
•
Global Business Experience
•
Human Capital Management Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
74
|
Table of Contents
|
|
|
|
|
|
||
Timothy M. Archer Director since 2018 Age 58 Public company directorship in last five years:
•
Johnson Controls
International plc |
|
|
Experience
Timothy M. Archer has served as the Company's President and Chief Executive Officer since December 5, 2018. Mr. Archer joined the Company in June 2012 as our executive vice president, chief operating officer, and was promoted to president and chief operating officer in January 2018. Prior to joining us, he spent 18 years at Novellus Systems, Inc. in various technology development and business leadership roles, including most recently as chief operating officer from January 2011 to June 2012; executive vice president of Worldwide Sales, Marketing, and Customer Satisfaction from September 2009 to January 2011; and executive vice president of the PECVD and Electrofill Business Units from November 2008 to September 2009. His tenure at Novellus also included assignments as senior director of technology for Novellus Systems Japan from 1999 to 2001 and senior director of technology for the Electrofill Business Unit from April 2001 to April 2002. He started his career in 1989 at Tektronix, where he was responsible for process development for high-speed bipolar integrated circuits. Mr. Archer has served as a member of the board of directors of Johnson Controls International public limited company, a global provider of building technology, software, and services, since March 2024, where he is a member of the compensation and talent development committee. He also serves on the International Board of Directors for SEMI, the global industry association representing the electronics manufacturing and design supply chain. From 2020 to 2022, Mr. Archer served as chair of the board for the National GEM Consortium, a nonprofit organization that is dedicated to increasing the participation of underrepresented groups at the master's and doctoral levels in engineering and science. Mr. Archer completed the Program for Management Development at the Harvard Graduate School of Business and earned a B.S. degree in applied physics from the California Institute of Technology. Qualifications The Board has concluded that Mr. Archer should serve as a director of the Company because of his strong leadership; his knowledge and experience acquired from his current service as President, Chief Executive Officer and a director of the Company, and his past service as President and Chief Operating Officer, and as Executive Vice President and Chief Operating Officer of the Company; his deep knowledge and understanding of semiconductor processing equipment technologies; his understanding of our customers' markets and needs; and his mergers and acquisitions experience. Key Skills and Experiences
•
Industry Knowledge
•
Customer/Deep Technology Knowledge
•
Marketing, Disruptive Technology, and Strategy Experience
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Cybersecurity Experience
•
Human Capital Management Experience
•
Risk Management Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 75
|
Table of Contents
|
|
|
|
|
|
||
Eric K. Brandt Director since 2010 Age 63 Board Committees:
•
Audit
°
Chair since 2024,
previously 2014-2020 ° Member: 2010-2014
•
Compensation and
Human Resources ° Chair: 2020-2024
•
Nominating and
Governance ° Member since 2019
Public company
directorships in last five years:
•
Nutanix, Inc.
•
Option Care Health, Inc.
•
Gen Digital Inc.
•
The Macerich Company (former)
•
Dentsply Sirona Inc. (former)
|
|
|
Experience
Eric K. Brandt is the former Executive Vice President and Chief Financial Officer of Broadcom Corporation, a global supplier of semiconductor devices, a position he held from March 2007 until its merger with Avago Technologies Limited in February 2016. From September 2005 to March 2007, Mr. Brandt served as President and Chief Executive Officer of Avanir Pharmaceuticals, Inc., a pharmaceutical company. Prior to Avanir Pharmaceuticals, Mr. Brandt was Executive Vice President-Finance and Technical Operations and Chief Financial Officer of Allergan Inc., a global specialty pharmaceutical company, where he also held a number of other senior positions following his arrival there in May 1999. Mr. Brandt has served as a member of the board of directors of: Nutanix, Inc., a cloud computing company, since May 2025, where he serves as a member of the audit committee; Option Care Health, Inc., a health provider of home and alternate site infusion services, since May 2024, where he serves as a member of the compensation committee and the regulatory and compliance committee, and has served as a member of the finance and investment committee; Gen Digital Inc. (formerly NortonLifeLock, Inc.), a consumer cyber security provider, since February 2020, where he is the chair of the audit committee and serves on the nominating and governance committee; and Altaba Inc. (formerly Yahoo! Inc.), a private company that remained, and was subsequently renamed, following the completion of Yahoo!'s sale of its operating businesses in June 2017 (and which is in the process of a stockholder approved plan of dissolution and liquidation), since its inception, where he is the chair of the audit committee, and has served as chair of the board, chair of the nominating and governance committee, and a member of the compensation committee. He previously served on the board of directors of: The Macerich Company, a real estate investment trust focused on retail real estate, from June 2018 to June 2025, where he was the chair of the capital allocation committee and a member of the compensation committee; Dentsply Sirona Inc. (formerly Dentsply International, Inc.), a manufacturer and distributor of dental product solutions, from 2004 to 2024, where he was the non-executive chair of the board, chair of the executive committee, and served as a member of the corporate governance and nominating committee, the human resources committee, and the audit and finance committee; MC10, Inc., a privately-held medical device Internet of Things (IoT) company, from March 2016 until February 2018, where he was chair of the compensation committee and governance committee; Yahoo! Inc., a digital information discovery company, from March 2016 to June 2017, where he was chair of the board and chair of the audit and finance committee; Vertex Pharmaceuticals, Inc., a pharmaceutical company, from 2002 to 2009, where he was chair of the audit committee, and a member of the nominating and governance committee; and Avanir Pharmaceuticals from 2005 to 2007. Mr. Brandt earned an M.B.A. degree from the Harvard Graduate School of Business and a B.S. degree in chemical engineering from the Massachusetts Institute of Technology. He has competed the NYU Law - Nasdaq Cyber Scholar Program and the U.S. Secret Service and the National Association of Corporate Directors Cybersecurity Program. Qualifications The Board has concluded that Mr. Brandt should serve as a director of the Company because of his financial expertise including as a former chief financial officer of a publicly traded company that is a customer of our customers; his knowledge of and experience in the semiconductor industry and other technology industries; his mergers and acquisitions experience; his board governance experience from service on other public company boards, including as an audit committee member and chair, a compensation committee member, and a nominating and governance committee member and chair; and his cybersecurity expertise. Key Skills and Experiences
•
Industry Knowledge
•
Customer/Deep Technology Knowledge
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Cybersecurity Experience
•
Human Capital Management Experience
•
Risk Management Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
76
|
Table of Contents
|
|
|
|
|
|
||
Ita M. Brennan Director since 2024 Age 58 Board Committee:
•
Audit
° Member since 2024 Public company
directorships in last
five years:
•
Planet Labs PBC
•
Cadence Design Systems, Inc.
|
|
|
Experience
Ita M. Brennan is the former Senior Vice President, Chief Financial Officer of Arista Networks, Inc., a cloud networking solutions company, a position she held from May 2015 to February 2024. Over her career, Ms. Brennan has held several key finance roles. From March 2014 to May 2015, she served as Chief Financial Officer of QuantumScape Corporation, a battery manufacturing company. Prior to joining QuantumScape, she served as the Chief Financial Officer of Infinera Corporation, a telecommunications equipment company, from July 2006 to February 2014, and as Vice President of Finance and Corporate Controller from July 2006 to July 2010. From 1997 to 2006, Ms. Brennan held various roles at Maxtor Corporation, an information storage solutions company, including Vice President of Finance for the company's worldwide operations. Ms. Brennan has served as a member of the board of directors of: Nexthop Systems Inc., a privately held AI company, since March 2025; Planet Labs PBC, an earth imaging company, since June 2021, where she serves as the chair of the audit committee; Cadence Design Systems, Inc., a computational software company, since March 2020, where she serves as the chair of the corporate governance and nominating committee and a member of the audit committee; and the Community Services Agency, Mountain View, a provider of supportive services to the homeless population, since April 2024, where she serves as a member of the board and the chair of the finance committee. She previously served on the board of directors of LogMeIn, Inc., a provider of web-based remote access software and services, from November 2018 to September 2020, where she served as a member of the audit committee. Ms. Brennan studied accounting, finance, and management at the Institute of Chartered Accountants in Ireland, qualifying as a chartered accountant and fellow of the institute. In addition, Ms. Brennan is a public accounting alumna of Deloitte & Touche, having worked at the firm in both Ireland and the U.S. Qualifications The Board has concluded that Ms. Brennan should serve as a director of the Company because of her extensive financial and accounting expertise; her executive leadership experience from her roles as chief financial officer and other finance positions at companies in the technology industry; and her extensive board experience as a director on other public company boards, including service on audit and governance and nominating committees. Key Skills and Experiences
•
Industry Knowledge
•
Marketing, Disruptive Technology, and Strategy Experience
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Cybersecurity Experience
•
Risk Management Experience
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 77
|
Table of Contents
|
|
|
|
|
|
||
Michael R. Cannon Director since 2011 Age 72 Board Committees:
•
Audit
° Member: 2013-2024
•
Compensation and
Human Resources
°
Member since 2024, previously 2011-2013
•
Nominating and
Governance ° Chair since 2019 ° Member: 2011-2019 Public company
directorships in last
five years:
•
Seagate Technology Holdings plc
•
Dialog Semiconductor Plc
(former) |
|
|
Experience
Michael R. Cannon is the General Partner of MRC & LBC Partners, LLC, a private management consulting company. From February 2007 until his retirement in January 2009, Mr. Cannon served as President of Global Operations of Dell Inc., a computer systems manufacturer and services provider; and from January 2009 to January 2011, he served as a consultant to Dell. Prior to joining Dell, he was President and Chief Executive Officer of Solectron Corporation, an electronic manufacturing services company, from January 2003 to February 2007. From July 1996 to January 2003, Mr. Cannon served as President and Chief Executive Officer of Maxtor Corporation, a disk drive and storage systems manufacturer. Prior to joining Maxtor, Mr. Cannon held senior management positions at International Business Machines Corp. (IBM), a global services, software and systems company. Mr. Cannon has served as a member of the board of directors of Seagate Technology Holdings public limited company, a disk drive and storage solutions company, since February 2011, where he became chair of the board in July 2020, is a member of the nominating and corporate governance committee and the compensation and people committee, and has served as lead independent director, as the chair of the nominating and corporate governance committee, and as a member of the audit and finance committees. He previously served on the board of directors of Dialog Semiconductor Plc, a mixed signal integrated circuits company, from February 2013 until it was acquired in August 2021, where he served as the chair of the remuneration committee and as a member of the nomination committee; Adobe Systems Inc., a diversified software company, from December 2003 to April 2016, where he had been a member of the audit committee and chair of the compensation committee; Elster Group SE, a precision metering and smart grid technology company, from October 2010 until the company was acquired in August 2012; Solectron Corporation, an electronic manufacturing services company, from January 2003 to January 2007; and Maxtor Corporation, a disk drive and storage solutions company, from July 1996 until Seagate acquired Maxtor in May 2006. Mr. Cannon studied mechanical engineering at Michigan State University and completed the Advanced Management Program at the Harvard Graduate School of Business. Qualifications The Board has concluded that Mr. Cannon should serve as a director of the Company because of his industry knowledge; his marketing experience; his experience as President at a public corporation that is a customer of our customers; his finance experience; his 20 years of international business experience; his experience with mergers and acquisitions; and his extensive board experience as a director on other public company boards, including service on audit, compensation and nominating and governance committees. Key Skills and Experiences
•
Industry Knowledge
•
Marketing, Disruptive Technology, and Strategy Experience
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Cybersecurity Experience
•
Human Capital Management Experience
•
Risk Management Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
78
|
Table of Contents
|
|
|
|
|
|
||
John M. Dineen Director since 2023 Age 62 Board Committee:
•
Audit
° Member since 2023 Public company
directorships in last
five years:
•
Cognizant Technology
Solutions Corporation
•
Syneos Health, Inc. (former)
|
|
|
Experience
John M. Dineen served as an Operating Advisor at Clayton, Dubilier & Rice LLC, a private equity investment firm, from January 2015 to December 2022. Previously, Mr. Dineen served in various senior leadership roles at General Electric Company (GE), a global digital industrial company, from 1986 to 2014, where he managed several key business divisions of GE. Most recently, from 2008 to 2014, he was president and chief executive officer of London-based GE Healthcare, a leading provider of medical imaging, diagnostics, and other health information technology. Before that, he served as president and chief executive officer of GE Transportation from 2005 to 2008. In addition, he served in several international management roles in Asia and Europe during his time at GE. Mr. Dineen has served as a member of the board of directors of: Cognizant Technology Solutions Corporation, a professional services company, since April 2017, where he is the chair of the finance and strategy committee and a member of the audit committee and has served as a member of the nominating, governance, and public affairs committee. He previously served on the boards of directors of: Carestream Dental LLC, a privately-held provider of digital imaging, software, and practice management solutions for dental practitioners, where he has served as the chair of the board, from April 2017 to October 2024; Healogics, Inc., a privately-held provider of advanced wound care, from June 2015 to October 2024; Syneos Health, Inc., a fully integrated biopharmaceutical solutions company, from December 2018 to September 2023, where he served as the chair of the board; Merrimack Pharmaceuticals, Inc., a pharmaceutical company specializing in the development of drugs for the treatment of cancer, from June 2015 to October 2019, where he served as the chair of the organization and compensation committee; and Torque Therapeutics, Inc., a privately-held developer of immunotherapies to address cancers, that was since combined with Cogen Immune Medicine and renamed Repertoire Immune Medicines, from January 2016 to December 2019. Mr. Dineen earned a B.S. degree in computer science and biological sciences from the University of Vermont. Qualifications The Board has concluded that Mr. Dineen should serve as a director of the Company because of his leadership skills and his extensive global management and operations experience across several industries, including healthcare, technology, and international management, and his board governance experience from service on public company boards with global operations. Key Skills and Experiences
•
Marketing, Disruptive Technology, and Strategy Experience
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Cybersecurity Experience
•
Human Capital Management Experience
•
Risk Management Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 79
|
Table of Contents
|
|
|
|
|
|
||
Mark Fields Director since 2024 Age 64
•
Compensation and Human Resources
° Member since 2024 Public company
directorships in last
five years:
•
Hertz Global Holdings, Inc.
•
QUALCOMM Incorporated
•
TPG Pace Beneficial II Corp. (former)
•
TPG Pace Solutions Corp. (former)
|
|
|
Experience
Mr. Fields has served as a Senior Advisor at TPG Capital LP, a global alternative asset firm, since October 2017. From October 2021 to February 2022, he served as Interim Chief Executive Officer of Hertz Global Holdings, Inc., which operates the Hertz, Thrifty and Dollar rental car brands. Prior to Hertz Global Holdings, Inc., Mr. Fields served as President and Chief Executive Officer of Ford Motor Company, an automotive company, from July 2014 to May 2017, and as Chief Operating Officer from December 2012 to July 2014. He joined Ford in 1989 and served in various leadership positions throughout his tenure, including as Executive Vice President and President, Americas; Executive Vice President and Chief Executive Officer, Ford of Europe and Premier Automotive Group; Chair and Chief Executive Officer, Premier Automotive Group; and President and Chief Executive Officer, Mazda Motor Corporation. He has served as a member of the board of directors of: Hertz Global Holdings, Inc. since June 2021; QUALCOMM Incorporated, a semiconductors, software, and services company, since June 2018, where he is a member of the audit committee; Tanium Inc., a privately-held cybersecurity and systems management company, where he has served as the lead independent director since September 2020; Planview, Inc., a privately-held global enterprise software company, since April 2022; Boomi, LP, a privately-held software company, since September 2022; and Classic Collision, a privately-held collision repair company, since May 2024. Mr. Fields previously served on the board of directors of: TPG Pace Beneficial II Corp. from April 2021 to April 2023; TPG Pace Solutions Corp from April 2021 to December 2021; Ford Motor Company from July 2014 to May 2017; and IBM Corporation from March 2016 to April 2018. Mr. Fields earned a B.A. in Economics from Rutgers University and an M.B.A. degree from Harvard Business School. Qualifications The Board has concluded that Mr. Fields should serve as a director of the Company because of his extensive operational experience in executive management positions in the automotive industry, including leading complex global business organizations; his extensive experience serving on other public company boards; and his designation as an audit committee financial expert. Key Skills and Experiences
•
Industry Knowledge
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Human Capital Management Experience
•
Risk Management Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
80
|
Table of Contents
|
|
|
|
|
|
||
Ho Kyu Kang Director since 2023 Age 63 Board Committee:
•
Innovation and Technology
° Chair since 2024 |
|
|
Experience
Ho Kyu Kang has served as a Professor in the Department of Systems Semiconductor Engineering at Yonsei University since March 2021. Prior to his current position, Dr. Kang served as Executive Vice President and Head of Research at the Semiconductor R&D Center of Samsung Electronics Co., Ltd., (Samsung), a manufacturer of consumer electronics, information technology and mobile communications products, and semiconductor devices, from 2017 to 2021. Before that, he served as Executive Vice President and leader of process development at the Semiconductor R&D Center from 2015 to 2017, as Senior Vice President and team leader from 2010 to 2015, and as Vice President responsible for the system large-scale integration process architecture team and advanced technology development from 2003 to 2010. Dr. Kang joined Samsung as a research and development engineer in 1985. He is the author or co-author of numerous international papers. Dr. Kang previously served on the boards of directors of: the Semiconductor Research Corporation (SRC), a U.S.-based, non-profit, multinational research and development consortium, from 2017 to 2020; SEMATECH, a U.S.-based, non-profit, multinational research and development consortium, from 2010 to 2015. Dr. Kang earned a Ph.D. in material science and engineering from Stanford University, a M.S. degree in material science and engineering from Korea Advanced Institute of Science and Technology (KAIST), and a B.S. degree in metallurgical engineering from Hanyang University. Qualifications The Board has concluded that Dr. Kang should serve as a director of the Company because of his decades of experience in semiconductor engineering and development; his extensive knowledge and experience acquired as an executive of a major semiconductor manufacturer; his deep knowledge and understanding of the semiconductor equipment industry and technologies; and his experience as a senior executive of Samsung, a major company customer. Key Skills and Experiences
•
Industry Knowledge
•
Customer/Deep Technology Knowledge
•
Leadership Experience
•
Global Business Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 81
|
Table of Contents
|
|
|
|
|
|
|
|
Bethany J. Mayer Director since 2019 Age 63 Board Committees:
•
Audit
° Member since 2019
•
Innovation and
Technology ° Member since 2024
•
Nominating and
Governance ° Member since 2022 Public company
directorships in last
five years:
•
Astera Labs, Inc.
•
Box, Inc.
•
Hewlett Packard Enterprise Company
•
Marvell Technology Group Ltd. (former)
•
Sempra (former)
|
|
|
Experience
Bethany J. Mayer served as an Executive Advisor of Siris Capital Group LLC, a private equity firm, from May 2021 to September 2024. Prior to that she served as an Executive Partner from January 2018 to April 2021. She was the Executive Vice President, Corporate Development and Technology of Sempra Energy, an energy services holding company, from November 2018 to January 2019. From September 2014 to December 2017, Ms. Mayer was the President and Chief Executive Officer of Ixia, a test, visibility, security solutions, network testing tools and virtual network security solutions provider for applications across physical and virtual networks that was ultimately acquired by Keysight Technologies in 2017. From May 2011 to May 2014, Ms. Mayer served as Senior Vice President and General Manager of Hewlett-Packard Company's (HP) Networking business unit and the Network Function Virtualization business unit. From 2010 until 2011, she served as Vice President, Worldwide Marketing and Alliances of HP's Enterprise Servers Storage and Networking Group. Prior to joining HP, she held leadership roles at Blue Coat Systems, Inc., a hardware, software, and services provider for cybersecurity and network management; Cisco Systems, Inc., an internet technology company; and Apple Computer, Inc., a technology company. She has served as a member of the boards of directors of: Mainspring Energy, Inc., a privately held green energy supplier, since October 2024; Securonix Inc., a privately held security analytics and operational management company, since October 2024; Astera Labs, Inc., a semiconductor-based connectivity solutions for AI and cloud infrastructure company, since June 2024, where she is a member of the audit committee; Hewlett Packard Enterprise Company, a multinational information technology company, since June 2023, where she is a member of the audit committee and a member of the technology committee; Celestial AI, a privately-held software computing and memory company, since April 2023, where she is the chair of the compensation committee; and Box, Inc., a cloud content management and file sharing service for businesses, since April 2020, where she is the chair of the board, chair of the compensation committee, and was a member of the operating committee. Ms. Mayer previously served on the boards of directors of: Electronics for Imaging Inc., a privately held print technology company, from July 2019 to October 2024; Ambri Inc., a battery manufacturing company, from November 2022 to July 2024; Marvell Technology Group Ltd, a infrastructure semiconductor solutions company, from May 2018 to June 2022, where she was a member of the executive compensation committee, nominating and governance committee, and audit committee; Pulse Secure, LLC, a privately-held provider of access and mobile security solutions to both enterprises and service providers, from September 2019 to December 2020, where she was the chairperson of the board, and previously served as a member from January 2018 to November 2018; Sempra from June 2019 to September 2024 after serving from February 2017 to November 2018, where she has previously served as the chair of the safety, sustainability and technology committee and a member of the executive committee and the audit committee; SnapRoute, Inc., a privately-held developer of open source network stacks for enterprises, from May 2018 to July 2019; DataStax, Inc., a privately-held database software provider for cloud applications, from May 2018 to April 2019; Delphi Automotive PLC, an auto parts supplier, from August 2015 to April 2016; and Ixia from September 2014 to December 2017. Ms. Mayer earned an M.S. degree in Cybersecurity Risk and Strategy from New York University, an M.B.A. degree from CSU-Monterey Bay and a B.S. degree in political science from Santa Clara University. Qualifications The Board has concluded that Ms. Mayer should serve as a director of the Company because of her leadership skills and her experience in operational roles at companies in various technology industries, including networks, network management, servers, security solutions, cybersecurity, and internet technology; and her board governance experience from service on other boards. Key Skills and Experiences
•
Industry Knowledge
•
Marketing, Disruptive Technology, and Strategy Experience
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Cybersecurity Experience
•
Human Capital Management Experience
•
Risk Management Experience
•
Manufacturing/Operations Experience
|
|
|
|
|
82
|
Table of Contents
|
|
|
|
|
|
||
Jyoti K. Mehra Director since 2021 Age 49 Board Committee:
•
Compensation and
Human Resources ° Chair since 2024 ° Member: 2022-2024 |
|
|
Experience
Jyoti K. Mehra has served as the Executive Vice President of Human Resources of Gilead Sciences, Inc., a biopharmaceutical company, since July 2019. She previously served as Vice President of Human Resources of Gilead from October 2017 to July 2019. Prior to joining Gilead, she held positions of increasing responsibility with Novartis Pharmaceuticals Corporation, a pharmaceutical company, and its affiliates, from 2005 through October 2017, most recently as Vice President of Human Resources of Novartis from July 2014 to October 2017. Ms. Mehra earned an M.A. degree in politics from Jawaharlal Nehru University, and a B.A. degree in political science from Delhi University. Qualifications The Board has concluded that Ms. Mehra should serve as a director of the Company because of her leadership and international business experience in a high-technology industry; her substantial human capital and talent development experience, including experience as the head of human resources of a public company with global operations; her governance experience; and her cybersecurity experience. Key Skills and Experiences
•
Leadership Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Cybersecurity Experience
•
Human Capital Management Experience
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 83
|
Table of Contents
|
|
|
|
|
|
||
Abhijit Y. Talwalkar Chair Director since 2011 Age 61 Board Committees:
•
Compensation and
Human Resources
°
Chair: 2012-2015
°
Member since 2015, previously 2011-2012
•
Innovation and
Technology
°
Member since 2024
•
Nominating and
Governance
°
Chair: 2015-2019
°
Member since 2019,
previously
2015-2015, 2011-2014
Public company
directorships in last five years:
•
Advanced Micro Devices
Inc.
•
iRhythm Technologies
Inc.
•
TE Connectivity Ltd.
|
|
|
Experience
Abhijit Y. Talwalkar is the former President and Chief Executive Officer of LSI Corporation, a leading provider of silicon, systems and software technologies for the storage and networking markets, a position he held from May 2005 until the completion of LSI's merger with Avago Technologies in May 2014. From 1993 to 2005, Mr. Talwalkar was employed by Intel Corporation, a leading producer of microchips, computing and communications products. At Intel, he held a number of senior management positions, including as Corporate Vice President and Co-General Manager of the Digital Enterprise Group, which was comprised of Intel's business client, server, storage and communications business, and as Vice President and General Manager for the Intel Enterprise Platform Group, where he focused on developing, marketing, and supporting Intel business strategies for enterprise computing. Prior to joining Intel, Mr. Talwalkar held senior engineering and marketing positions at Sequent Computer Systems, a multiprocessing computer systems design and manufacturer that later became a part of IBM; Bipolar Integrated Technology, Inc., a very-large-scale integration (VLSI) bipolar semiconductor company; and Lattice Semiconductor Inc., a service driven developer of programmable design solutions widely used in semiconductor components. Mr. Talwalkar has served as a member of the board of directors of: Advanced Micro Devices Inc., a developer of high performance computing, graphics and visualization technologies, since June 2017, where he is a member of the compensation and leadership resources committee, chair of the innovation and technology committee and has served as a member of the nominating and corporate governance committee and the innovation and technology committee; TE Connectivity Ltd, a connectivity and sensor solutions company, since March 2017, where he is the chair of the management development and compensation committee and has served as a member of the audit committee; and iRhythm Technologies Inc., digital health care solutions company, since May 2016, where he is the chair of the board and a member of the compensation and human capital management committee and the nominating and corporate governance committee, and has served as a member of the audit committee. He previously served as a member of the board of directors of LSI from May 2005 to May 2014 and the U.S. Semiconductor Industry Association from May 2005 to May 2014. He was additionally a member of the U.S. delegation for World Semiconductor Council proceedings. Mr. Talwalkar earned a B.S. degree in electrical engineering from Oregon State University. Qualifications The Board has concluded that Mr. Talwalkar should serve as a director of the Company because of his experience in the semiconductor industry, including as the former chief executive officer of a semiconductor company and his previous role in the semiconductor industry's trade association; his technology experience; his business and operations leadership roles at other semiconductor companies that include a customer of the Company; his finance experience; his global business experience; his mergers and acquisitions experience; his board governance experience from service on other public company boards, including as chair of another board; and his cybersecurity expertise. Key Skills and Experiences
•
Industry Knowledge
•
Customer/Deep Technology Knowledge
•
Marketing, Disruptive Technology, and Strategy Experience
•
Leadership Experience
•
Finance Experience
•
Global Business Experience
•
M&A Experience
•
Comparative Board/Governance Experience
•
Human Capital Management Experience
•
Risk Management Experience
|
|
|
|
|
84
|
Table of Contents
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE APPROVAL, ON AN ADVISORY OR NON-BINDING BASIS, OF OUR NAMED EXECUTIVE OFFICER COMPENSATION.
|
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 85
|
Table of Contents
86
|
Table of Contents
•
|
Outstanding stock options: 1,285,300 shares (0.1% of our outstanding shares). Our outstanding stock options have a weighted-average exercise price of $57.5344 and an average remaining term of 3.6916 years;
|
•
|
Unvested RSU awards: 7,146,798 shares (0.6% of our outstanding shares);
|
•
|
Outstanding Market-Based PRSUs, assuming that the outstanding awards achieve maximum performance: 1,742,374 shares (0.1% of our outstanding shares);
|
•
|
Total shares subject to outstanding awards, as described above (stock options, unvested RSU awards, and outstanding Market-Based PRSUs, assuming achievement of maximum performance level): 10,174,472 shares (0.8% of our outstanding shares);
|
•
|
Total shares available for future awards under the 2015 Plan: 62,670,388 shares (5.0% of our outstanding shares);
|
•
|
The total number of shares subject to outstanding awards: 10,174,472 shares, plus the total number of shares available for future awards under the 2015 Plan (62,670,388 shares), represents a current overhang percentage of 5.8% (in other words, the dilution of our stockholders represented by the 2015 Plan).
|
•
|
96,800,000 new shares (7.7% of our outstanding shares - this percentage reflects the simple dilution of our stockholders that would occur if the 2025 Plan is approved assuming, for purposes of the 2025 Plan's 2:1 fungible share ratio, that all available shares are used for stock options or SARs4), plus
|
•
|
the total shares available for future awards under the 2015 Plan immediately prior to expiration of the 2015 Plan, which shares become available for awards under the 2025 Plan (these "rollover shares" equal 62,670,388 shares available under the 2015 Plan as of August 24, 2025); plus
|
•
|
shares subject to outstanding 2015 Plan awards that may, in part, become available for grant under recycling provisions (this amount of outstanding 2015 Plan awards as of August 24, 2025 was 10,174,472 shares).
|
•
|
The total of the three amounts above (96,800,000 new shares, plus 62,670,388 rollover shares, plus 10,174,472 shares subject to outstanding awards) as of August 24, 2025 represents an overhang of 169,644,860 shares (13.4% of our outstanding shares)
|
4
|
Under the 2025 Plan's 2:1 fungible share ratio, any stock options and SARs granted under the 2025 Plan will be counted against the maximum share limit as one share of our common stock for each share subject to an award, and any grant of "full value" awards such as restricted stock, RSUs, PRSUs or other awards will be counted against the 2025 Plan's maximum share limit as two shares for every one share subject to an award. Because of this 2:1 fungible share ratio, the 96,800,000 newly-requested shares under the 2025 Plan equates to full value awards with respect to 48,400,000 shares, and the 62,492,709 shares remaining available under the 2015 Plan (that would become available for awards under the 2025 Plan) as of August 24, 2025 would equate to full value awards under the 2025 Plan with respect to 31,246,354 shares.
|
Lam Research Corporation 2025 Proxy Statement 87
|
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year 2025
|
|
|
Fiscal Year 2024
|
|
|
Fiscal Year 2023
|
|
|
|
Stock Options Granted (A)
|
|
|
18,030
|
|
|
298,080
|
|
|
396,630
|
|
|
RSUs and target Market-based PRSUs Granted
|
|
|
4,448,445
|
|
|
3,559,320
|
|
|
5,883,220
|
|
|
RSUs Granted (B)
|
|
|
3,877,391
|
|
|
3,055,920
|
|
|
5,123,130
|
|
|
Market-based PRSUs Granted (target) (C)
|
|
|
571,054
|
|
|
503,400
|
|
|
760,090
|
|
|
Weighted-Average Common Shares Outstanding (D)
|
|
|
1,276,932,878
|
|
|
1,311,118,060
|
|
|
1,343,917,330
|
|
|
Burn Rate ((A+B+C)/D)
|
|
|
0.35%
|
|
|
0.29%
|
|
|
0.47%
|
|
|
3 year average Burn Rate
|
|
|
0.37%
|
|
||||||
|
|
|
|
|
|
•
|
Stock options.A stock option (whether an incentive stock option or nonstatutory stock option) entitles the grantee to purchase a specified number of shares of common stock at a price not less than market value per share on the date of grant.
|
•
|
Restricted stock.A grant of restricted stock involves the immediate transfer by the Company to a grantee of ownership of a specific number of shares of common stock in consideration of the performance of services.
|
•
|
RSUs.A grant of RSUs constitutes an agreement by the Company to deliver shares of common stock or cash, or a combination of both, to the grantee in the future in consideration of the performance of services, but subject to the fulfillment of such conditions during the restriction period as the Administrator may specify.
|
•
|
SARs.A SAR is a right to receive from the Company an amount equal to 100%, or such lesser percentage as the Administrator may determine, of the spread between the base price and the value of the Company's shares of common stock on the date of exercise.
|
•
|
Other Awards.Other awards under the 2025 Plan are awards denominated or payable shares or cash, including, but not limited to, purchase rights for shares, the grant of shares as a bonus, deferred shares, performance shares, phantom shares, and other similar types of awards, each with the terms and conditions as determined by the Administrator pursuant to an award agreement.
|
88
|
Table of Contents
Lam Research Corporation 2025 Proxy Statement 89
|
Table of Contents
•
|
Shares that have actually been issued (e.g.,restricted stock) pursuant to an award, except in the case of unvested shares that are forfeited, or repurchased by the Company at the lower of their original purchase price or their fair market value.
|
•
|
Shares tendered or withheld in payment of an option or SAR exercise price, or withheld by the Company to satisfy any option or SAR tax withholding obligation.
|
•
|
Shares subject to share-settled SARs that are not actually issued in connection with the settlement of such SARs upon exercise.
|
•
|
Shares reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of options.
|
90
|
Table of Contents
•
|
Nonstatutory Stock Options.In general, (1) no income will be recognized by an optionee at the time a non-qualified stock option is granted; (2) at the time of exercise of a non-qualified stock option, ordinary income will be recognized by the optionee in an amount equal to the difference between the option price paid for the shares of common stock and the fair market value of the shares of common stock, if unrestricted, on the date of exercise; and (3) at the time of sale of shares of common stock acquired pursuant to the exercise of a non-qualified stock option, appreciation (or depreciation) in value of the shares of common stock after the date of exercise will be treated as either short-term or long-term capital gain (or loss) depending on how long the shares of common stock have been held.
|
Lam Research Corporation 2025 Proxy Statement 91
|
Table of Contents
•
|
Incentive Stock Options.No income generally will be recognized by an optionee upon the grant or exercise of an Incentive Stock Option. The exercise of an Incentive Stock Option, however, may result in alternative minimum tax liability. If shares of common stock are issued to the optionee pursuant to the exercise of an Incentive Stock Option, and if no disqualifying disposition of such shares of common stock is made by such optionee within two years after the date of grant or within one year after the transfer of such shares of common stock to the optionee, then upon sale of such shares of common stock, any amount realized in excess of the option price will be taxed to the optionee as a long-term capital gain and any loss sustained will be a long-term capital loss.
|
•
|
SARs.No income will be recognized by a participant in connection with the grant of a SAR. When the SAR is exercised, the participant normally will be required to include as taxable ordinary income in the year of exercise an amount equal to the amount of cash received and the fair market value of any unrestricted shares of common stock received on the exercise.
|
•
|
Restricted Stock.The recipient of restricted stock generally will be subject to tax at ordinary income rates on the fair market value of the restricted stock (reduced by any amount paid by the participant for such restricted stock) at such time as the shares of common stock are no longer subject to forfeiture or restrictions on transfer for purposes of Section 83 of the Code (which we refer to as the "Restrictions"). However, a recipient may instead elect under Section 83(b) of the Code within 30 days of the date of transfer of the shares of common stock to have taxable ordinary income on the date of transfer of the shares equal to the excess of the fair market value of such shares of common stock (determined without regard to the Restrictions) over the purchase price, if any, of such restricted stock. If a Section 83(b) election has not been made, any dividends received with respect to restricted stock that is subject to the Restrictions generally will be treated as compensation that is taxable as ordinary income to the participant.
|
•
|
RSUs.No income generally will be recognized upon the award of RSUs. The recipient of an RSU award generally will be subject to tax at ordinary income rates on the fair market value of unrestricted shares of common stock on the date that such shares are transferred to the participant under the award (reduced by any amount paid by the participant for such RSUs, if any), and the capital gains/loss holding period for such shares will also commence on such date.
|
•
|
Other Awards.No income generally will be recognized upon the grant of other awards under the 2025 Plan, such as performance shares. Upon payment in respect of other awards, the recipient generally will be required to include as taxable ordinary income in the year of receipt an amount equal to the amount of cash received and the fair market value of any unrestricted shares of common stock received.
|
92
|
Table of Contents
|
|
|
|
|
|
|
Name and Position
|
|
|
Dollar Value
($)
|
|
|
Timothy M. Archer, President, Chief Executive Officer
|
|
|
N/A
|
|
|
Douglas R. Bettinger, Executive Vice President, Chief Financial Officer
|
|
|
N/A
|
|
|
Patrick J. Lord, Executive Vice President, Chief Operating Officer
|
|
|
N/A
|
|
|
Ava A. Harter, Senior Vice President, Chief Legal Officer and Secretary
|
|
|
N/A
|
|
|
Seshasayee (Sesha) Varadarajan, Senior Vice President, Global Products Group
|
|
|
N/A
|
|
|
Executive Officers as a Group
|
|
|
N/A
|
|
|
Non-Executive Directors as a Group(1)
|
|
|
2,400,000
|
|
|
Non-Executive Officer Employees as a Group
|
|
|
N/A
|
|
|
|
|
|
|
|
(1)
|
The amount disclosed is an estimate for all RSUs to be issued to our 10 non-employee directors after the Annual Meeting, using the current $240,000 target grant date value per non-employee director for restricted stock unit awards under the current non-employee director compensation program.
|
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE APPROVAL OF THE ADOPTION OF THE LAM 2025 STOCK INCENTIVE PLAN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan Category
|
|
|
Number of Securities
to be Issued
Upon Exercise of
Outstanding Options,
Warrants, and Rights
(a)
|
|
|
Weighted-Average
Exercise Price of
Outstanding
Options, Warrants,
and Rights(1)
($) (b)
|
|
|
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans
(excluding securities
reflected in column (a))
(c)
|
|
|
Equity compensation plans approved by security holders
|
|
|
11,125,673(2)
|
|
|
57.53
|
|
|
111,034,928(3)
|
|
|
Equity compensation plans not approved by security holders
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Total
|
|
|
11,125,673
|
|
|
57.23
|
|
|
111,034,928
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Weighted-average exercise prices do not include service-based RSUs or Market-based PRSUs, which do not have an exercise price.
|
(2)
|
Includes 11,125,673 shares issuable upon service-based RSUs vesting, Market-based PRSUs vesting or stock option exercises under the 2015 Plan. The share total assumes shares will be issued at the maximum vesting amount for outstanding Market-based PRSUs.
|
(3)
|
Includes 62,666,508 shares available for future issuance under the 2015 Plan and 48,368,420 shares available for future issuance under the 1999 ESPP. All of the shares available for future issuance under the 1999 ESPP are available to purchase during the current purchase period, but the actual number of shares that can be purchased depends on the purchase price, which is not fixed until the end of the purchase period, and is subject to limits on purchases by individuals. The number of shares that may be purchased by an individual in the current purchase period under the 1999 ESPP cannot exceed 10,000 shares and the total fair market value of shares that can be purchased by an individual during a calendar year cannot exceed $25,000.
|
Lam Research Corporation 2025 Proxy Statement 93
|
Table of Contents
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2026.
|
|
|
|
|
|
|
|
|
94
|
Table of Contents
Lam Research Corporation 2025 Proxy Statement 95
|
Table of Contents
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" APPROVAL OF AN AMENDMENT TO THE COMPANY'S RESTATED CERTIFICATE OF INCORPORATION TO LIMIT THE LIABILITY OF CERTAIN OFFICERS AS PERMITTED BY DELAWARE LAW.
|
|
|
|
|
|
|
|
|
96
|
Table of Contents
Lam Research Corporation 2025 Proxy Statement 97
|
Table of Contents
98
|
Table of Contents
•
|
Independent Board:All of the Company's eleven current Board members are independent except for the CEO.
|
•
|
Independent Committees:Each of the Board's three key standing committees-the Audit Committee, the Compensation and Human Resources Committee, and the Nominating and Governance Committee-are comprised solely of independent directors.
|
•
|
Independent Board Leadership:The Company maintains separate CEO and Board chair roles, and the Board chair is an independent director.
|
•
|
Annual Election of Directors:The Company's directors stand for election on an annual basis.
|
•
|
Strong Director Refreshment and Evaluation Practices: We regularly review the composition of the Board and seek ways to deepen and maintain the Board's expertise. We have an annual evaluation process for the Board, each Board committee, and each director.
|
•
|
Proxy Access:Stockholders may nominate directors through the existing proxy access right that is consistent with market practice.
|
•
|
Majority Voting Standard:The Company has a majority voting standard for uncontested elections of directors and a director resignation policy.
|
•
|
Retirement Policy:No director may be nominated to a new term after having attained the age of 75 years.
|
•
|
Board Communication:Stockholders may contact the Board, any Board committee, or any individual director.
|
•
|
Stockholder Right to Act by Written Consent:Stockholders may act by written consent in accordance with the Company's Certificate of Incorporation and bylaws.
|
|
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "AGAINST" THE STOCKHOLDER PROPOSAL
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement 99
|
Table of Contents
100
|
Table of Contents
|
|
Voting and Meeting Information
|
Lam Research Corporation 2025 Proxy Statement 101
|
Table of Contents
102
|
Table of Contents
Lam Research Corporation 2025 Proxy Statement 103
|
Table of Contents
104
|
Table of Contents
|
|
Appendices
|
1.
|
Purposes of the Plan. The purposes of this Stock Incentive Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company's business.
|
2.
|
Definitions. The following definitions shall apply as used herein and in the individual Award Agreements except as defined otherwise in an individual Award Agreement. In the event a term is separately defined in an individual Award Agreement, such definition shall supersede the definition contained in this Section 2.
|
(a)
|
"Administrator" means the Board, the Compensation Committee or any of the Committees appointed to administer the Plan.
|
(b)
|
"Affiliate" and "Associate" shall have the respective meanings ascribed to such terms in Rule 12b-2 promulgated under the Exchange Act.
|
(c)
|
"Applicable Laws" means the legal requirements relating to the Plan and the Awards under applicable provisions of federal securities laws, state corporate and securities laws, the Code, the rules of any applicable stock exchange or national market system, and the rules of any foreign jurisdiction applicable to Awards granted to residents therein.
|
(d)
|
"Assumed" means that pursuant to a Corporate Transaction either (i) the Award is expressly affirmed by the Company or (ii) the contractual obligations represented by the Award are expressly assumed (and not simply by operation of law) by the successor entity or its Parent in connection with the Corporate Transaction with appropriate adjustments to the number and type of securities of the successor entity or its Parent subject to the Award and the exercise or purchase price thereof which at least preserves the compensation element of the Award existing at the time of the Corporate Transaction as determined in accordance with the instruments evidencing the agreement to assume the Award.
|
(e)
|
"Award" means the grant of an Option, Restricted Stock, Restricted Stock Unit, Stock Appreciation Right, or Other Award under the Plan.
|
(f)
|
"Award Agreement" means the written agreement evidencing the grant of an Award executed by the Company and the Grantee, including any amendments thereto.
|
(g)
|
"Board" means the Board of Directors of the Company.
|
(h)
|
"Code" means the Internal Revenue Code of 1986, as amended.
|
(i)
|
"Committee" means the Compensation Committee or any committee appointed by the Board or Compensation Committee to administer the Plan or any aspect of the Plan, and may include a committee of Officers or employees of the Company where permitted under Applicable Laws.
|
(j)
|
"Common Stock" means the common stock of the Company, par value $0.001 per share.
|
(k)
|
"Company" means Lam Research Corporation, a Delaware corporation, or any successor entity that adopts the Plan in connection with a Corporate Transaction.
|
(l)
|
"Compensation Committee" means the Compensation and Human Resources Committee of the Board.
|
(m)
|
"Consultant" means any person (other than an Employee or a Director, solely with respect to rendering services in such person's capacity as a Director) who is engaged by the Company or any Related Entity to render consulting or advisory services to the Company or such Related Entity.
|
(n)
|
"Continuous Service" means that the provision of services to the Company or a Related Entity in any capacity of Employee, Director or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance of an effective termination as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services to the Company or a Related Entity notwithstanding any required notice period that must be fulfilled before a termination as an Employee, Director or Consultant can be effective under Applicable Laws. A Grantee's
|
Lam Research Corporation 2025 Proxy Statement A-1
|
Table of Contents
(o)
|
"Corporate Transaction" means, except as otherwise set forth in an Award Agreement, any of the following transactions:
|
(i)
|
a merger or consolidation in which the Company is not the surviving entity or survives only as a subsidiary of another entity whose stockholders did not own all or substantially all of the Common Stock in substantially the same proportions as immediately prior to such transaction (which transaction shall not include a merger or consolidation with a wholly-owned subsidiary, a reincorporation of the Company in a different jurisdiction, or other transaction in which there is no substantial change in the stockholders of the Company or their relative stock holdings and the Awards granted under this Plan are assumed, converted or replaced by the successor corporation, which assumption shall be binding on all participants);
|
(ii)
|
the sale, transfer or other disposition of all or substantially all of the assets of the Company, including a liquidation or dissolution of the Company; or
|
(iii)
|
the acquisition, sale, or transfer of more than fifty percent (50%) of the outstanding shares of the Company by tender offer or similar transaction.
|
(p)
|
"Director" means a member of the Board or the board of directors of any Related Entity.
|
(q)
|
"Disability" shall be defined by the Administrator with respect to all Awards other than Incentive Stock Options and as defined by Section 22(e) of the Code with respect to Incentive Stock Options.
|
(r)
|
"Employee" means any person, including an Officer or Director, who is an employee of the Company or any Related Entity. The payment of a director's fee by the Company or a Related Entity shall not be sufficient to constitute "employment" by the Company.
|
(s)
|
"Exchange Act" means the Securities Exchange Act of 1934, as amended.
|
(t)
|
"Fair Market Value" means, that as of any date, the value of Common Stock determined as follows:
|
(i)
|
If the Common Stock is listed on one or more established stock exchanges or national market systems, including without limitation The NASDAQ Global Select Market, The NASDAQ Global Market or The NASDAQ Capital Market of The NASDAQ Stock Market LLC, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on the principal exchange or system on which the Common Stock is listed (as determined by the Administrator) on the date of determination (or, if no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable;
|
(ii)
|
If the Common Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing sales price for such stock as quoted on such system or by such securities dealer on the date of determination, but if selling prices are not reported, the Fair Market Value of a share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the date of determination (or, if no such prices were reported on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or
|
(iii)
|
In the absence of an established market for the Common Stock of the type described in (i) and (ii), above, the Fair Market Value thereof shall be determined by the Administrator in good faith.
|
(u)
|
"Grantee" means an Employee, Director or Consultant who receives an Award pursuant to an Award Agreement under the Plan.
|
(v)
|
"Incentive Stock Option" means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code.
|
A-2
|
Table of Contents
(w)
|
"Nonstatutory Stock Option" means an Option not intended to qualify as an Incentive Stock Option.
|
(x)
|
"Officer" means a person who is an officer of the Company or a Related Entity within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.
|
(y)
|
"Option" means an option to purchase Shares pursuant to an Award Agreement granted under the Plan.
|
(z)
|
"Other Award" means an Award that may be denominated or payable in Shares or cash, including, but not limited to, purchase rights for Shares, the grant of Shares as a bonus, deferred Shares, performance Shares, phantom Shares, and other similar types of Awards, each with the terms and conditions as determined by the Committee pursuant to an Award Agreement.
|
(aa)
|
"Outside Director" means a Director who is not an Employee.
|
(bb)
|
"Parent" means a "parent corporation," whether now or hereafter existing, as defined in Section 424(e) of the Code.
|
(cc)
|
"Plan" means this 2025 Stock Incentive Plan, as adopted by the Company.
|
(dd)
|
"Related Entity" means any Parent or Subsidiary and any business, corporation, partnership, limited liability company or other entity in which the Company, a Parent or a Subsidiary holds a substantial ownership interest, directly or indirectly.
|
(ee)
|
"Related Entity Disposition" means the sale, distribution or other disposition by the Company, a Parent or a Subsidiary of all or substantially all of the interests of the Company, a Parent or a Subsidiary in any Related Entity effected by a sale, merger or consolidation or other transaction involving that Related Entity or the sale of all or substantially all of the assets of that Related Entity, other than any Related Entity Disposition to the Company, a Parent or a Subsidiary.
|
(ff)
|
"Restricted Stock" means Shares issued under the Plan to the Grantee for such consideration, if any, and subject to such restrictions on transfer, rights of first refusal, repurchase provisions, forfeiture provisions, and other terms and conditions as established by the Administrator.
|
(gg)
|
"Restricted Stock Units" means an Award which may be earned in whole or in part upon the passage of time or the attainment of performance criteria established by the Administrator and which may be settled for cash, Shares or other securities or a combination of cash, Shares or other securities as established by the Administrator.
|
(hh)
|
"Rule 16b-3" means Rule 16b-3 promulgated under the Exchange Act or any successor thereto.
|
(ii)
|
"Share" means a share of the Common Stock.
|
(jj)
|
"Stock Appreciation Right" means an Award to receive the appreciation in value of a Share from the date of grant until the time of exercise.
|
(kk)
|
"Subsidiary" means a "subsidiary corporation," whether now or hereafter existing, as defined in Section 424(f) of the Code.
|
3.
|
Stock Subject to the Plan.
|
(a)
|
Subject to the provisions as set forth in Section 10, below, the maximum aggregate number of Shares which may be issued pursuant to all Awards is (i) 96,800,000 Shares, plus (ii) any Shares that remain available for grants under the Company's 2015 Stock Incentive Plan (the "Prior Plan") on November 3, 2025, plus (iii) Shares that are subject to awards granted under the Plan or the Prior Plan that are added (or added back, as applicable) to the aggregate Shares available for grant under this Section 3(a) pursuant to the share counting rules of the Plan or Prior Plan. The maximum aggregate number of Shares which may be issued pursuant to Incentive Stock Options is 96,800,000 Shares. Any Shares subject to Awards granted under the Plan other than Options and Stock Appreciation Rights shall be counted against the limit set forth herein as two (2) Shares for every one (1) Share subject to such Award (and shall be counted as two (2) Shares for every one (1) Share returned to the Plan pursuant to Section 3(b), below). Options and Stock Appreciation Rights shall be counted against the limit set forth herein as one (1) Share subject to such Award (and shall be counted as one (1) Share returned to the Plan pursuant to Section 3(b), below). The Shares to be issued pursuant to Awards may be authorized, but unissued, or reacquired Common Stock.
|
(b)
|
Any Shares covered by an Award (or portion of an Award) which is forfeited, canceled or expires (whether voluntarily or involuntarily), or is settled in cash, shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares which may be issued under the Plan. Shares that actually have been issued under the Plan (e.g., Restricted Stock) pursuant to an Award shall not be returned to the Plan and shall not become available for future issuance under the Plan, except that if unvested Shares are forfeited, or repurchased by the Company at the lower of their original purchase price or their Fair Market Value at the time of repurchase, such Shares shall become available for future grant under the Plan. Notwithstanding anything to the contrary contained herein: (i) Shares tendered or withheld in payment of an Option or Stock Appreciation Right exercise price shall not be returned to the Plan and shall not become available for future issuance under the Plan, (ii) Shares withheld by the Company to satisfy any Option or Stock Appreciation Right tax
|
Lam Research Corporation 2025 Proxy Statement A-3
|
Table of Contents
(c)
|
Any Shares covered by an award (or portion of an award) under the Prior Plan which is forfeited, canceled or expires (whether voluntarily or involuntarily), or is settled in cash, shall be available for the granting of Awards under the Plan. Shares that actually have been issued under the Prior Plan (e.g., restricted stock) pursuant to an award shall not be available for Awards under the Plan, except that if unvested Shares are forfeited, or repurchased by the Company at the lower of their original purchase price or their Fair Market Value at the time of repurchase, such Shares shall become available for the granting of Awards under the Plan. Shares withheld by the Company to satisfy any tax withholding obligation for an award under the Prior Plan other than for an option or stock appreciation right shall be available for the granting of Awards under the Plan. For purposes of the Share recycling provisions set forth above in this Section 3(c) applicable to Shares subject to Prior Plan awards, if any such Shares were subject to stock options or stock appreciation rights under the Prior Plan, the number of Shares available for Awards under the Plan shall increase by one (1) for each such Share, and if any such Shares were subject to awards other than stock options or stock appreciation rights under the Prior Plan, the number of Shares available for Awards under the Plan shall increase by two (2) for each such Share. On the other hand, (i) Shares tendered or withheld in payment of an option or stock appreciation right exercise price under the Prior Plan shall not be available for Awards under the Plan, (ii) Shares withheld by the Company to satisfy any tax withholding obligation for an option or stock appreciation right under the Prior Plan shall not be available for Awards under the Plan, (iii) Shares subject to share-settled stock appreciation rights under the Prior Plan that are not actually issued in connection with the settlement of such stock appreciation rights on the exercise thereof shall not be available for Awards under the Plan, and (iv) Shares reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of options under the Prior Plan shall not be available for Awards under the Plan.
|
4.
|
Administration of the Plan.
|
(a)
|
Plan Administrator.
|
(i)
|
Administration with Respect to Directors and Officers. With respect to grants of Awards to Directors or Employees who are also Officers or Directors of the Company, the Plan shall be administered by (A) the Board or (B) the Compensation Committee or a Committee designated by the Board, each of which Committee shall be constituted in such a manner as to satisfy the Applicable Laws and to permit such grants and related transactions under the Plan to be exempt from Section 16(b) of the Exchange Act in accordance with Rule 16b-3. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board.
|
(ii)
|
Administration With Respect to Consultants and Other Employees. With respect to grants of Awards to Employees or Consultants who are neither Directors nor Officers of the Company, the Plan shall be administered by (A) the Board or (B) the Compensation Committee or a Committee that shall be constituted in such a manner as to satisfy the Applicable Laws. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the delegating authority.
|
(iii)
|
Administration Errors. In the event an Award is granted in a manner inconsistent with the provisions of this subsection (a), such Award shall be presumptively valid as of its grant date to the extent permitted by the Applicable Laws.
|
(b)
|
Powers of the Administrator. Subject to Applicable Laws and the provisions of the Plan (including any other powers given to the Administrator hereunder), and except as otherwise provided by the Board or the Compensation Committee, the Administrator shall have the authority, in its discretion:
|
(i)
|
to select the Employees, Directors and Consultants to whom Awards may be granted from time to time hereunder;
|
(ii)
|
to determine whether and to what extent Awards are granted hereunder;
|
(iii)
|
to determine the number of Shares or the amount of other consideration to be covered by each Award granted hereunder;
|
(iv)
|
to approve forms of Award Agreements for use under the Plan;
|
(v)
|
to determine the terms and conditions of any Award granted hereunder;
|
A-4
|
Table of Contents
(vi)
|
to amend the terms of any outstanding Award granted under the Plan, provided that (A) no modification of any Award, even in the absence of an amendment, suspension, or termination of this Plan, shall impair any existing contractual rights of any Grantee unless (1) the affected Grantee consents to the amendment, suspension, termination, or modification or (2) the Board determines, in its sole and absolute discretion, that the amendment, suspension, termination, or modification: (a) is required or advisable in order for the Company, this Plan or the Award to satisfy Applicable Laws, to meet the requirements of any accounting standard or to avoid any adverse accounting treatment, or (b) in connection with any Corporate Transaction, is in the best interests of the Company or its stockholders; provided, however, that an amendment or modification that may cause an Incentive Stock Option to become a Nonstatutory Stock Option shall not be treated as adversely affecting the rights of the Grantee, (B) the reduction of the exercise price of any Option or Stock Appreciation Right awarded under the Plan shall be subject to stockholder approval, except in connection with an adjustment described in Sections 6(d), 10 or 11, and (C) canceling an Option or Stock Appreciation Right at a time when its exercise price exceeds the Fair Market Value of the underlying Shares, in exchange for another Option, Restricted Stock, Restricted Stock Unit, Stock Appreciation Right, Other Award or for cash shall be subject to stockholder approval, unless the cancellation and exchange occurs in connection with an adjustment described in Sections 6(d), 10 or 11;
|
(vii)
|
to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan, including without limitation, any notice of Award or Award Agreement, granted pursuant to the Plan;
|
(viii)
|
to grant Awards to Employees, Directors and Consultants employed outside the United States on such terms and conditions different from those specified in the Plan as may, in the judgment of the Administrator, be necessary or desirable to further the purpose of the Plan; and
|
(ix)
|
to take such other action, not inconsistent with the terms of the Plan, as the Administrator deems appropriate.
|
5.
|
Eligibility. Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants of the Company and its Subsidiaries and Affiliates. Incentive Stock Options may be granted only to Employees of the Company, a Parent or a Subsidiary. An Employee who has been granted an Award may, if otherwise eligible, be granted additional Awards. Awards may be granted to such Employees who are residing in foreign jurisdictions as the Administrator may determine from time to time.
|
6.
|
Terms and Conditions of Awards.
|
(a)
|
Types of Awards; Dividends. The Administrator is authorized under the Plan to award Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, and Other Awards with an exercise or conversion privilege related to the passage of time or Continuous Service, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions as determined by the Administrator. The Administrator may provide for the payment of dividends or dividend equivalent rights in the terms of an Award other than Options or Stock Appreciation Rights, as evidenced in an Award Agreement. Such amounts may be paid in cash or additional Shares and will be subject to the same vesting restrictions as the underlying Award. For the avoidance of doubt, any dividends or dividend equivalent rights with respect to an Award shall be deferred until, and paid contingent upon, the vesting of such underlying Award.
|
(b)
|
Designation of Award. Each Award shall be designated in the Award Agreement. In the case of an Option, the Option shall be designated as either an Incentive Stock Option or a Nonstatutory Stock Option. However, notwithstanding such designation, an Option will qualify as an Incentive Stock Option under the Code only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded. The $100,000 limitation of Section 422(d) of the Code is calculated based on the aggregate Fair Market Value of the Shares subject to Options designated as Incentive Stock Options which become exercisable for the first time by a Grantee during any calendar year (under all plans of the Company or any Parent or Subsidiary of the Company). For purposes of this calculation, Incentive Stock Options shall be taken into account in the order in which they were granted, and the Fair Market Value of the Shares shall be determined as of the grant date of the relevant Option. In the event that the Code or the regulations promulgated thereunder are amended after the date the Plan becomes effective to provide for a different limit on the Fair Market Value of the Shares permitted to be subject to Incentive Stock Options, then such different limit will be automatically incorporated herein and will apply to any Options granted after the effective date of such amendment.
|
(c)
|
Conditions of Award. Subject to the terms of the Plan, the Administrator shall determine the provisions, terms, and conditions of each Award including, but not limited to, the Award vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions, form of payment (cash, Shares, or other consideration) upon settlement of the Award, payment contingencies, and satisfaction of any performance criteria. The performance criteria established by the Administrator may
|
Lam Research Corporation 2025 Proxy Statement A-5
|
Table of Contents
(d)
|
Acquisitions and Other Transactions. The Administrator may, as permitted by Nasdaq listing rule 5635(c), issue Awards under the Plan in the assumption, conversion, or in substitution, of outstanding awards in connection with the Company or a Related Entity acquiring another entity, an interest in another entity or an additional interest in a Related Entity whether by merger, stock purchase, asset purchase or other form of transaction. Any Shares that are issued in such circumstances will not reduce the number of Shares available for issuance under the Plan or otherwise count against the limits contained in Section 3 or Section 6(m).
|
(e)
|
Deferral of Award Payment. The Administrator may establish one or more programs under the Plan to permit selected Grantees the opportunity to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that absent the election would entitle the Grantee to payment or receipt of Shares or other consideration under an Award. The Administrator may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, Shares or other consideration so deferred, and such other terms, conditions, rules and procedures that the Administrator deems advisable for the administration of any such deferral program.
|
(f)
|
Separate Programs. The Administrator may establish one or more separate programs under the Plan for the purpose of issuing particular forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time to time.
|
(g)
|
Deferral. If the vesting or receipt of Shares under an Award is deferred to a later date, any amount (whether denominated in Shares or cash) paid in addition to the original number of Shares subject to such Award will not be treated as an increase in the number of Shares subject to the Award if the additional amount is based either on a reasonable rate of interest or on one or more predetermined actual investments such that the amount payable by the Company at the later date will be based on the actual rate of return of a specific investment (including any decrease as well as any increase in the value of an investment).
|
(h)
|
Early Exercise. The Award Agreement may, but need not, include a provision whereby the Grantee may elect at any time while an Employee, Director or Consultant to exercise any part or all of the Award prior to full vesting of the Award. Any unvested Shares received pursuant to such exercise may be subject to a repurchase right in favor of the Company or a Related Entity or to any other restriction the Administrator determines to be appropriate.
|
A-6
|
Table of Contents
(i)
|
Term of Award. The term of each Award shall be the term stated in the Award Agreement; provided, however, that the term shall be no more than ten (10) years from the date of grant thereof. However, in the case of an Incentive Stock Option granted to a Grantee who, at the time the Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary of the Company, the term of the Incentive Stock Option shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the Award Agreement. Notwithstanding the foregoing, the specified term of any Award shall not include any period for which the Grantee has elected to defer the receipt of the Shares or cash issuable pursuant to the Award.
|
(j)
|
Vesting. The Award Agreement will specify the period or periods of Continuous Service necessary before the Award will vest, provided that no Award may vest sooner than the one year anniversary of the date of grant except with respect to (i) Awards to Outside Directors that vest on or about the one year anniversary of the applicable date of grant and the date of the next annual meeting of the Company's stockholders, which vesting date is at least 50 weeks after the date of grant, (ii) Shares delivered in lieu of currently payable cash obligations, (iii) any additional Awards the Administrator may grant, up to a maximum of five percent (5%) of the maximum aggregate number of Shares that may be issued pursuant to the Plan or as otherwise described in this subsection (subject to adjustment under Section 10), or (iv) Awards granted in connection with the assumption, conversion, or in substitution of outstanding awards pursuant to Section 6(d). An Award may provide for the earlier vesting of such an Award in specific circumstances, including (x) in the event of the death or Disability of a Grantee, (y) in the event of the termination of a Grantee's Continuous Service, or (z) in the event of a Corporate Transaction or Related Entity Disposition where either (A) within a specified period the Grantee is involuntarily terminated for reasons other than for cause or terminates his or her employment for good reason or (B) such Awards are not assumed or converted into replacement awards as evidenced in the applicable Award Agreement.
|
(k)
|
Transferability of Awards. Incentive Stock Options may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Grantee, only by the Grantee. Awards other than Incentive Stock Options shall be transferable (i) by will and by the laws of descent and distribution and (ii) during the lifetime of the Grantee, to the extent and in the manner authorized by the Administrator, but only to the extent such transfers are made to family members, to family trusts, to family controlled entities, to charitable organizations, and pursuant to domestic relations orders or agreements, in all cases without payment for such transfers to the Grantee. Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries of the Grantee's Award in the event of the Grantee's death on a beneficiary designation form provided by the Administrator.
|
(l)
|
Time of Granting Awards. The date of grant of an Award shall for all purposes be the date on which the Administrator makes the determination to grant such Award, or such other later date as is determined by the Administrator. Notice of the grant determination shall be given to each Employee, Director or Consultant to whom an Award is so granted within a reasonable time after the date of such grant.
|
(m)
|
Limitation on Outside Director Compensation. Notwithstanding anything to the contrary contained in the Plan, in no event will the value of any Awards granted to any Outside Director in any one calendar year for such service, when added to any cash fees payable to such Outside Director for such service in such calendar year, have an aggregate maximum value (computed as of the date of grant in accordance with applicable financial accounting rules) in excess of $1,000,000 (or, for a non-executive chair of the Board, $1,500,000).
|
7.
|
Award Exercise or Purchase Price, Consideration and Taxes.
|
(a)
|
Exercise or Purchase Price. The exercise or purchase price, if any, for an Award shall be as follows:
|
(i)
|
In the case of an Incentive Stock Option granted to an Employee who, at the time of the grant of such Incentive Stock Option owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price shall be not less than one hundred ten percent (110%) of the Fair Market Value per Share on the date of grant.
|
(ii)
|
In cases other than the case described in the preceding paragraph, the per Share exercise price of an Option or Stock Appreciation Right shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.
|
(iii)
|
In the case of a Restricted Stock, Restricted Stock Unit, or Other Award grant, such price, if any, shall be determined by the Administrator.
|
(iv)
|
Notwithstanding the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(d), above, the exercise or purchase price for the Award shall be determined in accordance with the provisions of the relevant instrument evidencing the agreement to issue such Award.
|
(b)
|
Consideration. Subject to Applicable Laws, the consideration to be paid for the Shares to be issued upon exercise or purchase of an Award including the method of payment, shall be determined by the Administrator (and, in the case of an
|
Lam Research Corporation 2025 Proxy Statement A-7
|
Table of Contents
(i)
|
cash;
|
(ii)
|
check;
|
(iii)
|
surrender of Shares or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require (including withholding of Shares otherwise deliverable upon exercise of the Award) which have a Fair Market Value on the date of surrender or attestation equal to the aggregate exercise price of the Shares as to which said Award shall be exercised (but only to the extent that such exercise of the Award would not result in an accounting compensation charge with respect to the Shares used to pay the exercise price unless otherwise determined by the Administrator);
|
(iv)
|
with respect to Options, payment through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall provide written (or electronic) instructions to a Company designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (B) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the sale transaction;
|
(v)
|
with respect to Options, payment through a "net exercise" such that, without the payment of any funds, the Grantee may exercise the Option and receive the net number of Shares equal to (A) the number of Shares as to which the Option is being exercised, multiplied by (B) a fraction, the numerator of which is the Fair Market Value per Share (on such date as is determined by the Administrator) less the Exercise Price per Share, and the denominator of which is such Fair Market Value per Share (the number of net Shares to be received shall be rounded down to the nearest whole number of Shares); or
|
(vi)
|
any combination of the foregoing methods of payment.
|
(c)
|
Taxes. No Shares shall be delivered under the Plan to any Grantee or other person until such Grantee or other person has made arrangements acceptable to the Administrator for the satisfaction of any foreign, federal, state, or local income and employment tax withholding obligations, including, without limitation, obligations incident to the receipt of Shares. Upon exercise or vesting of an Award, the Company shall withhold or collect from Grantee an amount sufficient to satisfy such tax obligations, including, but not limited to, by surrender of the whole number of Shares covered by the Award sufficient to satisfy the applicable tax withholding obligations incident to the exercise or vesting of an Award. Notwithstanding the foregoing, in no event will the fair market value of the Shares to be withheld or collected for the satisfaction of tax obligations pursuant to this Section 7(c) exceed the minimum amount required to be withheld unless (i) an additional amount can be withheld and not result in adverse accounting consequences and (ii) such additional withholding amount is authorized by the Administrator. The Administrator shall have the sole discretion to establish the terms and conditions applicable to any alternative made available for payment of the required withholding taxes.
|
8.
|
Exercise of Award.
|
(a)
|
Procedure for Exercise; Rights as a Stockholder.
|
(i)
|
Any Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under the terms of the Plan and specified in the Award Agreement.
|
(ii)
|
An Award shall be deemed to be exercised when written or electronic notice of such exercise has been given to the Company or Company designated brokerage firm in accordance with the terms of the Award by the person entitled to exercise the Award and full payment for the Shares with respect to which the Award is exercised has been made, including, to the extent selected, use of the broker-dealer sale and remittance procedure to pay the purchase price as provided in Section 7(b)(iv).
|
(iii)
|
Exercise of Award Following Termination of Continuous Service.
|
A.
|
An Award may not be exercised after the termination date of such Award set forth in the Award Agreement and may be exercised following the termination of a Grantee's Continuous Service only to the extent provided in the Award Agreement.
|
A-8
|
Table of Contents
B.
|
Where the Award Agreement permits a Grantee to exercise an Award following the termination of the Grantee's Continuous Service for a specified period, the Award shall terminate to the extent not exercised on the last day of the specified period or the last day of the original term of the Award, whichever occurs first.
|
C.
|
Any Award designated as an Incentive Stock Option to the extent not exercised within the time permitted by law for the exercise of Incentive Stock Options following the termination of a Grantee's Continuous Service shall convert automatically to a Nonstatutory Stock Option and thereafter shall be exercisable as such to the extent exercisable by its terms for the period specified in the Award Agreement.
|
9.
|
Conditions Upon Issuance of Shares.
|
(a)
|
If at any time the Administrator determines that the delivery of Shares pursuant to the exercise, vesting or any other provision of an Award is or may be unlawful under Applicable Laws, the vesting or right to exercise an Award or to otherwise receive Shares pursuant to the terms of an Award shall be suspended until the Administrator determines that such delivery is lawful and shall be further subject to the approval of counsel for the Company with respect to such compliance. The Company shall have no obligation to effect any registration or qualification of the Shares under federal, state or applicable non-U.S. laws.
|
(b)
|
As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws.
|
10.
|
Adjustments Upon Changes in Capitalization. Subject to any required action by the stockholders of the Company and Section 11 hereof, the number of Shares covered by each outstanding Award, and the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted or which have been returned to the Plan, the exercise or purchase price of each such outstanding Award, the maximum number of Shares with respect to which Awards may be granted to any Grantee in any fiscal year of the Company, as well as any other terms that the Administrator determines require adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Shares, or similar event affecting the Shares, (ii) any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company, or (iii) any other transaction with respect to Common Stock including a corporate merger, consolidation, acquisition of property or stock, separation (including a spin-off or other distribution of stock or property), reorganization, liquidation (whether partial or complete) or any similar transaction; provided, however that conversion of any convertible securities of the Company shall not be deemed to have been "effected without receipt of consideration." In the event of any distribution of cash or other assets to stockholders other than a normal cash dividend, the Administrator shall also make such adjustments as provided in this Section 10 or substitute, exchange or grant Awards to effect such adjustments (collectively "adjustments"). Any such adjustments to outstanding Awards will be effected in a manner that precludes the enlargement of rights and benefits under such Awards. In connection with the foregoing adjustments, the Administrator may, in its discretion, prohibit the exercise of Awards or other issuance of Shares, cash or other consideration pursuant to Awards during certain periods of time. Except as the Administrator determines, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment by reason hereof shall be made with respect to, the number or price of Shares subject to an Award.
|
11.
|
Corporate Transactions and Related Entity Dispositions. Except as may be provided in an Award Agreement:
|
(a)
|
In the event of a Corporate Transaction, any or all outstanding Awards shall be subject to the definitive agreement governing the Corporate Transaction. Such transaction agreement may provide, without limitation and in a manner that is binding on all parties, for (A) the assumption, substitution or replacement with equivalent awards of outstanding Awards (but in each case adjusted to reflect the transaction terms) by the surviving corporation or its parent, (B) continuation of outstanding Awards (but again adjusted to reflect the transaction terms) by the Company if the Company is a surviving corporation, (C) accelerated vesting, or lapse of repurchase rights or forfeiture conditions applicable to, and accelerated expiration or termination of, the outstanding Awards, or (D) settlement of outstanding Awards (including termination thereof) in cash. Except for adjustments to reflect the transaction terms as referenced above or, to the extent any Award or Shares are subject to accelerated vesting or lapse of restrictions approved by the Board or Committee upon specific events or conditions (and then only to the extent such acceleration benefits are reflected in the transaction agreement, the applicable Award Agreement or another written agreement between the Grantee and the Company), any outstanding Awards that are assumed, substituted, replaced with equivalent awards or continued shall continue following the transaction to be subject to the same vesting or other restrictions that applied to the original Award. The Administrator need not adopt the same rules or apply the same treatment for each Award or Grantee.
|
(b)
|
Notwithstanding anything herein to the contrary, in the event of a dissolution or liquidation of the Company, to the extent an Award has not been exercised or the Shares subject thereto have not been issued in full prior to the earlier of the completion of the transaction or the applicable expiration date of the Award, then outstanding Awards shall terminate immediately prior to the transaction.
|
Lam Research Corporation 2025 Proxy Statement A-9
|
Table of Contents
(c)
|
Any Incentive Stock Option accelerated under this Section 11 in connection with a Corporate Transaction or Related Entity Disposition shall remain exercisable as an Incentive Stock Option under the Code only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded. To the extent such dollar limitation is exceeded, the accelerated excess portion of such Option shall be exercisable as a Nonstatutory Stock Option.
|
12.
|
Effective Date and Term of Plan. The Plan shall become effective on November 4, 2025 and shall continue in effect for a term of ten (10) years from its effective date unless sooner terminated or suspended by the Board. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of: (i) the date the Plan is first approved by the Board, or (ii) the date the Plan is approved by the Company's stockholders. Subject to Section 17, below, and Applicable Laws, Awards may be granted under the Plan upon its becoming effective.
|
13.
|
Amendment, Suspension or Termination of the Plan.
|
(a)
|
The Board may at any time amend, suspend or terminate the Plan; provided, however, that no such amendment shall be made without the approval of the Company's stockholders to the extent such approval is required by Applicable Laws, or if such amendment would:
|
(i)
|
lessen the stockholder approval requirements of Section 4(b)(vi) or this Section 13(a), which, except in connection with the adjustments described in Sections 6(d), 10 or 11, are intended to prevent (A) the repricing of "underwater" Options and Stock Appreciation Rights by reducing the exercise price of an Option or Stock Appreciation Right and (B) the cancellation of an Option or Stock Appreciation Right in exchange for cash, another Award, or an Option or Stock Appreciation Right with a lower exercise price;
|
(ii)
|
increase the benefits accrued to participants under the Plan;
|
(iii)
|
increase the number of securities which may be issued under the Plan; or
|
(iv)
|
modify the requirements for participation in the Plan.
|
(b)
|
No Award may be granted during any suspension of the Plan or after termination of the Plan.
|
(c)
|
No suspension or termination of the Plan (including termination of the Plan under Section 11 above) shall adversely affect any rights under Awards already granted to a Grantee which, regardless of any suspension or termination, shall continue to be subject to the terms of the Plan.
|
14.
|
Reservation of Shares.
|
(a)
|
The Company, while the Plan is effective, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.
|
(b)
|
The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company's counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.
|
15.
|
No Effect on Terms of Employment/Consulting Relationship. The Plan shall not confer upon any Grantee any right with respect to the Grantee's Continuous Service, nor shall it interfere in any way with his or her right or the right of the Company or any Related Entity to terminate the Grantee's Continuous Service at any time, with or without cause.
|
16.
|
No Effect on Retirement and Other Benefit Plans. Except as specifically provided in a retirement or other benefit plan of the Company or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or contributions under any retirement plan of the Company or a Related Entity, and shall not affect any benefits under any other benefit plan of any kind or any benefit plan subsequently instituted under which the availability or amount of benefits is related to level of compensation. The Plan is not a "Pension Plan" or "Welfare Plan" under the Employee Retirement Income Security Act of 1974, as amended.
|
17.
|
Stockholder Approval. The grant of Incentive Stock Options under the Plan shall be subject to approval by the stockholders of the Company within twelve (12) months before or after the date the Plan is adopted, excluding Incentive Stock Options issued in substitution for outstanding Incentive Stock Options pursuant to Section 424(a) of the Code. Such stockholder approval shall be obtained in the degree and manner required under Applicable Laws.
|
18.
|
Plan History. On August 26, 2025, the Board adopted the Plan, effective as of the date of stockholder approval, which occurred on [ ], 2025 (the "Effective Date"). No grants will be made under the Prior Plan on or after the Effective Date, except that outstanding awards under the Prior Plan will continue unaffected following the Effective Date and will continue to be subject to the terms of the Prior Plan regardless of the termination of such Prior Plan with regard to new grants.
|
A-10
|
Table of Contents
19.
|
Unfunded Obligation. Grantees shall have the status of general unsecured creditors of the Company. Any amounts payable to Grantees pursuant to the Plan shall be unfunded and unsecured obligations for all purposes, including, without limitation, Title I of the Employee Retirement Income Security Act of 1974, as amended. Neither the Company nor any Related Entity shall be required to segregate any monies from its general funds, or to create any trusts, or establish any special accounts with respect to such obligations. The Company shall retain at all times beneficial ownership of any investments, including trust investments, which the Company may make to fulfill its payment obligations hereunder. Any investments or the creation or maintenance of any trust or any Grantee account shall not create or constitute a trust or fiduciary relationship between the Administrator, the Company or any Related Entity and a Grantee, or otherwise create any vested or beneficial interest in any Grantee or the Grantee's creditors in any assets of the Company or a Related Entity. The Grantees shall have no claim against the Company or any Related Entity for any changes in the value of any assets that may be invested or reinvested by the Company with respect to the Plan.
|
20.
|
Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term "or" is not intended to be exclusive, unless the context clearly requires otherwise.
|
21.
|
Non-exclusivity of the Plan. Neither the adoption of the Plan by the Board, the submission of the Plan to the stockholders of the Company for approval, nor any provision of the Plan will be construed as creating any limitations on the power of the Board or the Compensation Committee of the Board to adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of Awards otherwise than under the Plan, and such arrangements may be either generally applicable or applicable only in specific cases.
|
22.
|
Non-U.S. Grantees. In order to facilitate the making of any grant or combination of grants under this Plan, the Administrator may provide for such special terms for awards to Grantees who are foreign nationals or who are employed by the Company or any Subsidiary or Affiliate outside of the United States of America or who provide services to the Company under an agreement with a foreign nation or agency, as the Administrator may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Administrator may approve such supplements to or amendments, restatements or alternative versions of this Plan (including, without limitation, sub-plans) as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of this Plan as in effect for any other purpose, and the Secretary or other appropriate officer of the Company may certify any such document as having been approved and adopted in the same manner as this Plan. No such special terms, supplements, amendments or restatements, however, will include any provisions that are inconsistent with the terms of this Plan as then in effect unless this Plan could have been amended to eliminate such inconsistency without further approval by the stockholders of the Company.
|
23.
|
Recoupment/Clawback Provisions.
|
(a)
|
Awards issued under the Plan are subject to the terms and conditions of the Lam Research Corporation Policy for the Recovery of Erroneously Awarded Compensation (effective December 1, 2023) and any other clawback provisions, policy or policies (if any) as may be in effect from time to time, including any that specifically implement section 10D of the Exchange Act, and any applicable rules or regulations promulgated thereunder (including applicable rules and regulations of any national securities exchange on which the Shares at any point may be traded) (collectively, the "Clawback Policy"), and applicable sections of any Award Agreement to which the Plan is applicable or any related documents shall be interpreted consistently with (or deemed superseded by and/or subject to, as applicable) the terms and conditions of the Clawback Policy. Further, by accepting any Award under the Plan, each Grantee agrees (or has agreed) to fully cooperate with and assist the Company in connection with any of such Grantee's obligations to the Company pursuant to the Clawback Policy, and agrees (or has agreed) that the Company may enforce its rights under the Clawback Policy through any and all reasonable means permitted under applicable law as it deems necessary or desirable under the Clawback Policy, from and after the effective date thereof. Such cooperation and assistance shall include, but is not limited to, executing, completing and submitting any documentation necessary to facilitate the recovery or recoupment by the Company from such Grantee of any such amounts, including from such Grantee's accounts or from any other compensation, to the extent permissible under Section 409A of the Code.
|
(b)
|
The Administrator may also specify in any Award Agreement that the Grantee's rights, payments, and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture, or recoupment upon the occurrence of certain specified events, including but not limited to, a breach by Grantee of any confidentiality or other restrictive covenants that may apply to Grantee.
|
24.
|
Whistleblower Protection. Notwithstanding anything in the Plan or an Award Agreement to the contrary, (a) nothing in the Plan or in an Award Agreement or otherwise limits a Grantee's right to any monetary award offered by a government-administered whistleblower award program for providing information directly to a government agency (including the Securities and Exchange Commission pursuant to section 21F of the Exchange Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act or The Sarbanes-Oxley Act of 2002); and (b) nothing in the Plan or in an Award Agreement prevents a Grantee from providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise
|
Lam Research Corporation 2025 Proxy Statement A-11
|
Table of Contents
25.
|
Governing Law. To the extent not preempted by federal law, this Plan and the Awards issued hereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to its principles of conflict of laws.
|
26.
|
Compliance with Section 409A of the Code.
|
(a)
|
To the extent applicable, it is intended that this Plan and any grants made hereunder comply with the provisions of Section 409A of the Code, so that the income inclusion provisions of Section 409A(a)(1) of the Code do not apply to the Grantees. This Plan and any grants made hereunder will be administered in a manner consistent with this intent. Any reference in this Plan to Section 409A of the Code will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.
|
(b)
|
Neither a Grantee nor any of a Grantee's creditors or beneficiaries will have the right to subject any deferred compensation (within the meaning of Section 409A of the Code) payable under this Plan and grants hereunder to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment. Except as permitted under Section 409A of the Code, any deferred compensation (within the meaning of Section 409A of the Code) payable to a Grantee or for a Grantee's benefit under this Plan and grants hereunder may not be reduced by, or offset against, any amount owing by a Grantee to the Company or any of its Subsidiaries.
|
(c)
|
If, at the time of a Grantee's separation from service (within the meaning of Section 409A of the Code), (i) the Grantee will be a specified employee (within the meaning of Section 409A of the Code and using the identification methodology selected by the Company from time to time) and (ii) the Company makes a good faith determination that an amount payable hereunder constitutes deferred compensation (within the meaning of Section 409A of the Code) the payment of which is required to be delayed pursuant to the six-month delay rule set forth in Section 409A of the Code in order to avoid taxes or penalties under Section 409A of the Code, then the Company will not pay such amount on the otherwise scheduled payment date but will instead pay it, without interest, on the tenth business day of the seventh month after such separation from service.
|
(d)
|
Notwithstanding any provision of this Plan and grants hereunder to the contrary, in light of the uncertainty with respect to the proper application of Section 409A of the Code, the Company reserves the right to make amendments to this Plan and grants hereunder as the Company deems necessary or desirable to avoid the imposition of taxes or penalties under Section 409A of the Code. In any case, a Grantee will be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on a Grantee or for a Grantee's account in connection with this Plan and grants hereunder (including any taxes and penalties under Section 409A of the Code), and neither the Company nor any of its Subsidiaries or Affiliates will have any obligation to indemnify or otherwise hold a Grantee harmless from any or all of such taxes or penalties.
|
A-12
|
Table of Contents
•
|
for calendar year 2024: amortization related to intangible assets acquired through certain business combinations; elective deferred compensation-related liability increase; restructuring charges, net; transformational costs; and impairment of long-lived assets.
|
•
|
for fiscal year 2025: amortization related to intangible assets acquired through certain business combinations; and elective deferred compensation-related liability increase;
|
•
|
for fiscal year 2024: amortization related to intangible assets acquired through certain business combinations; elective deferred compensation-related liability increase; restructuring charges, net; transformational costs; and impairment of long-lived assets;
|
•
|
for fiscal and calendar year 2023: amortization related to intangible assets acquired through certain business combinations; elective deferred compensation-related liability increase; restructuring charges, net; product rationalization costs; and transformational costs;
|
•
|
for fiscal year 2022: amortization related to intangible assets acquired through certain business combinations; and elective deferred compensation-related liability decrease; and
|
•
|
for fiscal year 2021: amortization related to intangible assets acquired through certain business combinations; elective deferred compensation-related liability increase; and product rationalization costs.
|
Lam Research Corporation 2025 Proxy Statement B-1
|
Table of Contents
|
|
|
|
|
|
|
|
|
Calendar Year
|
|
|
|
|
|
2024
|
|
|
|
U.S. GAAP gross margin
|
|
|
$7,716,298
|
|
|
Pre-tax non-GAAP items:
|
|
|
|
|
|
Amortization related to intangible assets acquired through certain business combinations
|
|
|
12,045
|
|
|
Elective deferred compensation-related liability valuation increase
|
|
|
14,067
|
|
|
Restructuring charges, net
|
|
|
20,478
|
|
|
Transformational costs
|
|
|
38,677
|
|
|
Impairment of long-lived assets
|
|
|
8,705
|
|
|
Non-GAAP gross margin
|
|
|
$7,810,270
|
|
|
U.S. GAAP gross margin as percent of revenue
|
|
|
47.6%
|
|
|
Non-GAAP gross margin as a percent of revenue
|
|
|
48.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
Fiscal Year Ended
|
|
|||||||||||||
|
|
|
June 29, 2025
|
|
|
June 30, 2024
|
|
|
June 25, 2023
|
|
|
June 26, 2022
|
|
|
June 27, 2021
|
|
|
|
U.S. GAAP operating income
|
|
|
$5,900,968
|
|
|
$4,263,913
|
|
|
$5,174,860
|
|
|
$5,381,822
|
|
|
$4,482,023
|
|
|
Pre-tax non-GAAP items:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Amortization related to intangible assets acquired through certain business combinations
|
|
|
13,573
|
|
|
15,428
|
|
|
15,337
|
|
|
51,822
|
|
|
54,152
|
|
|
Elective deferred compensation-related liability valuation increase (decrease)
|
|
|
42,615
|
|
|
61,409
|
|
|
22,087
|
|
|
(35,175)
|
|
|
62,238
|
|
|
Restructuring charges, net
|
|
|
-
|
|
|
61,562
|
|
|
120,316
|
|
|
-
|
|
|
-
|
|
|
Product rationalization costs
|
|
|
-
|
|
|
-
|
|
|
13,522
|
|
|
-
|
|
|
6,200
|
|
|
Transformational costs
|
|
|
-
|
|
|
101,654
|
|
|
9,178
|
|
|
-
|
|
|
-
|
|
|
Impairment of long-lived assets
|
|
|
-
|
|
|
8,705
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Non-GAAP operating income
|
|
|
$5,957,156
|
|
|
$4,512,671
|
|
|
$5,355,300
|
|
|
$5,398,469
|
|
|
$4,604,613
|
|
|
U.S. GAAP operating income as percent of revenue
|
|
|
32.0%
|
|
|
28.6%
|
|
|
29.7%
|
|
|
31.2%
|
|
|
30.6%
|
|
|
Non-GAAP operating income as a percent of revenue
|
|
|
32.3%
|
|
|
30.3%
|
|
|
30.7%
|
|
|
31.3%
|
|
|
31.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B-2
|
Table of Contents
|
|
|
|
|
|
|
|
|
Calendar Year
|
|
|
|
|
|
2024
|
|
|
|
U.S. GAAP operating income
|
|
|
$4,781,753
|
|
|
Pre-tax non-GAAP items:
|
|
|
|
|
|
Amortization related to intangible assets acquired through certain business combinations
|
|
|
14,815
|
|
|
Elective deferred compensation-related liability valuation increase
|
|
|
62,126
|
|
|
Restructuring charges, net
|
|
|
34,956
|
|
|
Transformational costs
|
|
|
64,461
|
|
|
Impairment of long-lived assets
|
|
|
8,705
|
|
|
Non-GAAP operating income
|
|
|
$4,966,816
|
|
|
U.S. GAAP operating income as percent of revenue
|
|
|
29.5%
|
|
|
Non-GAAP operating income as a percent of revenue
|
|
|
30.6%
|
|
|
|
|
|
|
|
Lam Research Corporation 2025 Proxy Statement B-3
|
Table of Contents
Table of Contents